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Summary and Thesis outline 
The present work has been performed under the Erasmus Mundus Doctorate in Membrane 
Engineering (EUDIME) program. The home institute was the Chemical and Environmental 
Engineering Department at the University of Zaragoza, within the Nanostructured Films and 
Particles (NFP) group. The NFP is a member of the Nanoscience Institute of Aragon (INA). 
Two host universities were:  Faculdade de Ciências e Tecnologia at the University Nova de 
Lisboa (Portugal) and Mesoscale Chemical Systems group at the University of Twente (The 
Netherlands). This research has been carried out for approximately 4 years (2013-2017) and it 
was part of the EUDIME (FPA 2011-0014, SGA 2012-1719), which was funded by the 
European Union. 
The target of the research presented in this thesis is a design, development and fabrication 
of a microfluidic device with integrated membrane in the form of a membrane contactor for 
various biological applications. The microfluidic devices are fabricated and tested for 
oxygenation of blood and separation of anaesthetic gas. 
In the first part of the work, the microfluidic system for blood oxygenation, so called lung-
on-a-chip, is introduced. In such system, one chamber is devoted to pure oxygen, and the other 
chamber is designed for blood and they are separated by a dense permeable membrane. 
Computer modelling is performed in order to design the liquid chamber with homogenous 
liquid flow, low pressure drop of the system and low shear stress without compensation of high 
oxygenation. Two different microdevice geometries are proposed: alveolar and meander type 
design with vertical membrane arrangement. Fabricated devices as well as integrated 
membranes are made of PDMS by soft-lithography and their surface is modified in order to 
make them more hydrophilic. The experiments of blood oxygenation are performed and the 
oxygen concentration is measured by an oximeter electrode and compared to the 
mathematically modelled values. The sensitivity analysis of the key parameters and the possible 
improvements of the proposed architectures based on the mathematical simulations are 
presented as well. 
The second part of the thesis, introduces the concept of an alveolar microfluidic device as 
gas-ionic liquid micro-contactor for removal of CO2 from anaesthesia gas, containing Xe. The 
working principle involves the transport of CO2 through a flat PDMS membrane followed by 
the capture and enzymatic bioconversion in the ionic liquid solvent. As proof of concept 
demonstration, simple gas permeability experiments are performed followed by the 
experiments with ionic liquid and ionic liquid with the enzyme.  
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Finally, an alternative concept of a silicon/glass microfluidic device with an integrated 
membrane in the form of a fractal geometry with nanonozzles as pores at the vertices of the 
third-level octahedra for the controlled addition of gaseous species is introduced. Fractal 
geometry, that is a three-dimensional repetitive unit, is fabricated by a combination of 
anisotropic etching of silicon and corner lithography. As a proof of concept, simple gas 
permeation experiments are performed, and the achieved results reveal the potentialities of the 
chip for high temperature gas-liquid contactors. 
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Resumen y Esquema de Tesis 
El objetivo principal de esta tesis es el desarrollo y fabricación de un dispositivo 
microfluídico basado en membranas integradas y el estudio de diversos “contactores de 
membrana” para las diversas aplicaciones biomedicas. Los dispositivos microfluídicos se 
fabricaron y se aplicarón en la oxigenación de la sangre y separación de la mezcla de gas 
anestésico.  
En la primera parte del trabajo, se introduce el dispositivo microfluídico propuesto para 
oxigenación de la sangre, también denominado “lung-on-a-chip”. Este sistema consta de dos 
cámaras independientes, una alimentada con oxígeno puro y otra a la que se bombea sangre, 
separadas por una membrana densa de espesor controlado. El uso de herramientas de 
fluidodinámica computacional y la revisión del estado del arte, ha permitido el diseño de 
microdispositivos que cumplan los requisitos hemodinámicos exigidos en cuanto a distribución 
del flujo de sangre, pérdida de carga y esfuerzo rasante y aseguren una alta velocidad de 
oxigenación por unidad de superficie. A la vista de los resultados de simulación se han fabricado 
microdispositivos con dos geometrías bien diferenciadas: diseño tipo “alveolar” con arreglo 
horizontal de membrana y diseño tipo “meandro” con arreglo vertical de membrana. La 
fabricación de estos microdispositivos y de la membrana densa integrada se ha llevado a cabo 
utilizando herramientas clásicas de microfabricación y PDMS como material. La superficie de 
los microcanales por donde circula la sangre fue modificada para aumentar su hidrofilicidad y 
de este modo reducir la adhesión de las proteínas y minimizar el riesgo de coagulación. Todos 
los microdispositivos fabricados han sido aplicados para oxigenación de sangre de oveja bajo 
condiciones de operación equivalentes que permitieran la comparación de resultados. En 
paralelo, se ha desarrollado un modelo matemático para describir la transferencia de oxígeno 
desde la fase gas a la sangre a través de la membrana permeable de PDMS. Dicho modelo, una 
vez validado con los resultados experimentales obtenidos en los microdispositivos tipo 
“meandro”, ha sido utilizado para realizar un análisis de sensibilidad de parámetros clave como: 
concentración de oxígeno en fase gas, permeación de membrana, ancho de microcanal. Además, 
el modelo matemático se ha utilizado para determinar el impacto que ejerce sobre el 
rendimiento de oxigenación el miniaturizar tanto el microcanal por donde circula la sangre 
como el espesor de la membrana y de este modo identificar arquitecturas mejoradas.  
La segunda parte del trabajo se dedica a la aplicación del dispositivo microfluídico con 
diseño tipo alveolar como contactor de membrana gas- líquido iónico para la separación 
selectiva de CO2 de una mezcla anestésica enriquecida en Xe. En esta aplicación, la cámara del 
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gas es presurizada con una corriente de CO2 o Xe y a la cámara de líquido se bombea la fase 
solvente basada en un líquido iónico. El principio de trabajo se basa en el transporte selectivo 
de CO2 a través de la membrana densa de PDMS seguido de su captura y bioconversión 
catalítica en el seno de un líquido iónico biocompatible (propionato de colina) que alberga la 
enzima anhidrasa carbónica. Los resultados de transporte obtenidos para gases puros han 
demostrado la viabilidad del concepto y su utilidad como plataforma de trabajo de bajo coste 
para un análisis preliminar con distintos solventes de las principales variables operacionales. 
Por último, esta tesis doctoral explora por primera vez el concepto de un dispositivo 
microfluídico construido en Si/vidrio que integra una membrana de SiO2 cuya estructura porosa 
es la impuesta por una geometría fractal en 3D con poros del orden de 100 nm para la 
permeación de gases a su través. La estructura fractal, embebida en un microcanal, se ha 
fabricado combinando la técnica de “corner lithography” y al ataque húmedo anisotrópico del 
Si bajo condiciones controladas. Los chips fabricados se caracterizan por presentar una alta 
relación S/V y un mecanismo de permeación controlado por difusión Knudsen. Las propiedades 
de permeación evaluadas han demostrado la viabilidad del concepto para aplicaciones de 
contacto entre fases a alta temperatura. 
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Esboço de Resumo e Tese 
O objetivo da pesquisa apresentada nesta tese é um projeto, desenvolvimento e fabricação 
de um dispositivo microfluídico com membrana integrada na forma de um contactor de 
membrana para várias aplicações biológicas. Os dispositivos microfluídicos são fabricados e 
testados quanto à oxigenação do sangue e à separação do gás anestésico. 
Na primeira parte do trabalho, o sistema microfluídico para a oxigenação do sangue, 
chamado de lung-on-a-chip, é introduzido. Em tal sistema, uma câmara é dedicada ao oxigênio 
puro e a outra câmara é projetada para o sangue e são separadas por uma membrana permeável 
densa. A modelagem computacional é realizada para projetar a câmara de líquido com fluxo de 
líquido homogêneo, baixa queda de pressão do sistema e baixo esforço de cisalhamento sem 
compensação de alta oxigenação. São propostas duas geometrias de microdispositivo 
diferentes: tipo alveolar e meandro com disposição de membrana vertical. Os dispositivos 
fabricados e as membranas integradas são feitas de PDMS por soft-lithography e sua superfície 
é modificada para torná-las mais hidrofílicas. Os experimentos de oxigenação do sangue são 
realizados e a concentração de oxigênio é medida por um eletrodo de oxímetro e comparada 
aos valores modelados matematicamente. A sensibilidade dos parâmetros e as possíveis 
melhorias das arquiteturas propostas com base nas simulações matemáticas também são 
apresentadas. 
A segunda parte do trabalho é dedicada à aplicação do dispositivo microfluídico com design 
de tipo alveolar como contactor de membrana gás-líquido iônico para a separação seletiva de 
CO2 de uma mistura anestésica enriquecida em Xe. Nesta aplicação, a câmara de gás é 
pressurizada com uma corrente de CO2 ou Xe e a fase solvente baseada em um líquido iônico 
é bombeada para dentro da câmara de líquido. O princípio de funcionamento baseia-se no 
transporte seletivo de CO2 através da membrana densa do PDMS seguido de captura e 
bioconversão catalítica em um líquido iônico biocompatível (propionato de colina) que abrigam 
a enzima anidrase carbônica. Os resultados de transporte obtidos para gases puros 
demonstraram a viabilidade do conceito e sua utilidade como plataforma de trabalho de baixo 
custo para uma análise preliminar com diferentes solventes das principais variáveis 
operacionais. 
Finalmente, esta tese de doutorado explora pela primeira vez o conceito de um dispositivo 
microfluídico construído em Si / vidro que integra uma membrana SiO2 cuja estrutura porosa é 
a imposta por uma geometria fractal em 3D com poros da ordem de 100 nm para a permeação 
de gases através dele. A estrutura fractal, incorporada em um microcanal, foi fabricada 
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combinando a técnica de litografia de canto e o ataque de Si úmido anisotrópico em condições 
controladas. Os chips fabricados são caracterizados por uma alta relação S / V e um mecanismo 
de permeação controlado por difusão Knudsen. As propriedades de permeação avaliadas 
demonstraram a viabilidade do conceito de contato entre as fases em alta temperatura. 
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Samenvatting en omvang van dit Proefschrift 
Het doel van het onderzoek in dit proefschrift is het ontwerpen, ontwikkelen en fabriceren 
van een microfluidisch apparaat met geïntegreerd membraan in de vorm van een membraan 
contactor voor verschillende biologische toepassingen. De microfluidische 
apparaten zijn gefabriceerd en getest voor zuurstofvoorziening van bloed en 
separatie van verdovingsgassen. 
In het eerste deel van dit onderzoek wordt het microfluidische systeem voor 
zuurstofvoorziening van bloed, de zogenoemde lung-on-a-chip, geïntroduceerd. In dit system 
is een kamer gewijd aan pure zuurstof en is een kamer ontworpen voor bloed. Deze kamers zijn 
gescheiden door een dicht, permeabel membraan. Om de vloeistofkamer te 
ontwerpen met een homogene vloeistofstroom, lage drukverschillen en lage 
schuifspanning zonder compenstatie van hoog zuurstofverbruik, is deze eerst gemodelleerd via 
een computerprogramma. Twee verschillende microgeometrieën voor het apparaat worden 
voorgesteld: een alveolaar en een meander type ontwerp met verticaal membraan. Zowel de 
gefabriceerde apparaten als de geïntegreerde membranen zijn gemaakt met soft-lithography 
PDMS waarbij het oppervlak gemodificeerd is om zo een hogere hydrofiliteit to creëren. The 
experimenten met bloedoxygenatie worden uitgevoerd en de zuurstofconcentratie wordt 
gemeten door een oximeter electrode, waarna deze wordt vergeleken met de gesimuleerde 
waarden. De op simatie gebaseerde gevoeligheids- en mogelijke beweging variabelen van de 
voorgestelde ontwerpen worden ook gepresenteerd. 
Het tweede deel van het proefschrift introduceert het concept van een alveolaar 
microfluidisch apparaat als gas-ionische vloeistof contactor voor het verwijderen van CO2 uit 
verdovingsgas dat Xe bevat. Het werkende principe heeft te maken met het transporteren van 
CO2 door een plat PDMS membraan, gevolgd door het opvangen en enzymatisch converteren 
van de CO2 in een vloeibaar oplosmiddel. Als proof of concept demonstratie worden simpele 
gas permeabiliteits experimenten uitgevoerd, gevolgd door experimenten met een ionische 
vloeistof en een ionische vloeistof met het enzym. 
Als laatste wordt een alternatief concept van een microfluïdisch apparaat met geïntegreerd 
membraan in de vorm van fractale geometrie met nanosproeiers als poriën van het derde niveau 
octahedra voor de gecontroleerde toevoeging van een gasvormige stof geïntroduceerd. Fractale 
geometrie, dat wil zeggen een driedimensionale herhaalde vorm, wordt gefabriceerd met een 
combinatie van anisotropische etsen van silicium en hoek lithografie. Als proof of concept 
worden simpele gas permeatie experimenten uitgevoerd. De resultaten van deze experimenten 
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worden vervolgens vergeleken met de resultaten van gas permeatie door een dicht PDMS 
membraan.  
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Chapter I 
 
 
 
Summary 
This chapter introduces the field of membrane integration in microfluidic devices for 
various biomedical applications in the form of a membrane contactor. It demonstrates the 
importance of miniaturization in everyday future utilization. Two main applications involving 
mass transfer between Gas and Liquid phase are described here: blood oxygenation and 
anaesthesia gas recovery. State of the art for the artificial commercially available 
Extracorporeal Membrane Oxygenators as well as lung-on-a-chip under research is presented 
with main milestones up to date. The importance of the liquid side geometry in the microfluidic 
device is introduced. On the other hand, the conventional methods and available solvents for 
carbon dioxide separation from anaesthesia gas together with the G-L membrane contactors 
being under research are introduced.  
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1. Introduction 
1.1. Membrane contactors 
Membrane based operations have the potential to replace conventional energy-intensive 
technologies and provide reliable solutions for sustainable growth [1, 2]. Among those, 
membrane contactors (MC) have experienced increasing interest over the last decade for diverse 
applications, some of them validated at an industrial scale: carbonation of beverages [3], 
degassing of water [4], blood oxygenation [5], solute recovery by liquid-liquid extraction [6], 
membrane emulsification [7], CO2 removal and capture [8, 9], ammonia recovery [10] among 
others. They are considered as an interesting and promising alternative for petrochemical, 
pharmaceutical, chemical, galvanic and agro-food industries both as end-of-pipe technology for 
product recovery in water and gas treatment and as an integrated process solution [11]. 
Although the mass-transfer coefficients achievable in MC systems do not present higher values 
than those obtained with conventional separation methods, MC provides more surface area per 
unit volume than conventional packed towers leading to higher mass transfer rates [1]. In many 
applications, the membrane contactor is not even called a contactor, but it is rather referred to 
the specific functions that it possesses, e.g. blood oxygenator, gas transfer membrane, 
membrane distillation device, membrane gas absorber etc. For some applications, this approach 
was found to be cost effective technology; and was anticipated to replace other conventional 
technologies that may or may not be membrane based [12].  
The conventional membrane contactors are commonly based on microporous membranes, 
which keep two immiscible fluid phases, i.e. liquid-liquid (L-L), gas-liquid (G-L), in contact 
with each other without dispersion. Avoidance of dispersion is of paramount importance to 
facilitate the subsequent isolation of two fluids. Both phases are brought into intimate contact 
at each pore in order to achieve efficient transfer of the solute from one phase to the other; while 
avoiding their mixing at the same time. This means that, unlike conventional dispersed phase 
contactors, the liquid as well as gas flow rates can be varied independently over a wide range 
eliminating the problems of foaming, flooding, channelling, loading and liquid entrainment 
which usually limit both packed tower and mixer-settler performance. Generally, in case of a 
G-L membrane contactor, elevated liquid flow rate results in a reduction of the liquid boundary 
layer and thus it leads to an augment in the flux of the solute to be separated. On the contrary, 
as a general rule, the higher is the liquid flow rate, the higher is the risk of membrane wetting 
which results in an increase of the membrane resistance.  
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Depending on the particular application, porous membranes in the MC module can be 
hydrophilic or hydrophobic. It has to be taken into account that, in both cases the membrane 
acts as a passive barrier and there is no selectivity for the target component. Hydrophobic 
membranes are most commonly made of polymers such as: polypropylene (PP), polyethylene 
(PE), polytetrafluoroethylene (PTFE), poly(tetrafluoroethylene-co-perfluorovinylether (PFA), 
or polyvinylidene fluoride (PVDF). The working principle of hydrophobic microporous 
membranes is based on the natural phenomenon of capillary forces. Therefore, the liquid is 
prevented from entering the micropores due to the surface tension effect, and the membrane is 
gas filled [1, 13]. When hydrophilic membranes are used, the membrane is liquid filled. This 
approach is advantageous only if the reaction between the sorbent solution and sorbate species 
is fast or instantaneous. If this is not the case, it is more beneficial to work with gas-filled 
membrane, in order to reduce the mass-transfer resistance [12]. 
Table 1.1 indicates the advantages and drawbacks of membrane contactor technology in 
comparison to conventional systems. Hollow fibre module is, by far, the most commonly used 
commercially available membrane contactor. It mainly consists of a bundle of fibres closed in 
a hard-shelled jacket. In this MC approach, gas flows into the lumen of the fibres while the 
liquid flows at the shell side. Membrane hollow fibre module systems take advantage of their 
high surface-area-per-unit-volume, and their control of the level of contact and/or mixing 
between two phases. 
Table 1.1 Main advantages and disadvantages of MC with respect to conventional systems 
[1] 
Advantages Disadvantages 
-High interfacial area per volume 
 
-Operative pressures dependent on 
breakthrough ones 
-No dispersion between phases -Additional resistance to mass transfer due to the membrane 
-Wide range of operative flow rates -Shell side bypassing 
-No loading or flooding limitations -Membrane fouling 
-No foaming -Pretreatments to reduce fouling 
-No separation of phases after the operation -Limited lifetime 
-Low-pressure drop  
-Constant interfacial area between phases  
-Flexibility and compactness  
-Reduced size and weight  
-No moving parts  
-Easy scale-up due to a modular design  
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In spite of the fact that most of the membranes used in MC are microporous, the use of dense 
membrane for G-L mass transfer was already reported in the 1960s [14]. Dense polymeric films 
around 100 μm thick, were proposed for wastewater treatment, VOC or artificial gills 
(underwater breathing equipment). Due to the limitations of membrane preparation 
technologies at that time, the thickness of the membrane led to elevated mass transfer resistance. 
Therefore, this idea was abandoned and replaced by porous thin films. Figure 1.1 shows the 
concentration profile of the solute species “A” in the porous (A) and dense (B) membranes in 
the G-L contactor. 
 
Figure 1.1 Concentration profile of the solute species “A” at the G-L interface for membrane contactors based 
on A) porous and B) dense membranes 
The membrane system approach presented in the following sections comprises a dense-
polydimethylsiloxane (PDMS) membrane integrated in the microfluidic device in between two 
fluid microchambers, i.e. gas-liquid. Thanks to miniaturization of the membrane based system, 
high interfacial area per volume of the separation unit is provided, and higher mass transfer 
rates in comparison to the traditional material-agent driven separation processes are expected.  
Dense type membranes were chosen to avoid the risk of bubble creation when dealing with 
blood oxygenation, and to provide selective separation properties for Xe recovery. Furthermore, 
dense membranes ensure no liquid drainage, avoid flooding, and, in general, they are easier to 
handle and integrate when compared to porous counterparts. 
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1.2. Devices for blood oxygenation 
The natural lung exhibits exceptional properties for exchange of gas. It possesses branching 
architecture with alveoli at the end of each airway. Such geometry presents a remarkable 
possibility to connect inspired gas with blood flowing through capillaries. The magnitude of 
oxygen and carbon dioxide exchange depends on the surface area available for gas transfer and 
on the distance between alveolar-capillary channels. The surface area for gas exchange of a 
natural lung is comparable to the surface of a tennis court, 70-100 m2. Moreover, it is packed 
compactly leading to surface area to volume ratio of about 300000 m-1. The thickness of the 
alveolar-capillary membrane is in the range of 0.5 μm, the effective diffusion distance is 1-2 
μm and the gas transfer rate is approximately 200-250 mL·min-1 for O2 in average adult for 
resting levels and 2000 mL·min-1 during exercise [15]. These parameters, among others related 
to blood fluidodynamics, have to be taken into account to design and fabricate an artificial lung.   
The urge of new technologies for blood oxygenation appeared as a result of high morbidity 
caused by pulmonary disorders. Lung diseases are one of the main causes of death. It was 
estimated that in 2015, there would be 3 million deaths globally due to Chronic Obstructive 
Pulmonary Disease (COPD). This results in 5% of all deaths all over the world in that particular 
year [16, 17]. Only in 2010 the total cost of the medical care of COPD was $2.1 trillion 
worldwide making it one of the most economically significant diseases.  It is expected that by 
2030 this amount will be more than double [18]. Lung transplantation is nowadays the only 
available clinical therapy for patients with the end-stage of chronic lung disease. However, the 
regular time that the patients need to wait for the organ transplantation is about 2 years, and 
approximately 10% of them are dying while waiting for the organ to be available [19]. 
Furthermore, the preterm infants who were born younger than 32 weeks are at a high risk of 
suffering from severe respiratory problems. Insufficient respiration in new-borns is a result of 
smaller available surface area for gas exchange or due to the poor diffusion properties of the 
lung’s membrane [20]. The lung transplant cannot be executed due to the fact that implanted 
organs in infants do not grow with them. Mechanical ventilation is commonly used for 
delivering sufficient amount of oxygen; however, for small lung tissue which is under 
development, some serious complications may occur.   
This has established a considerable need for artificial lung technologies in order to support 
gas exchange while waiting for a lung transplant or to improve the quality of life meanwhile 
the lung transplantation is not possible. Such device is also anticipated during the surgical 
operations or the vital organs transplantation where the exchange of gas has to be constantly 
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supported. In case of preterm infants, which cannot be treated with the mechanical ventilation 
or organ transplant, the market opportunities for artificial lung technologies are quite promising. 
1.2.1. Commercially available lung assist devices 
One of the first significant attempts that were executed as a replacement to mechanical 
ventilation during surgical operations was Extracorporeal Membrane Oxygenator (ECMO) 
developed in 1950. The working principle of ECMO was focused on the blood oxygenation 
“out” of the body. Venous blood was withdrawn from the organism and was carried throughout 
the device, next it was oxygenated outside the corpus, and carbon dioxide was removed at the 
same time. Later, the oxygenated blood returned to the systemic circulation [21]. Most of the 
artificial lung oxygenators used nowadays are made of porous hollow fibres bundles inside a 
hard-shelled jacket. Oxygen is carried through the fibres, i.e. lumen side, and it diffuses into 
venous blood which is flowing around the filaments, i.e. shell side (see Figure 1.2).  
 
Figure 1.2 Hollow fibre membrane module. Figure adapted from [6]. The magnification represents the 
additional biocompatible amphiphilic polymer layer added to the ECMO HF of Capiox FX commercial 
oxygenator 
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Such configuration allows a better control of the main parameters governing the mass 
transport of solutes. The membrane is commonly made of microporous polypropylene or 
polymethylpentene; and sometimes is covered with a thin dense layer of a biocompatible 
material. For instance, Terumo company that fabricates CAPIOX blood oxygenators uses 
specific biopassive surface coatings which reduces platelet adhesion and minimizes platelet 
activation. Moreover, the effective surface area of such devices is in the range of 0.5 – 4.5 m2; 
which leads to a surface to volume ratio twenty times lower than of the natural lung. The S/V 
ratio for this hollow fibre membrane module, which varies inversely with the fibre diameter, is 
approximately 15000 m-1[21, 22].  
Table 1.2 shows the list of commercially available membrane oxygenators together with 
their most important parameters. The table is divided into two sections: devices devoted to treat 
neonates and infants, characterized by lower priming volumes but also by lower blood flow 
rate, and the other section focused on the devices dedicated to adults.  
One of the main concerns around ECMO devices is related to the non – physiological blood 
flow pathway which leads to highly unpredictable and uncontrolled behaviour [23-25] and 
complications such as: device clotting, inflammation and haemolysis. Additionally, current 
systems only allow minimal ambulation. Most of the devices possess short life time and can 
support respirational needs only of a patient in rest [26].  
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Table 1.2 Commercially available membrane oxygenators 
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1.3. Microfluidic devices as lung oxygenators-main milestones 
in 21st century 
A biomimetic microfluidic technology has been reported by several authors for the 
application of lung assist device [20, 23, 25, 27-29] and recently reviewed by J. A. Potkay [26]. 
In these microchips blood flows through branched vascular microchannels which are separated 
from flowing oxygen by a gas permeable membrane. Such architecture presents exceptional 
advantages over conventionally used hollow fibre technology. Mainly, due to controlled 
dimensions and shape of vascular channels, the physiologic blood flow can be achieved 
mimicking the natural lung structure and properties. Moreover, such microfluidic devices offer 
an easier access for cellularization which leads to an improved biocompatibility of the material.  
Along the last years, there was a remarkable advancement in the design, fabrication, 
improvement, test and “in vivo” demonstration [29] of the microchips for blood oxygenation. 
The first publications about artificial lungs in the form of a microfluidic device started around 
1970s. Main milestones of the lung oxygenators in the form of a microfluidic device in the 21st 
century include: 1) development of soft-lithography and replica moulding in PDMS, 2) 
computer modelling and parameter study for physiological blood flow, 3) PDMS surface 
modification to avoid blood clotting and haemolysis, 4) liquid chamber architecture and 
membrane material and/or morphology evolution, 5) in-vivo experiments, and 6) microfluidic 
device scale-up. The listed achievements are shown in Figure 1.3. A short discussion about the 
main results and contributions presented by the different groups for these milestones is 
presented below. 
The pioneering group of the modern microfluidic artificial lung is the group of Borenstein 
from Draper Laboratory, Cambridge, MA, USA. In 2002 and 2004, they focused on the 
establishment of silicon micromachining technology for replica moulding of PDMS. Such 
technology allowed to control the geometry and dimensions of the microfluidic platforms. 
Additionally, it was decided to use PDMS for the fabrication of microdevices thanks to its easy 
handling, transparency, low cost, chemical inertia, high oxygen and carbon dioxide 
permeability, non-toxic and non-flammable character, and relative biocompatibility. Such 
fabrication procedure was relatively fast, easy and economical; making the overall process more 
efficient [30, 31]. Nowadays, thanks to the progress of soft lithography, broader variety of 
shapes, depths and lengths can be obtained and controlled at the same time.  
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Figure 1.3 Timeline of the main milestones in the design of a lung oxygenator in the form of a microdevice 
Over the last decade, the same group continued mastering the design and fabrication of a 
lung oxygenator in the form of a microfluidic device by studying the crucial parameters that 
need to be obeyed in order to keep the blood on a physiological level. The parameters were 
defined and the limits were set. The criterion such as shear stress (which should not overcome 
the limit of 6 N/m2), pressure drop (not higher than 20 mmHg) and physiological blood flow 
were taken into account in the design of the artificial lung chip. This guideline was based on 
the behaviour of blood inside the natural human lung (for more explanation of the design 
parameters see section 1.4). Computer modelling was used in order to predict such restrictions 
and to design an architecture which will not overcome such limits but which will ensure high 
level of oxygenation at the same time [30, 31]. Variety of branching human-lung-like 
geometries were obtained with regulated channel depth, width and length [32].  
The next breakthrough was the surface modification. It was noticed that in blood contacting 
applications, the surface of the microfluidic platforms as well as the membranes should be 
haemocompatible, i.e. blood should not react with the surface of the device, hence no blood 
clotting would be observed. In 2002, the group of Borenstein, and in 2009, the group of 
Federspiel from the University of Pittsburgh, independently on each other; attempted to modify 
the surface of PDMS by dynamic cell seeding with immortalized human microvascular 
endothelial cell line. The decrease of blood clotting was confirmed by the experiments of 
measuring pressure drop as a function of liquid flow rate [30, 31, 33]. This was the first time, 
when not only the efficiency in oxygenation was taken into account; but, also the behaviour of 
blood after the experiment that has to come back to the systemic circulation in the body.  
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Along with the improvement of the fabrication procedure and after defining artificial lung 
parameters, variety of different and more sophisticated architectures of the liquid chamber were 
constructed with integrated membranes of various materials and morphologies. The group of 
Vacanti (from the Centre of Regenerative Medicine, Massachusetts General Hospital, USA), 
tested the blood oxygenation in the devices with different membranes such as: porous 
polycarbonate (PC), silicone coated with porous PC, silicone commercial MDX4-4210 
membrane, ultra – thin free-standing membrane (FSM) from tertiary butyl acrylate (tBA) or n-
butyl acrylate (nBA) and composite membrane made of polytetrafluoroethylene (PTFE) and 
poly maleic anhydride (pMA).The oxygen transfer rate obtained for all the membranes at 
various thicknesses was comparable [23, 27]. In 2012, the group of Fusch (from the McMaster 
University, Hamilton, ON, Canada), published the article about different thin PC membranes, 
i.e. 6 μm thick, placed inside the microchip. Two types of PC membranes were examined: with 
0.1 μm and 0.05 μm pore size, respectively. Comparable O2 transfer rate for both thin films was 
obtained confirming that the main transport resistance is due to the liquid phase [20, 28]. 
Therefore, the geometry and dimensions of the liquid chamber were emphasized.  
The group of Potkay (from the Medical Centre, Cleveland, OH, USA), designed a liquid 
chamber with very shallow blood channels, i.e. 20 μm and 10 μm [34]. It was noticed that the 
shallower the blood channels the fastest the oxygenation. Nevertheless, blood chamber width 
should not be decreased too much due to the risk of a high shear stress, elevated pressure drop, 
collapse of a chamber or channel blockage by red blood cells (RBCs). The big milestone in the 
design and fabrication of a liquid chamber for blood oxygenation was the architecture 
constructed by the group of Vacanti which possessed different channel depths along the entire 
structure, i.e. 700 μm to 100 μm. This procedure, significantly decreased pressure drop and 
shear stress along the chamber [35]. Along the years, the fabrication procedure was 
impressively improved. Nowadays, the fabricated devices are not only effective but also the 
risk of membrane deflection, leaking or chamber collapse decreased significantly.    
In 2014, for the first time the in-vivo blood oxygenation experiment was performed. The 
device, designed previously by the group of Fusch [28], was used for the in vitro and in vivo 
oxygenation on a newborn piglet model (≈1.6 kg in weight). The system was optimized for gas 
exchange to raise the O2 saturation in blood from 70% to 100% for extracorporeal blood flow 
of 0.5-4 mL/min per device. Five newborn piglets were studied and the average gas exchange 
for oxygen was 30 mL·min-1·m-2 for an extracorporeal blood flow rate up to 24 mL/min. This 
promising experiment however, did not achieve 100% O2 saturation of blood due to the 
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operational conditions, i.e. short residence time values. It was suggested by the authors that the 
device with higher volume for the liquid chamber, need to be designed and tested [29]. 
Finally, the last milestone up to date is the possibility to scale-up the microfluidic devices 
which increases the throughput and improves the performance. The lung assist device, 
fabricated by the group of Fusch, consisted of  an array of 10 microfluidic single oxygenator 
units (SOUs) made of PDMS and arranged in parallel [29]. In 2015, the group of Reinecke 
(from the University of Freiburg, Germany) stacked 21 layers (10 for blood and 11 for gas) of 
the same device [36] and the group of Borenstein in 2016 stacked 14 layers of the same device 
one above another [37].  In 2017, the group of Potkay presented a new approach  of a 
microfluidic device with a four-layer structure (blood layer/membrane/air layer/capping layer) 
that was assembled by rolling a cylindrical substrate over the patterned PDMS substrate, 
thereby stacking the four layers [38]. This highlighted the straightforward scaling-up when 
dealing with artificial lung microfluidic technology. However, the authors observed some 
obstacles connected with stacking one device onto another. The limitations were mainly 
connected with the interconnections among the platforms and elevated shear stress and pressure 
drop as the number of platforms and connections increased. Moreover, ensuring physiological 
blood flow rate is more challenging in the device made of many layers. 
The “state of the art” of artificial lung microchips still face some challenges related to gas 
exchange efficiency, cardiovascular parameters and coagulation and thrombus inhibition. First 
of all, the oxygen transfer rate has to be similar to the assured by the natural lung; 1.9 mL·kg-
1
·min-1 of O2 at 30 mL·kg-1·min-1 of blood, respectively [20]. Extracorporeal bypassing of the 
systemic circulation at high flow rates could compromise the cardiovascular system, leading to 
the decreased mean systemic arterial pressure, organ perfusion, and increased heart rate, cardiac 
output and energy expenditure. Current applications for extracorporeal membrane oxygenation 
require full-body anticoagulation, which is not feasible for preterm infant population due to the 
risk for intraventricular haemorrhage [29].  
Table 1.3 represents a summary of the microfluidic artificial lungs designed and fabricated 
by some key research groups with the most important parameters and obtained results. The best 
results in terms of the oxygen transfer rate up to date were obtained by the group of Borenstein 
and were in the range of 300 mL·min-1·m-2. The Potkay results are truly outstanding, i.e. 225 
mL·min-1·m-2 as O2 transfer rate with air as a supply gas, thanks to the small blood channels 
depth, i.e. 10 μm. However, such small channels could result in blood clotting and increased 
pressure drop inside the liquid side geometry. 
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Table 1.3 Key research groups and their microfluidic devices for blood oxygenation 
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1.4. Main Design Parameters of Microfluidic Blood 
Oxygenators 
1.4.1. Physiological blood flow, liquid chamber geometry and pressure 
drop 
Natural lung is made of small alveoli at the end of each airway that possesses membrane 
thickness of 0.5 μm (see Figure 1.4). These microchannels are dispersed inside the lung in a 
branching – like conformation. Such architecture results in a high surface area available for 
oxygenation (approximately 70 m2) and physiological as well as homogenous blood flow 
distribution. The branching arrangement of the lung channels obey bifurcation theory 
introduced by Murray in 1926 [39]. In other words, whenever the channel bifurcates or 
trifurcates the width must always be 1/2 or 1/3 of the width of the original main channel so the 
homogenous liquid distribution is kept.  
 
Figure 1.4 Schematic representation of Bronchi, bronchial tree and lungs and gas exchange in the lungs. Figure 
adapted from [40, 41] 
By ensuring laminar flow within the channels, it is simple to keep blood in its physiological 
levels. That is the reason why the liquid chamber geometry is one of the most important 
parameter in the design of the artificial lung chip. Therefore, the shape, depth, width and length 
of the channels are of crucial importance. Moreover, it is important to know what is the blood 
flow in a human body. The heartbeat of a healthy adult is approximately 72 beats/min, the stroke 
volume (which is the amount of blood ejected per beat of the heart) is equal to 2 mL/kg thus 
from the multiplication the blood flow rate is equal to 144 mL/min·kg [20]. 
Additionally, the device must be constructed in a way that the pressure drop across the 
branching architecture does not compromise heart rate and blood pressure. Elevated values of 
ΔP may cause significant obstruction in blood behaviour, such as red blood cells (RBCs) 
deformation or destruction, clotting and channel blockage. Thrombosis, which is defined as the 
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blood clotting formation inside the blood vessel, occurs at the pressure drop higher than 20 
mmHg [32, 34, 35]. Thus, it is of crucial importance not to exceed this value in the design of 
the liquid chamber of the artificial lung.  
Borenstein et al first introduced the importance of a pressure drop across the liquid chamber. 
The configuration of the channels, in order to mimic the branching conformation, was taken 
into consideration as well as the possibility of blood clotting on the surface of non – 
haemocompatible material [30]. This device however, was used only for the monitoring of the 
liquid distribution and not for the blood oxygenation.  
The main platform configurations, for the network architecture presented in the literature 
by different groups are summarized in Figure 1.5 A – E and discussed in detail below. 
Kniazeva et al. fabricated two independent platforms, one dedicated to gas in the form of a 
big, lemon shaped simple chamber, and second platform devoted to liquid in the form of 
bifurcated small channels (see Figure 1.5 A) [32]. The surface area of the membrane for gas 
exchange membrane was equal to 0.85 cm2, depicted in white colour in Figure 1.5 A. The flow 
distribution in the proposed geometry was homogenous and smooth and no channel blockage 
was observed. 
The group of Vacanti attempted to decrease the pressure drop inside the liquid geometry by 
designing and fabricating the chamber with various liquid channel depths within one geometry 
by micro machining technology. In this structure, the deepest channel was in the range of 700 
μm at the inlet and the shallowest one was 100 μm. The gas exchange surface was equal to 6.93 
cm2. It is known that the highest pressure is present at the main inlet of the liquid chamber, thus 
it was decided by the authors to make this channel the deepest one which resulted in a significant 
decrease of a pressure drop (see Figure 1.5 B) [35]. Another geometry presented by the same 
group was simple branching design shown in Figure 1.5 C. The channel depth was constant in 
the whole structure, i.e. 200 μm. The area for oxygen diffusion was significantly higher than in 
other devices and was equal to 18 cm2 [23]. 
In 2011, Potkay et al tried to extremely minimize the liquid channel depth in order to 
maximize the O2 transfer rate. A simple geometry (see Figure 1.5 D) with two types of 
microarchitectures was designed: one with 20 μm and the other with 10 μm liquid channel depth 
and with the gas exchange surface of 2.34 cm2. This obviously increased the oxygen transfer 
rate, although it dramatically elevated pressure drop inside the chamber and decreased the 
maximum liquid flow rate. In case of 0.5 mL/min of a blood flow rate, the pressure drop was 
equal to 190 mmHg and 120 mmHg for 10 μm and 20 μm channel depth, respectively. Such 
high pressure caused several problems: firstly, when some of the channels were blocked, the 
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total surface area available for oxygenation was not used. Moreover, high pressure was 
responsible for RBCs deformation or rupture [34].  
 
Figure 1.5 Microfluidic architectures for blood oxygenation. A) adapted from Kniazeva et al [25, 32], B) 
adapted from Vacanti et al [35], C) adapted from Hoganson et al [23], D) adapted from Potkay et al [34] and E) 
adapted from Fusch et al [20]. 
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The group of Fusch designed also a very simple architecture, see Figure 1.5 E, where 
channel depth was equal to 80 μm and the gas exchange surface area was 15.26 cm2. The 
pressure drop in this architecture was 40-60 mmHg for a liquid flow of 1 – 3 mL/min. The 
chambers were made of PDMS. Four types of membranes were fabricated: dense and porous 
PDMS, and two etched-through nanoporous PC membranes with 50 nm and 100 nm pore size. 
Moreover, the same design was used for device scalling-up and in-vitro experiments [20, 28].  
Figure 1.6 depicts the summary of the exhibited pressure drop values as a function of the 
blood flow rate obtained by some main research groups. 
 
Figure 1.6 Hydraulic losses reported for microfluidic devices. Each curve corresponds to the structure presented 
in Figure 1.5 A-E.  
It was observed by the group of Fusch that lower pressure drop was obtained when PDMS 
membrane was integrated in between the gas and liquid chambers than it was in the case of PC 
membrane (see Figure 1.6). The authors concluded that PC membrane is relatively rigid and 
less elastic than the PDMS membrane, which can expand with pressure. 
As it could be observed from the figure, many groups could achieve high blood flow rates 
(higher than 20 mL/min) however, all the devices crossed the limit of thrombus formation (20 
mmHg). Nevertheless, the group of Fusch (Figure 1.5 E) and Vacanti (Figure 1.5 B) obtained 
the highest blood flow rates and the lowest ΔP (in the range of 30 – 40 mmHg; still over the 
limit) due to the branching architecture of the liquid side as well as due to the various channel 
depths inside the same geometry in case of the design of Vacanti. It is then anticipated that in 
the design of the artificial lung, not only the oxygenation performance will be taken into account 
but also the pressure drop will be considered in order to protect red blood cells.  
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The devices presented above need to be scale-up, since higher membrane area is needed for 
the real application of the oxygenation. On the other hand, it has to be taken into account that 
the priming volume of the device designed for neonates should not exceed 50% of the total 
blood volume (approximately 96 mL/kg). Moreover, the oxygenation parameters for neonates 
should be considered as well. Potkay introduced the term called rated flow (Q) [26] that is the 
maximum blood flow rate at which an inlet blood saturation of 70% can be oxygenated to an 
outlet oxygen saturation of 95%. 
1.4.2. Device “scale up” 
In 2014, the group of Fusch attempted to scale up the microfluidic device for blood 
oxygenation, shown in Figure 1.5 E in section 1.4.1. The lung assist device proposed by the 
group consisted of an array of 10 microfluidic single oxygenator units (SOUs) made of PDMS, 
arranged in parallel and connected by polymeric interconnects leading to a very low total 
priming volume, i.e. 4.8 mL. Each SOU consisted of a vascular network with a thin gas 
exchange membrane of a surface area equal to 18.49 cm2. The microchannels in the vascular 
network were 80 μm in depth and 500 μm in width (see Figure 1.7) [29]. This promising 
experiment did not achieve 100% O2 saturation of blood due to the operational conditions, i.e. 
short residence time values. It was suggested that SOUs with higher volume of the liquid 
chamber need to be designed and tested. Nevertheless, the increase in the O2 transfer rate in 
comparison to the single device designed by this group earlier [20] was visible (see Table 1.3). 
In case of air as a supply gas, the O2 transfer increased by approximately a double in comparison 
to the experiment with a single unit. 
 
Figure 1.7 Liquid chamber geometry and device made of SOUs. Figure adapted from [29] 
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In 2015, Reinecke et al tried to increase the gas transfer by using straight microchannels in 
the blood compartment with a width of 1 mm. The structure for the gas and liquid compartments 
were not prepared by commonly used soft-lithography, but from the steel frames which were 
fabricated by wire electrical discharge machining of precision steel sheets. One layer of the 
blood compartment was made of 40 microchannels with the PDMS membrane thickness of 90 
μm. Both, membrane and gas, liquid chambers were connected by curing a thin PDMS layer. 
The device used for the oxygenation experiments was made of 21 layers (10 for blood and 11 
for gas) and had the membrane surface area of 120 cm2.  Pure O2 was used as the ventilating 
gas. The O2 transfer rate obtained by the authors was equal to 2.5 mL/min.m2 and 1.3 
mL/min.m2 for pure O2 and air as ventilating gas, respectively at a blood flow rate of 5 mL/min 
[36]. These authors obtained significantly lower gas exchange rates in comparison to the other 
groups (see Table 1.3) due to the height of the liquid channels, i.e. 200 μm. It is worthy to 
mention that the group of Vacanti worked with liquid chamber geometry that possessed 200 
μm channel depth as well. This group however, obtained 100 times higher oxygenation [23]. 
This is related to the design of the liquid chamber itself which in case of Reinecke et al did not 
obey the bifurcation guideline and did not possess branching geometry which clearly affected 
the device performance (see Figure 1.8). 
 
Figure 1.8 Schematic representation of the A) microfluidic channels conformation and B) photograph of the 
assembled device. Figure adapted from [36] 
In 2016 the group of Borenstein tried to further develop already existing alveolar structure 
presented earlier (see Figure 1.5 A) [32] by stacking more layers (in this case 14 layers) and by 
increasing the gas exchange area (up to 3.3 cm2). The resulting device could operate in the range 
of high liquid flow rates, i.e. up to 25 mL/min, due to blood flow network size expansion and 
the scaled number of gas transfer modules (see Figure 1.9). Obtained O2 transfer was equal to 
190 mL/min.m2 of 14 layers device and 90 mL/min.m2 of 10 layered device (taking into account 
the footprint of the chip) at liquid flow rate equal to 12 mL/min which is the flow rate at the 
inlet of the entire structure [37].  
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Figure 1.9 Scaled up microfluidic device made of 14 layers. Adapted from [37] 
Finally, in 2017 the group of Potkay presented a new approach of a microfluidic device with 
a four-layer structure (blood layer/membrane/air layer/capping layer) that was assembled by 
rolling a cylindrical substrate over the patterned PDMS substrate, thereby stacking the four 
layers (see Figure 1.10).  
 
Figure 1.10 Design overview of A) top view and B) side view. Adapted from [38] 
The depth of the channels in the presented artificial lung geometry was equal to 10 μm with the 
membrane thickness of 66 μm. Such a configuration resulted in elevated pressure drop, i.e. at 1 
mL/min of blood flow rate, the ΔP was equal to 100 mmHg. The in vitro experiments were 
performed resulting in high gas exchange rates, i.e. 153 mL·min-1·m-2 for O2. Nevertheless, the 
authors found some drawbacks connected with the rolled device conformation. They concluded 
that scaling up the device could be challenging from the fabrication point of view due to the 
number of limitations: 1) the device is made of a single mould thus during scaling up the length 
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of the mould might be too long to manage the fabrication as it is described in the article, 2) as 
devices are scaled up, the number of layers increased and the fluidic interconnections of all the 
layers by a single diameter feedthrough while maintaining physiological shear stress to avoid 
clotting would become more challenging [38]. 
Summarizing, the most outstanding results in terms of blood oxygenation were obtained by 
the group of Borenstein (see Table 1.3) [32]. Even though, the membrane surface area is much 
smaller than for instance in case of the device designed by the group of Fusch (3.3 cm2 vs 18.49 
cm2) the oxygen transfer rate is comparable. This is due to the truly branching architecture and 
imitation of the human lung structure of the design of Borenstein. 
1.4.3. Shear stress in the liquid channels 
Another important parameter influencing the performance of the device and the condition 
of blood is the shear stress. Shear stress, defined as the force exerted on the walls of the 
capillaries for a giving flow rate, depends on the dimensions and the shape of the channel and 
on the roughness of the wall. The maximum value of this force in the arteries is equal to 70 
dynes/cm2; however, platelet activation and subsequent thrombosis, which disturb the blood 
flow through the circulatory system, can start at 60 dynes/cm2 [32]. Therefore, it is desirable 
and beneficial not to exceed this value in the design of the branching architecture of the liquid 
chamber. Small number of research institutes working on the development of the artificial lung 
focused on the control of shear stress up to date. The group of Borenstein emphasized the 
importance of physiological blood flow and the parameters which control it [30]. After some 
years, the group continued targeting the importance of the shear stress and made a computer 
modelling which predicted the value of this force in a given geometry and at a certain inlet 
pressure, i.e. at 80 mmHg the shear stress was equal to 14.5 dynes/cm2 [25].  
As it was mentioned above, Potkay et al designed the structure with very shallow liquid 
chamber (see Figure 1.5 D). The average shear stress did not exceed the limit values: it was 
equal to 2.1 dynes/cm2 and 4.9 dynes/cm2 for 20 μm and 10 μm channel depth respectively and 
at the liquid flow rate equal to 1 mL/min. Although the overall shear stress was still below the 
blood coagulation threshold; the corners of the branching points, where the flow velocity 
undergoes a sudden direction change, are the regions where the maximum shear stress appeared 
[34].  The group of Vacanti obtained the value of a shear stress equal to 57 dynes/cm2 at a liquid 
flow rate of 6 mL/min (see Figure 1.5 C) [23]. 
All the above-mentioned parameters, ΔP and shear stress, depends on blood velocity within 
the channels. Thus, depth, length and shape of the liquid microchannels have to be judiciously 
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chosen to keep the physiological parameters for pressure drop and shear stress, and to ensure 
homogenous liquid flow distribution capable to provide the required O2 transfer rates.  
1.4.4. Haemocompatibility/Biocompatibility of the membrane and 
platform material 
Biomaterial is defined as any material that has been synthesized in order to interact with 
biological systems for medical purposes. The definition of biocompatibility for blood 
contacting biological devices is given by IUPAC: “Biocompatibility is the ability to be in 
contact with a living system without producing an adverse effect” , i.e. uncontrolled activation 
of cells or plasma protein [42]. The International Organization of Standardization (ISO) and 
Food and Drug Administration (FDA) established some rules connected with the 
biocompatibility of a device designed for the blood flowing purposes. For external 
communicating devices where blood is circulating during prolonged time exposure (24 hours-
30 days), the following standards for the materials involved were adopted: 1) haemocompatible, 
that is not causing inappropriate activation or destruction of blood, 2) non irritative nor reactive; 
and 3) it should not cause loss of cells viability [43].  
In artificial lung assist devices, the adhesion of red blood cells is highly undesired to avoid 
membrane fouling and blood channels blockage. The protein adsorption is determined by 
thermodynamic changes within the wall surface-water-protein system. The sorption driving 
force depends on the surface itself (possible redistribution of charged groups) and on the 
potential conformational changes of the proteins [44]. Essentially, biomaterials are divided into 
those with hydrophobic and hydrophilic surfaces, respectively. For protein adsorption, material 
surface has to partially dehydrate which is thermodynamically favourable in case of a 
hydrophobic surface (gain of entropy). In the hydrophilic surfaces, there is a displacement of 
surface-bound water molecules which presents an energy barrier resulting in less protein 
adsorption to hydrophilic material. Moreover, hydrophilic surfaces generally allow reversible 
protein adsorption, due to less protein unfolding (see Figure 1.11) [45, 46]. Fibrinogen, a large 
protein present in blood, has a high affinity to be adsorbed on the hydrophobic, positively 
charged surfaces [47].  
The first scientific research centre which focused on the haemocompatibility of the material 
for artificial lungs was the Draper Laboratory, (Cambridge, MA, USA) lead by J. T. Borenstein. 
At the beginning of the year 2000, the group published an article on the vascularized tissue 
engineering for artificial organs application which was a first small step towards fabricated 
lung. They developed the dynamic cell seeding in order to minimize blood clotting inside the 
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PDMS chambers. The immortalized human microvascular endothelial cell line (HMEC-1) was 
used for the culture seeding in order to increase haemocompatibility. Decrease of blood clotting 
was confirmed by the experiments of measuring pressure drop as a function of liquid flow rate. 
The device could withstand a liquid flow rate up to 12 mL/min without rupturing, cracks and 
leaks [30, 31]. 
 
Figure 1.11 Protein conformation on different types of surfaces. Figure adapted from [48] 
Burgess et al [33] designed and fabricated simple device for blood oxygenation. In this 
article, the authors did not focus on the sophisticated liquid architecture, but rather on the 
haemocompatibility and the performance of the device. The vascular PDMS channels were 
covered with endothelial cells (EC). Briefly, prior to cell seeding, the channels of the device 
were coated with collagen solution in order to facilitate endothelial cells adhesion. The EC was 
added to the vascular network at a concentration of 20 million cells/mL. After 3 hours of the 
incubation, the device was turned upside down in order to ensure cells attachment to the ceiling 
of the device. Cell attachment and viability were monitored using inverted light microscope. 
The authors concluded that the endothelial cells play a crucial role in avoiding the coagulation. 
The experiments of blood perfusion with high amount of anticoagulant inside the bare PDMS 
channels demonstrated that significant thrombus formation was seen in over half of the 
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channels. In contrast, covering blood channels of a microdevice with EC provides the blood 
biocompatibility and allows blood perfusion with minor amount or no anticoagulant [33].  
The use of polyurethane (PU) as a substitute to hydrophobic PDMS was proposed by Wu 
et al [49]. PU has been widely used in various blood-contact applications such as haemodialysis 
membranes, heart valves, artificial heart, and intra-aortic balloons. The authors reported a 
method for fabrication of PU leading to devices with hydrophilic interior surfaces. Additionally, 
attempts were made to diminish protein adsorption. For these purposes, PU was grafted with 
polyethylene oxide (PEO). The hydrophobicity/hydrophilicity was measured by contact angle. 
Unmodified PU was more hydrophilic than PDMS, i.e. contact angle of 63o of PU in 
comparison to 113o of PDMS. Moreover, the fibrinogen adsorption measurements were 
performed, indicating that the protein adsorption decreased by approximately 80% in case of 
PU-PEO surface in comparison to unmodified PU or PDMS  [49].  
The surface of PDMS was also coated with other polymers to avoid clotting of the liquid 
channels. Polyethylene glycol (PEG) is well known for its protein and cell resistant properties. 
It is a linear polymer with repeat unit -CH2-CH2-O- which is considered non-toxic. The 
flexibility and mobility of PEG chains is the mechanism that explains the protein resistance to 
PEG attached to a surface. When the protein is near the PEG modified surface, it compresses 
the flexible PEG chains. This implies the repulsive interaction, i.e. pushing the protein away 
from the surface. Such flexibility is due to the conformational freedom of the -C-C-O- backbone 
of PEG as a result of unrestricted rotation around the C-O bonds. This mechanism is called 
“excluded volume-steric repulsion” (see Figure 1.12) [50, 51]. The pressure drop of the design 
of Potkay, decreased significantly upon PEG coating: at the blood flow rate of 0.4 mL/min the 
ΔP was equal to 6 mmHg in comparison to 190 mmHg before coating, which was a great 
advancement. Moreover, uncoated device could withstand only 150 min of testing on this 
configuration while the PEG coated chips were performing the experiment of more than 240 
min without collapsing [24]. However, such a shallow liquid channel, i.e. 10-20 μm deep, could 
cause a number of problems connected with blood itself. Starting from the modification of 
RBCs (which size is approximately 6-8 μm in diameter) [52, 53], to gradual blocking of the 
smallest channels. In fact, blood was not analysed after the oxygenation experiments in the 
device.  
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Figure 1.12 Excluded volume-steric repulsion. Figure adapted from [51] 
Although tissue engineering has made some significant progress towards creating artificial 
organs, some challenges are identified: 1) the fabricated structures still differs from the native 
vessels, i.e. round vessels and rectangular microfluidic channels, 2) demonstration of long-term 
viability and function of such devices is necessary if clinical applications are considered. 
1.4.5. Gas exchange membrane properties 
The function of the human lung is to provide oxygen and remove carbon dioxide to and out 
of the blood respectively. The parameters discussed above are mainly connected with the 
behaviour of blood while the gas exchange is the parameter which directly influences the 
performance of the artificial lung chip. Oxygen diffuses through the membrane and connects to 
blood first as dissolved oxygen and next it binds to haemoglobin (Hb) creating oxyHb (HbO2) 
(see Figure 1.13).  
 
Figure 1.13 Schematic representation of the gas exchange in the artificial lung 
In the artificial lung assist device, thin film is used as a barrier to avoid direct mixing of 
blood and gas that may result in bubbles formation inside the liquid causing stroke or heart 
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attack after returning to the systemic circulation. Thus, a durable and highly permeable 
membrane, well attached to the gas and liquid chambers and with high gas exchange area is 
crucial for successful operation. In case of porous membrane, blood plasma leakage could 
occur. This would decrease the performance dramatically. Taking all these factors into 
consideration variety of different membrane materials, morphology and thicknesses were 
examined by different research groups.  
Membrane material, morphology and thickness 
It was mentioned that for the lung assist device application the membrane should be non-
toxic and biocompatible. However, it should also possess high oxygen permeability values. The 
most commonly used membrane materials integrated in the microfluidic chip for artificial lung 
applications with their main characteristics are presented in Table 1.4. Out of all the polymers 
presented in the table, the one with the highest oxygen permeability is PDMS. When other 
polymers are employed, the membranes should be porous, so the oxygen will be diffusing 
through these pores. It is also important to notice that the main mass transfer limitations for 
oxygen transport reside in the liquid phase and not in the membrane. Furthermore, this 
resistance becomes controlling when increased channel depth. For this reason, as it will be 
shown below, in most of the cases the increase of the permeance of the membrane is not 
translated into an increase of the oxygen transfer rate due to its relative low contribution to the 
total mass transfer resistance.  
The group of Vacanti focused on identifying the influence of various membrane types on 
the oxygenation process [27, 28]. Initially, two types of membranes were fabricated: ultra-thin 
free-standing membrane (FSM) and composite membrane. The thin film which belonged to 
FSM was: nBA (n-butyl acrylate) with the thickness ranging from 1-5 μm. For composite 
membrane, the PTFE (0.1 μm pore diameter and 20 μm thickness) coated with 0.5, 1, 2, 3 μm 
thick of pMA (poly maleic anhydride) was used. The authors did not notice any significant 
improvement in gas exchange after coating PTFE with pMA with different thicknesses. In this 
publication, the oxygenation experiments were not performed, only the permeability was 
measured (permeability of pMA was 0.3 barrers) [27]. 
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Table 1.4 Main characteristics of the most commonly used membrane materials for artificial 
lung oxygenators 
Material Chemical structure O2 perm [Barrer] 
    Pros Cons Ref 
PDMS 
 
620 
-Optically 
transparent 
-Non-toxic 
-High gas 
permeability 
-Rapid 
prototyping 
-Hydrophobic [54] 
PC 
 
1.4 
-Easy 
moulding 
-Thermo-
forming 
-Brittle 
-Low 
biocompatible 
[55] 
PU 3 
-Less 
hydrophobic 
than PDMS 
-Rapid 
prototyping 
-Easy 
biodegradable 
[56] 
PP 
 
1.2 
-Resistant to 
many 
chemical 
solvents 
-Flexible and 
tough 
-Low energy 
surface 
-Easy 
biodegra-dable 
[55] 
pMA 
 
0.3 
-Flexible and 
tough 
-Hydrophobic 
-Non-stable in 
alkalies 
[27] 
PTFE 
 
4.2 -Non-reactive -Hydrophobic [55] 
The same group also studied different types of membranes inside microfluidic platforms 
made of PDMS. These membranes included: porous polycarbonate control membrane with 1 
μm pore size and 12 μm thickness (8% porosity), silicone membrane coated with porous PC 
(15 μm thick with 3 μm PC coating on the top) and silicone (MDX4-4210) commercial 
membrane 63 μm thick. Obtained results were comparable among all three membranes in case 
of O2 transfer [23]. 
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Wu et al [20] also analysed different morphologies of a PC thin films placed inside the 
microchip. The commercial PC membrane with 6 μm thickness was used. Two types of PC 
membranes were examined: first with 0.1 μm pore size and 4x108 pores/cm2 as pore density; 
and second with 0.05 μm and 6x108 pores/cm2, respectively. The oxygen transfer rate of 
approximately 20 mL/min·m2 was significantly lower in comparison to other leading groups 
due to the usage of air as a supply gas. However, there was no significance difference in gas 
transport due to the implementation of different membranes because the controlling mass 
transfer resistance was located in the liquid side with 80 μm deep channels [20, 28].  
The group of Borenstein focused on the influence of membrane thickness and liquid channel 
depth, rather than on the membrane material or morphology, for the oxygenation. In 2012, they 
published the article where two types of dense PDMS membranes were used in order to be 
integrated in an artificial lung chip. The membranes had two different thicknesses: 30 μm and 
117 μm while the depth of the liquid channels inside the chip was 50 μm or 100 μm. Figure 
1.14 represents the oxygen transfer rates as a function of blood flow rate for two membrane 
thicknesses, i.e. 30 and 117 μm [25, 32]. The performance of both devices at low blood flow 
rates did not change significantly. On the contrary, when increasing blood flow rates, the 
oxygen demand for full oxygenation also increases; and consequently, the relative contribution 
of the membrane resistance to O2 transport. Thus, the lower the membrane thickness, the higher 
PO2 on the membrane wall and the higher driving force for O2 diffusion in the liquid phase. 
Accordingly, the influence of membrane thickness becomes notorious with increasing blood 
flow rates.  
 
Figure 1.14 O2 transfer rate for PDMS membrane with different thicknesses obtained by the group of Borenstein 
[32] 
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The group of Vacanti analysed the influence of the membrane structure, material and 
thickness on the oxygenation performance. MDX4-4210 commercial silicone membrane was 
“sandwiched” in between PDMS microfluidic platforms. Three types of membrane 
configurations were tested: 1) commercial silicon dense membrane, 63 μm thick, 2) commercial 
silicon dense membrane, 3 μm thick, coated by porous PC layer, 15 μm thick, and 3) porous 
PC membrane, 12 μm thick. Figure 1.15 represents the comparison of the experimental values 
of the oxygen transfer rate respectively at various liquid flow rates inside the liquid channels 
with equal depths, i.e. 200 μm [23, 35]. It can be seen that the oxygen transfer did not change 
significantly within the operational window studied due to the large diffusional distances in the 
blood that are controlling. Since the geometry of the liquid chamber and depth of the channels 
were identical in the presented experiments, it can be concluded that the membrane related 
parameters barely affected oxygen exchange rate.  
 
Figure 1.15 O2 transfer rate obtained by the group of Vacanti as a function of the liquid flow rate and various 
membrane thickness, material and morphology 
From the number of articles presented by the various research groups and from Figure 1.14 
and Figure 1.15 it could be concluded that the importance of the individual mass transfer 
resistance of the membrane on the oxygen transport depends on the microfluidic design and 
operational regime. Obviously the thinner the membrane the lower its individual resistance and 
eventually higher oxygen exchange rates could be achieved, especially in case of high liquid 
flow rates. Whenever mass transfer limitations are located in the membrane it is advantageous 
to increase membrane permeance, i.e. lower thickness and/or higher permeability values. This 
should be done without compromising the mechanical stability and durability of the membrane 
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and without changing shear stress (roughness of the membrane surface) in order to increase gas 
exchange.      
1.4.6. Priming volume 
One of the significant obstacles connected with the usage of ECMO, mentioned in section 
1.2.1, was the high priming volume. Blood priming volume is the amount of blood which must 
be withdrawn from the body in order to be oxygenated. In case of adults it might not be a 
significant problem while in case of children or preterm infants this raise to a serious 
complication. The typical ECMOs have priming volumes in the range of 95-310 mL for adults 
and 31-87 mL for infants. The total volume of blood in an adult is around 5 L, thus the priming 
volume in the ECMO device accounts for approximately 5% of the total blood volume. On the 
other hand, the total volume of blood in neonate is about 100 mL/kg, hence the priming volume 
in the ECMO accounts for around 28%. This shows that the amount of blood which is 
withdrawn from the preterm infant body is meaningful. Minimizing the amount of blood which 
is directly exposed to an artificial surface at a given time will lead to an increase of haematocrit 
values, advance patient recovery and reduce post-operative blood transfusions [26]. Therefore, 
the target of the artificial lung assist device is to have a portable system with low priming 
volumes. Priming volumes in microfluidic devices, which considers only a volume of the liquid 
chamber without considering any external piping, are very small, i.e. from 5 to 400 μL, which 
accounts for approximately 1% of the total blood volume of the neonate. Fusch et al, focused 
entirely on designing and fabricating the microdevice exclusively addressed to neonates, i.e. 
with total priming volume of 0.122 mL [20, 28].  
1.5. Other applications of microfluidic artificial lungs 
The design and fabrication of the artificial lung in the form of a microfluidic device do not 
always have to be considered as a self-standing artificial organ and be exclusively devoted to 
blood oxygenation. Nowadays, microfluidic chips are commonly used in drug toxicology as a 
replacement to animal tests or conventional petri dishes taking into account that certain drugs 
can behave differently on a flat two dimensional surface than in a three dimensional human 
capillaries [57, 58]. Microfluidic technology is used to mimic the real structure and properties 
of the target organ. In 2010, Ingber et al developed a multifunctional microdevice that 
reproduced structural, functional and mechanical properties of the human alveolar-capillary 
interface (see Figure 1.16). The PDMS device was fabricated by soft-lithography and a 
membrane with 10 μm thickness was integrated in between the chambers. The membrane was 
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coated with fibronectin, and collagen human pulmonary microvascular endothelial cells were 
cultured on the other side of the membrane. The chambers were 1-2 cm long and they were in 
the form of small reservoirs rather than branching architecture. In this approach, vacuum was 
applied to the gas channel to mimic breathing. Silica nanoparticles, which induce cell toxicity, 
were used for the experiments. A surprising result showed that the breathing movement 
increases the transport of Si NPs from the air to the vascular channel [59, 60]. 
 
Figure 1.16 Biologically inspired design of a human breathing lung-on-a-chip microdevice. Figure adapted from 
[59] 
In 2015, the group of Guenat also published the article about artificial lung for drug 
toxicology application. The alveolar barrier is exposed to different xenobiotics of which some 
portion can enter the bloodstream and can be transported to other organs. The mechanical strain 
can affect the uptake of such molecules significantly. The microfluidic device proposed by the 
group of Guenat was designed to enable the investigations of an influence of breathing 
movements on the uptake of drugs. The microdevice was comprised of the microfluidic chip 
and a pneumatic system to emulate the respiration. The fluidic part consisted of two PDMS 
chambers between which a thin, porous and flexible PDMS membrane was sandwiched and 
bonded. The bottom plate was structured with a cell culture medium reservoir. The pneumatic 
part was made of a 40 μm thin PDMS layer bonded with the actuation plate in which pneumatic 
channels were structured. The porous and flexible PDMS membrane was fabricated by a 
microstructuring-lamination process which gave a final pore of 3 - 8 μm in diameter and 
thickness of 3.5 – 10 μm. Since this device was not focused on the lung transplantation, no 
physiological blood flow had to be controlled. Thus, there was no branching architecture in the 
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liquid geometry, as it was observed in the case of previous authors, but only three liquid 
reservoirs were present (see Figure 1.17). The external force was applied to the device in order 
to mimic natural process of breathing. In order to stretch the membrane at a frequency of 0.2 
Hz, the lung-on-a-chip was connected to an external electro-pneumatic setup. Moreover, the 
cells were seeded on a PDMS membrane: epithelial cells on the apical side and endothelial cells 
on the basal side of the membrane. The permeability experiments were performed. It was 
noticed by the authors that the stretch of the membrane and the dynamic environment increases 
the permeability of small hydrophilic molecules if they are kept in the dynamic mode, i.e. 
breathing imitation. Therefore, it was demonstrated that the mechanical stress significantly 
affects epithelial barrier permeability. Additionally, the metabolic activity of human pulmonary 
alveolar epithelial cells that were cultured in a dynamic mode was found to be higher than that 
of cells cultured in static mode. It was also commented that the breathing “movement” did not 
interfere with the human cells proliferation or cell injury in the first 24 hours [61].  
 
Figure 1.17 Working principle and design of the lung-on-a-chip. The chip is made of (i) fluidic part with 3 
cultural vells, (ii) porous and flexible membrane, (iii) lateral chambers, (iv) micro-diaphragms integrated in the 
pneumatic part, (v) pneumatic microchannels. Figure adapted from reference [61] 
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1.6. Devices for Anaesthetic Gas Separation 
1.6.1. Conventional Anaesthesia Procedure and Commercial Systems 
Anaesthesia is a state of unconsciousness that is used to ensure loss of response to pain or 
muscle relaxation during the surgical operation where the pain would be intolerable for a patient 
or where being awake is strongly precluded. Anaesthesia results from a treatment with several 
anaesthetic agents. Nowadays, commonly used anaesthetic gas mixture for surgical operations 
is composed of: 1) anaesthetic gas, mainly nitrous oxide, 2) oxygen, 3) water vapour and 4) one 
volatile anaesthetic: isoflurane, sevoflurane or desflurane. In this section, the state of the art of 
the conventional anaesthesia procedure and its possible drawbacks are presented. The 
alternatives for controlled anaesthetic gas composition are discussed. Additionally, the desired 
properties for the liquid phase used as separating agent in the G-L absorption process are 
described as well.  
The most commonly used anaesthetic gas for surgical operations is nitrous oxide (N2O). 
The mixture of nitrous oxide (65-70% in the inhaled mixture) and volatile anaesthetic 
compounds, mainly isoflurane (0.2-0.8%), desflurane (<2.5%) and sevoflurane (0.4-1.2%), is 
introduced to the closed breathing system [62]. During the patient’s respiration, the mixture of 
anaesthetic gas and carbon dioxide, as the patient breaths out, is introduced to the closed 
breathing system. Therefore, it is of crucial importance to remove CO2 from the closed circuit.  
In the commonly used anaesthetic closed systems (see Figure 1.18), the anaesthetic mixture 
first flows through the inspiratory part, enters the patient via Y-piece, flows through the 
expiratory breathing system, passes in and out of the reservoir bag where an excess of the gas 
is vented out and passes through a sorbent canister where CO2 is removed. Then, the gas returns 
to the systemic circulation after addition of fresh anaesthetic gas.  
The sorbent canister for separating CO2 from the exhaled gas mixture in a closed – circuit 
technology consists of soda lime in granular form (i.e. Drägersorb® [63]) which has a high 
affinity towards CO2. Soda lime consists mainly of: calcium hydroxide, water, sodium 
hydroxide and potassium hydroxide.  
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Figure 1.18 The circle of a breathing system under anaesthetic gas treatment [64] 
The absorption of CO2 by soda lime occurs as following: 
???(?) → ???(??) CO2 dissolves in water-
slow and rate-determining 
(1) 
???(??) + ???? → ?????? Bicarbonate formation at 
high pH 
(2) 
?????? + ??(??)? → ????? + ??? + ???? Carbonate formation and 
NaOH recovery 
(3) 
These reaction steps emphasize the catalytic role played by sodium hydroxide in elimination 
of carbon dioxide from the rebreathing circuit. As expected, the CO2 sorption recovery is 
limited by the size of the fixed bed canister, i.e. 0.6 L for standard equipment [65]. Even though 
the process is relatively efficient and commonly used, it suffers from a number of problems. 
The canister with caustic material, if allowed to dry up, can produce hydrogen and release heat; 
resulting in an explosion hazard. Moreover, soda lime can react with volatile anaesthetic 
compounds producing toxic side products (e.g. fluoromethyl-1-2,2-difluoro-a-(trifluoromethyl) 
vinyl ether [66] or carbon monoxide [62]) in the gas circuit.  
One of the main concerns related to the use of N2O is the risk of hypoxia. Hypoxia is a 
condition where the body, or a region of the body, does not possess sufficient amount of oxygen 
at the tissue level. When high quantity of nitrous oxide, also called a “third gas effect”, is present 
in the alveoli, O2 and CO2 are diluted by this gas which leads to the decrease of their respective 
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partial pressures resulting in insufficient blood oxygenation [67]. Taking everything into 
consideration, alternative, potent and non-toxic, anaesthetic gas together with non-hazardous 
and more efficient strategies for carbon dioxide separation have to be developed.  
1.6.2. Xenon as an alternative anaesthetic gas 
The properties of xenon as an anaesthetic gas were described for the first time in 1950s. The 
concept was created as a response to a diver’s report where it was claimed that the mixture 
containing Xe in their gas bottles made them suffer from fatigue and debility [67]. In 1946 the 
effect of xenon-oxygen mixture inhalation in mice was firstly reported. The authors noticed that 
this blend possesses narcotic properties and causes dizziness [68]. The first tests involving 
humans were performed in early 1950s. Different mixture ratio, various time exposure and 
distinct Xe concentration were inspected in order to observe the effect on human body. The 
obtained results were compared to commonly used nitrous oxide and it was concluded that 
xenon is more potent and less toxic than N2O. 
Xenon is defined as a gas which possesses a number of characteristics making it a perfect 
anaesthetic compound. It is haemodynamically stable which results in lack of cardiac 
depression and supress of catecholamine neuromodulator responses. Xe possesses low 
solubility in liquids, thus the risk of hypoxia is greatly reduced. Additionally, it produces high 
regional blood flow, which is clearly advantageous because hypoxia may result from the 
problems with blood flow to the end tissue causing insufficient oxygenation [69]. The minimum 
alveolar concentration (MAC) of xenon is 71%, indicating that it is more potent than N2O 
(approximately 100% of MAC) and the recovery of a patient is faster in that case. MAC is the 
concentration (normally expressed in %) of the anaesthetic compound in the gas phase that 
surrounds the alveoli which is needed to obtain anaesthetic effect [62]. Xe is particularly 
attractive for neonates as it increases neuroprotection. The neuroprotective features of xenon 
are based on its binding properties to glycine side of glutamatergic N-methyl-D-aspartate 
(NMDA) receptor which results in blocking it and inhibiting the excitotoxic pathways. NMDA 
is an ionotropic receptor that is activated by binding of glutamate. The prolonged and excessive 
activation of this receptor causes neuronal death [70]. Furthermore, xenon is non-flammable 
and non-toxic in comparison to nitrous oxide based anaesthesia. When compared to isoflurane 
containing anaesthetic gas, Xe is more environmental friendly [67, 71] as it does not exhibit 
ozone depleting potential. It was internationally agreed that the manufacture of this volatile 
compounds will be totally forbidden by the year 2030. Moreover, N2O is a potent greenhouse 
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gas and its release contributes to approximately 0.1% of the whole global warming. The lifetime 
of N2O in the atmosphere is around 120 years [71].  
Taking into consideration all the advantages of Xe it might be puzzling why it is not 
commonly used as an anaesthetic gas. The reason is its price. Xenon is far more expensive than 
commonly used nitrous oxide. As a noble gas, it is found in the air in small concentration (87 
ppb). Therefore, the only meaningful amount of this gas can be obtained by its separation. Xe 
is manufactured by cryogenic-distillation of liquefied air and after some separation processes it 
is possible to obtain approximately 99.995% of pure Xe with energy production costs around 
17740 kJ/mol [69]. The gas mixture exhaled from the patient during the surgical operation, 
where xenon is used as an anaesthetic gas, consists mainly of Xe (≈65%), O2 (≈27%), N2 (3.3%) 
and CO2 (5%) [62]. Hence, recycling of Xe from the anaesthetic exhaled gas rather than wasting 
it to the atmosphere is the only way to ensure sustainable xenon production. Herein, the main 
technological challenge is the on-line removal of CO2 from anaesthetic closed circuits from 5% 
down to 0.5%. 
1.7. Membrane Contactors for Anaesthesia Gas recovery 
Membrane contactors are considered as one of the most promising process intensification 
strategies with devices being possibly between 5 and 20 times smaller than conventional 
separation processes units [14]. In this section, we will particularly focus on the G-L membrane 
contactor for anaesthesia gas recovery by CO2 separation. A few numbers of manuscripts on 
non-porous membrane contactors have been published in recent years; and most of them deal 
with MEA-based absorbents [3, 10, 72]. In this section, the available liquid solvents for CO2 
capture are discussed and recent examples of membrane contactors for anaesthesia gas recovery 
are described.  
1.7.1. Liquid phase for CO2 absorption in the G-L membrane contactor 
The liquid phase for anaesthetic gas recovery should possess high affinity towards CO2 but 
no or less interaction with Xe. When aqueous solution is used as a liquid phase for CO2 
absorption, the bicarbonate is produced in the reaction of hydroxylation [73]. 
“Conventional solvents” for CO2 absorption 
The, so called “conventional solvents”, which are well-known solvents that present high 
CO2 sorption capacity, were commercialized in 1930s. They can be divided into physical and 
chemical solvents. The physical solvents absorb CO2 from the feed gas at high pressures, i.e. 
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one of the physical solvent, Selexol, absorbs CO2 in the pressure of 2.07 to 13.8 MPa [74]. In 
this process, no chemical reaction is involved in the gas absorption but rather physical 
conditions such as pressure and temperature are considered. The capacity of physical solvents 
at low pressure decreases and they have to be replaced by chemical absorbers. 
The catalysis of the acid-base reactions in the proximity of the liquid-gas interface in the 
chemical solvent enhances the absorption rate in comparison to the absorption of CO2 in water 
[73]. The aqueous amine solution is used in order to capture CO2 by chemical absorption 
process in which the carbon dioxide reacts with the amine in the form of a carbamate through 
a zwitterion mechanism (see reaction (4)). Table 1.5 shows main characteristics of some 
common chemical absorbents based on ethanolamines: -OH group to reduce vapour pressure 
and increase CO2 solubility; and -NH2 for the acid-base reaction, i.e. secondary and tertiary 
amines [75].  
 
(4) 
 
Table 1.5 Characteristic properties of some representative CO2 chemical solvents  
Absorbent Vapour pressure (25oC) [Pa] 
Heat of reaction for 
CO2 [kJ/kg] 
XCO2 
 
[mol/mol]* 
MEA1) <133 1920 0.50 
DEA2) <1.33 1510 0.32 
DIPA3) 9300 2180 - 
MDEA4) 1 1420 0.12 
1)Monoethanolamine, 2) Diethanolamine, 3) Diisopropylamine, 4) Methyldiethanolamine; *indicates moles of 
sour gas per mole of amine for solutions with 1.3 mole of amine per kilogram of water [76] 
 
Even though amines are very effective in CO2 capture due to high absorbing capacity, high 
reactivity and selectivity with CO2, there are some severe disadvantages, i.e. emission of toxic 
compounds, high vapour pressure, elevated desorption and recycling costs due to high reaction 
heat. In general, due to its volatility, large amounts of organic amines are present in clean gas 
which could potentially lead to the formation of dangerous secondary components, i.e. 
nitrosamines, amides and nitramines, and require additional water washing steps that can 
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increase the cost of the overall capture process. Accordingly, alternative type of solvents and 
technologies for a more efficient CO2 separation need to be implemented. 
Ionic liquids for CO2 absorption 
Ionic liquids (ILs) are defined as salts comprised of exclusively organic cations and 
organic/inorganic anions with a melting point lower than 100oC. These emerging class of novel 
materials are becoming extremely popular due to their remarkable properties, such as: high 
thermal and chemical stability, nearly negligible volatility, nonflammability, solvation 
properties and CO2 solubility [74, 77].  
It was described by several authors that ionic liquids are capable for both physical and 
chemical CO2 absorption [74, 75]. The physical absorption occurs where CO2 occupies the “free 
space” within the IL structure through Van der Waals forces. However, the solubility of carbon 
dioxide cannot be entirely explained by the anion-CO2 interaction. A free volume mechanism 
is another factor which plays a significant role. Basically, by increasing the free volume, molar 
volume and alkyl chain length, the carbon dioxide solubility raises as well. This effect correlates 
well with the elevated volume available for CO2 interaction [14, 74, 75, 78, 79]. Opposite to 
the solubility dependence, the diffusion coefficient decreases with the augment of the molar 
volume [80].   
On the other hand, the chemical CO2 absorption relies on acid-base interactions. The 
spectroscopic data obtained by Kazarian et al [81] revealed that this interaction is a Lewis acid-
base type, where the anion, considered as the key player, acts as a Lewis base and CO2 plays as 
a Lewis acid. 
One of the most widely investigated and reported in the literature ionic liquid family is the 
imidazolium type due to relatively large CO2 solubility. For instance, in 1-ethyl-3-
methylimidazolium bis(trifluoromethylsulfonyl)imide, [emim][Tf2N], the molar fraction of 
CO2 dissolved is 0.209 at 298.15 K and 9.03 bar [75, 82]. Table 1.6 shows CO2 solubility data 
for few examples of commonly used ILs. The ionic liquids are comparable in efficiency for 
CO2 capture to commercial amine solvents but at the same time are non-volatile, non-toxic and 
do not need water for the reaction to occur.  
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Table 1.6 CO2 solubility data for imidazolium-based ionic liquids [75] 
Ionic liquid Acronym T [K] P [bar] 
XCO2 
[mol/mol] 
1-buty-3-methylimidazolium 
tetrafluoroborate 
[bmim][BF4] 303 10 0.1461 
1-butyl-3-methylimidazolium 
hexafluorophosphate 
[bmim][PF6] 303 10 0.1662 
1-ethyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide 
[emim][Tf2N] 298 9.03 0.209 
1-hexyl-3-methylimidazolium 
bis(trifluoromethylsulfonyl)imide 
[hmim][Tf2N] 298.1 19.74 0.4330 
Even tough, the imidazolium based ILs possessed high affinity to CO2, the biodegradability 
obstacle appeared. The group of Scammells was the first one which reported poor 
biodegradability of widely used imidazolium based ILs [83]. The importance of toxicity and 
biodegradability should not be forgotten. Garcia et al evaluated the biodegradability of 
[bmim][X], where X corresponds to: Br, BF4, PF6, TF2N, DCA, and octylsulphate [OS]. The 
authors observed that only octysulphate was biodegraded in 25%, while all the other ILs 
followed the biodegradation of only 5%. Hence, these ILs could not be classified as “readily 
biodegradable” [84]. Doherty et al investigated the biodegradability of six imidazolium and 
pyridinium based ILs, all containing [Br] anion as the counterion. A longer alkyl chain seems 
to promote biodegradation in many cases. With the exception of pyridinium IL with the longest 
alkyl chain, none of the tested ILs could be classified readily biodegradable [85]. On the 
contrary, cholinium based ILs shown biodegradable character [86]. In summary, pyridinium 
and cholinium ILs are more biodegradable than imidazolium and phosphonium counterparts. 
These biodegradable, biocompatible and environmental-friendly ILs are synthesized by 
naturally-derived materials such as sugars and aminoacids and are gaining increasing 
importance since last decade.   
Cholinium cations are quaternary ammonium cations ([N,N,N - 
trimethylethanolammonium]+) fully derived from natural products [87, 88]. It was shown that 
the cholinium cations combined with a range of alkanoate anions or amino acids provides a 
media where living cells can actively grow [89, 90]. Moreover, they show high CO2 capturing 
effect due to absorption plus chemical reaction that take place thanks to their ammonium cations 
[91]. Table 1.7 shows solubility data for CO2 in case of three most commonly used cholinium 
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based ionic liquids. Furthermore, this novel class of ILs may provide an optimum media to 
stabilize proteins (i.e. enzyme) [92] which is of our interest for the increase in CO2 capturing 
effect. 
Table 1.7 CO2 Solubility data for three common cholinium-based ILs [87] 
Ionic Liquid Molecular 
structure T [K] P [bar] XCO2*[mol/mol] 
[Cho][Acetate] 
 
303 10 0.085 
[Cho][Propionate] 
 
303 10 0.152 
[Cho][Hexanoate] 
 
303 10 0.444 
* The measurements were performed for ILs at water activity of 0.753   
Taking everything into consideration, cholinium based ionic liquids demonstrate 
comparable carbon dioxide solubility to imidazolium based ILs and commercial chemical 
solvents. In addition, cholinium based ILs are biodegradable and possess appropriate 
environment to be combined with the enzyme in order to increase the CO2 capturing effect. 
Carbonic Anhydrase Enzyme 
The ability of Carbonic Anhydrase (CA) to catalyse CO2 hydration, as well as its reverse 
reaction is well known [93]. Carbonic Anhydrase is a naturally occurring thermoresistant 
metalloenzyme that works as a catalyst for the conversion of CO2 into bicarbonate (HCO3-) at 
extremely high turnover rates. It regulates important biological processes within humans and 
other living organisms such as the acid–base balance within the blood [94], the photosynthesis 
mechanism in plants and the carbon concentration mechanism in microorganisms [63]. The 
most commonly investigated class of CA is the ? form [95] which is generally found in 
mammals. In ?-CA, the enzyme activity is derived from a Zn2+ ion that is coordinated to three 
histidine residues near the centre of the molecule in a cone-shaped cavity (see Figure 1.19).  
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Figure 1.19 3D diagram of α-carbonic anhydrase structure. Active site zinc ion is shown as green space-filled 
sphere [96] 
The hydration of CO2 occurs when the Zn2+ ion abstracts a proton from a surrounding water 
molecule, creating a hydroxide ion that is negatively charged. Such active site consists of a 
specificity pocket for CO2. Thus, the first step of the enzyme catalytic pathway is the 
nucleophilic attack on carbon dioxide molecule by zinc-bounded hydroxyl group, giving rise to 
the formation of the enzyme-bicarbonate ion complex. The reaction mechanism can be 
summarized as follows: 
???? + ??? ↔ ?? + ???? − ??? (5) ???? − ??? + ??? ↔ ???? + ????? (6) 
 
The bicarbonate ion is easily released by the displacement of a water molecule that binds 
the zinc at the active site followed by the intramolecular proton transfer to imidazole group of 
the histidine group to restore the active site form zinc-bounded hydroxyl group. Figure 1.20 
demonstrates the CA catalytic mechanism for CO2 reversible hydration.  
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Figure 1.20 Catalytic mechanism of carbonic anhydrase active site during reversible hydration of carbon 
dioxide. Adapted from reference [73] 
Martins et al measured the influence of CA at low concentration (0.01% w/w) combined 
with cholinium priopionate IL on the CO2 transport and removal. As it was already explained 
above, water content is an important parameter on enzyme activity and stability. Therefore, by 
a proper selection of the working conditions, i.e. mainly water activity 0.753 for the IL; these 
authors found that supported liquid membrane contactor enhanced the CO2 capture by 63% [87, 
97].  
1.7.2. Membranes for G-L membrane contactors for anaesthesia gas 
recovery 
Mendes et al proposed commercial carbon molecular sieve (CMS) hollow fibres [98] and 
flat sheet porous membranes [62] for on-line removal of CO2 and N2 from anaesthetic closed 
circuits using diamine as CO2 solvent. High permeabilities (up to 111.4 Barrer for CO2 and 0.03 
Barrer for Xe) and ideal selectivities for CO2/Xe (up to 6020) and N2/Xe (up to 180) were 
obtained. On the other hand, the separation performance with real multicomponent mixtures 
was adversely affected by Xe. This molecule, with kinetic diameter of 4.04 Å, is able to block 
the pores close to the CMS membrane surface (with diameters in the range of 3-5 Å) hindering 
the diffusion of other species. 
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The group of Yong et al (2016) used hollow fibre membrane contactor in order to separate 
CO2 from the stream gas using potassium carbonate solution [99]. The authors propose the 
coating of the membrane surface, non-porous polydimethylsiloxane-polysulfone (PDMS-PS) 
or porous polypropylene (PP), with carbonic anhydrase enzyme by layer-by-layer (LbL) 
technique to: i) increase mass transfer rates due to the reduction in pore wetting by the adsorbed 
polyelectrolytes; ii) to promote the CO2 absorption kinetics into K2CO3. However, a slight loss 
in enzyme activity due to immobilization was observed even during the short term kinetic 
studies.  
The catalytic activity of CA for the integrated CO2 capture and enzymatic bioconversion 
has been preliminary tested by Neves et al who evaluated pure gas permeability values in 
supported IL membranes. Commercial hydrophobic porous membrane made of polyvinylidene 
fluoride (PVDF) was used as a support for the immobilization of CO2 solvents, i.e. polyethylene 
glycol (PEG) 300 and 1-butyl-3-methylimidazolium bis(trifluoromethanesulfonyl) imide 
[bmim][Tf2N] ionic liquid [97]. The CO2 solubility increased between 20% and 30%, even at 
low CA enzyme concentration (0.01% w/w) due to the chemical reaction enhancement factor.  
A similar G-L membrane contactor has been postulated by Chabanon et al [14] for the 
maximized mass transfer performances of gas-liquid separations application involving physical 
solvents and ionic liquids. This particular solution, to wetting prevention on hydrophilic 
microporous membranes, simultaneously offers acceptable mass transfer performance due to 
the larger viscosity and the lower overall gas-liquid mass transfer coefficients of solvents with 
extremely low breakthrough pressure. In addition to the above-mentioned advantages, the use 
of a non-porous thin composite membrane can also be an optimal solution to reduce the solvent 
evaporation towards the gas phase, thus allowing the use of absorbents with better energy 
performance but cannot be used in absorption columns due to their high volatility. This idea 
has been recently explored for volatile-amine based absorbents on Teflon AF2400 self-standing 
membranes (10-20 μm thick) [72]. 
The G-L membrane contactor scheme herein studied for anaesthesia gas recovery is shown 
in Figure 1.21. Our concept, based on non-porous membrane for anaesthesia gas recovery by 
CO2 absorption on cholinium based ionic liquids in presence of CA enzyme, has to address the 
main following issues: 
- Reduce the membrane mass transfer resistance to fully exploit the advantageous effect 
of the CO2 enzymatic reaction in the liquid phase: highly permeable self-standing dense 
membranes, i.e. high permeability values and/or low membrane thickness are required. 
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- Use biocompatible solvents and materials capable to withstand the chemically reactive 
environment of the liquid phase. 
 
 
Figure 1.21 Graphical representation of the self-standing dense membrane for anaesthesia gas removal 
1.8. Goals of the thesis 
The target of the research presented in this thesis is the design, development, fabrication 
and validation of microfluidic devices with integrated membrane in the form of a membrane 
contactor for various biomedical applications. The microfluidic system for blood oxygenation, 
so called lung-on-a-chip, is the first considered application. An implantable lung assist device 
would augment lung function as a bridge to transplant or possible destination therapy or it 
would serve as an artificial lung in case of neonates with not fully developed natural lung tissue. 
This thesis intends to improve already existing study on microfluidic lung oxygenators both 
theoretically and experimentally, with particular emphasis on the following aspects:  
• Providing high blood oxygenation for neonates, i.e. from 80% to 95% O2, in the 
fabricated microdevices  
• Optimization of the liquid side architecture of the microdevice to decrease pressure 
drop inside the channels (adding liquid flow distributors, changing the dimensions 
etc.), while maintaining high degree of oxygenation 
• Assurance of blood physiological conditions inside the proposed microfluidic 
geometries  
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• Theoretical study of the influence of the oxygen concentration profile along the 
liquid chamber geometry and as a function of the channel architecture to drive the 
design of microfluidic chips with enhanced performance 
Chapter 3 introduces the concept of an alveolar microfluidic device as gas-ionic liquid 
contactor for removal of CO2 from anaesthesia gas, containing Xe. Xenon, which is used as an 
alternative green anaesthetic gas, has to be separated from CO2 which is exhaled by a patient 
during the surgical operation. The present work pursues the proof of concept validation of a 
PDMS based microfluidic device as a gas-liquid contactor, with cholinium propionate and 
carbonic anhydrase (CA) enzyme as a liquid phase, for the removal of CO2 from Xe anaesthetic 
gas. A priori, the high gas permeability values of dense free standing PDMS membranes allows 
to fully exploit the advantageous effect of the CO2 enzymatic reaction in the liquid phase. In 
addition, due to miniaturization, the volume of ionic liquid required to fill the micro-chamber 
and the amount of CA are notably reduced while providing high throughput for the preliminary 
screening of different ionic liquid-enzyme formulations at several working conditions. Such 
hypothesis was confirmed by the following tasks: 
• Design and fabrication of a polymeric membrane and a microfluidic device with 
different geometries depending on the chamber purpose (liquid or gas) 
• Characterization of the fabricated chip in terms of leaks, membrane detachment and 
maximum tolerable pressure for its validation as G-L contactor 
• Determination of the single gas permeability values of free standing membrane 
• Evaluation of the G-L microcontactor performance for CO2 capture due to the 
presence of CP solvent flowing in the liquid chamber and the use of CA to accelerate 
CO2 transport 
Finally, this study also seeks an alternative silicon/glass microdevice for gas permeation. 
The novel concept of a microfluidic chip with an integrated membrane in the form of a three-
dimensional fractal geometry with nanopores which acts as a gas transport membrane is 
presented and is tested for simple gas permeation.  
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In this chapter, the microfluidic device used as a gas-liquid contactor for blood oxygenation in 
preterm infants is proposed. The design criteria for the fabricated devices was to increase the 
oxygen saturation level while ensuring the physiological blood conditions. Two different liquid 
chamber geometries are studied: 1) alveolar type architecture with horizontal membrane 
arrangement and 2) meander type architecture with vertical membrane arrangement. The 
selection of the geometric parameters, upon analysis of the fluiddynamics by computer 
modelling of the two architectures and fabrication procedures are described in detail in the 
following sections. The experimental system, working conditions and calculations are 
presented and discussed as well. A mathematical description of the oxygen transfer process has 
been successfully performed. Finally, a parameter sensitivity analysis is carried out to settle 
the guidelines for future developments.  
 
 
 
 
This chapter is in preparation for publication: 
Malankowska, M., Julian, I., Pellejero, I., Rho, H., Tiggelaar, R., Pina, P., Mallada, R., 
Gardeniers, H. 
“Understanding of blood oxygenation in a microfluidic meander double side membrane 
contactor”
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2. Microfluidic devices for blood oxygenation 
2.1. Objective 
A biomimetic microfluidic technology for the application of artificial organs, especially 
artificial lungs, has been reported previously by several authors [20, 28, 29, 100-102]. In these 
microchips blood flows through branched vascular microchannels which mimic the alveolar 
architecture of a human lung. The oxygen transfer from the gas phase to the blood involves 
pure oxygen transport through a polymeric dense membrane, diffusion into blood plasma, 
followed by oxygen binding to haemoglobin. In this work, two different chip conformations 
and liquid chamber geometries are presented. The main objective of the fabricated devices is to 
increase the oxygen saturation level while ensuring the physiological blood flow in order to 
avoid thrombus formation and channel blockage.  
2.2. Design of microfluidic devices based on fluiddynamics 
In order to design an artificial lung device, that will oxygenate blood, embrace its 
physiological behaviour, and identify devices operational limitations, the mathematical 
modelling was performed. The fluiddynamics modelling was carried out in COMSOL 
Multiphysics 5.0 software. It is one of the most inclusive software used for the CFD 
computation due to its wide range of applications. It possesses relatively straightforward user 
interface and allows customizing the model. Additionally, it is compatible with AutoCAD and 
CleWin softwares that facilitate importing of complicated geometries. 
2.2.1. Mathematical model 
Laminar flow physics adapted for blood inside the liquid chamber geometry was used to 
describe the liquid flow along the microchannels. The momentum conservation for laminar flow 
of incompressible fluids (Equation 2.1) together with the mass conservation (Equation 2.2), i.e. 
Navier-Stokes equations, were solved:  
?(? ∙ ∇)? = ∇ ∙ ?−?? + ?(∇? + (∇?)?) − 23 ?(∇ ∙ ?)?? + ? (2.1) ∇ ∙ (??) = 0 (2.2) 
Where, ρ is the blood density (1060 kg/m3), u stands for the flow velocity vector field, p is the 
pressure, μ is the blood viscosity (0.0035 Pa·s), superscript T is transposed of a matrix, and F 
is a source term. 
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In equation 2.1 the terms on the left side are acceleration forces, and on the right side, there are 
pressure gradient and viscous forces. Following assumptions have been made: 
1. No slip conditions on the walls of the liquid chamber geometry, u = 0 
2. No back-flow permitted 
3. The flow direction was defined as normal to the chamber inlet and outlet 
4. The outlet pressure was set as the atmospheric value 
The set of governing equations was solved using a finite element method for different studied 
microdevice geometries. The convergence criterion was based on the residual error in the 
momentum equation, which was set to 10-3. 
2.2.2. Alveolar design 
In this section, two different alveolar designs are presented and discussed, considering 
possible advantageous and limitations of each. The results of the computational fluid dynamics 
model inside the liquid chamber are shown and discussed. 
The combination of optimized haemodynamics with physiological blood flow and 
biocompatible material will diminish the risk of thrombus formation, which will result in less 
amount of anticoagulant that must be added to blood.  
The first alveolar design, AD1, is based on the liquid side geometry reported previously by 
the group of Borenstein [32, 100]. It is comprised of branching liquid channels with a depth of 
approximately 100 μm. The structure consists of a big entrance, i.e. 2 mm wide, 4 main branches 
with 8 identical single small units in each branch. Each unit possesses set of parallel and 
perpendicular channels with 50 μm and 100 μm in diameter (Figure 2.1).  
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Figure 2.1 AD1 scheme + magnification of a single unit 
 
The computational model described above was performed in order to calculate the shear 
stress and pressure drop and to visualize the liquid flow path at different liquid flow rates. The 
size of the mesh used in the simulation was chosen on the basis of computational cost and 
reproducibility of hydrodynamic results. On this regard, the computational domain was 
discretized by more than 160 000 triangular elements defining a structured mesh with an edge 
length in the range 0.3-0.0016 cm. An “opening” boundary of the outlet was applied, which 
means that the outlet of the structure was opened and the blood was not accumulating inside 
the chip. The velocity, pressure and shear stress distribution for the entire geometry as well as 
for the single unit for 1 mL/min blood flow rate are presented in Figure 2.2. The chosen single 
unit for all the mathematical modelling was the first unit in the first branch of the entire 
structure. This unit was the most affected one in terms of the highest ΔP and shear stress. 
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Figure 2.2 Mathematical computation results of A) flow velocity, B) pressure drop and C) shear stress for a 
blood flow rate 1 mL/min. A1, B1 and C1 represent the magnifications of single units 
The pressure drop and shear stress at 1 mL/min blood flow rate was equal to 2.57 mbar and 
7.93 N/m2, respectively (see Figure 2.2 B and Figure 2.2 C). However, due to the various 
dimensions of the perpendicular and parallel channels in a single unit, i.e. 50 μm and 100 μm 
diameter (see Figure 2.1), the liquid flow distribution lacked some homogeneity that could, 
eventually result in preferential pathways. Furthermore, high shear stress and elevated ΔP due 
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to accumulation in some zones of the structure is observed in the simulations. This could then 
lead to thrombus formation, red blood cells deformation or device ruptures and cracks. In the 
single unit of the alveolar structure presented, the difference between the highest and lowest 
flow velocity is approximately 20%. However, the parameter which establishes the 
homogenous flow distribution is the liquid flow profile. The objective is to obtain the highest 
flow across the entire unit with the lowest flow velocity located nearby the unit walls. This is 
clearly not the case in AD1 structure. 
Therefore, it was decided to start modifying the single unit design. The target of the 
proposed modifications was to decrease ΔP and shear stress of the liquid chamber keeping high 
level of oxygen transfer rate at the same time. A variety of computer simulations with different 
single unit conformation were performed. Basically, the single perpendicular and parallel 
channels were removed, and flow distributors were incorporated into the reservoir of a single 
unit. The following variables were taken into account: 1) shape and dimensions of the reservoir, 
2) flow distributors shape and size, 3) spacing among them and 4) position. Sometimes, even 
tough, the pressure drop in the proposed structure was small enough, the shear stress was high 
and the liquid was not well distributed. Hence, the balance among these parameters had to be 
considered. As an example, Figure 2.3 shows the pressure drop distribution at 1 mL/min blood 
flow rate for some of the proposed single unit structures.  
 
Figure 2.3 Simulation results of pressure drop of AD2 single unit with two different conformations 
The calculated values, i.e. 7.65 mbar and 3.36 mbar for structures presented in Figure 2.3 
A and B, respectively, are even higher that those previously shown for AD1 design, i.e. 2.57 
mbar. High values of ΔP in Figure 2.3 A are related to the big amount of flow distributors which 
were placed too close to the inlet of the unit and were separated from each other only by 20 μm 
spacing. Liquid did not have enough space to circulate through the reservoir; instead it had to 
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enter very small channels which dramatically elevated the pressure. On the other hand, the 
spacing among the diamonds presented in Figure 2.3 B is much bigger, i.e. 100 μm. This 
decreased the pressure by approximately a half. Nevertheless, ΔP presented in this unit is still 
higher than in the AD1 design. This is due to the dimensions of the reservoir, which seem to be 
too narrow, and the angle of the tapered channel transition at the inlet, i.e. wall inclination 
(approximately 100o). The lower value of such angle results in bigger transition of the flow 
which corresponds to elevated ΔP. As a result of these computer simulations, it was decided to 
increase the width of the single unit reservoir from 1450 μm to 1700 μm and to elevate the angle 
of the tapered channel transition from 100o to 130o. 
Figure 2.4 shows the computer simulation of the single unit slightly bigger in size, 15% 
higher, and with bigger angle of wall inclination at the inlet, i.e. approximately 130o, in 
comparison to the previously shown (100o) with liquid flow distributor at the inlet and outlet, 
i.e. mirror effect. The calculated pressure drop at 1 mL/min blood flow rate is significantly 
lower, i.e. 1.82 mbar (see Figure 2.4). Furthermore, identical structure with the flow distributors 
only at the inlet was simulated as well, resulting in slightly reduced pressure drop, therefore the 
idea of the mirror diamond effect was abandoned.  
 
Figure 2.4 Mathematical computational results of pressure of a single unit design with flow distributors at the 
inlet and outlet 
Table 2.1 summarizes the different computer simulations performed with AD2 type design in 
order to identify the most adequate structure for blood oxygenation testing. Accordingly, 
Design 5 was chosen as the final single unit architecture that was placed inside the entire 
geometry of AD2 chip (see Figure 2.5 and Figure 2.6 B1 for ΔP simulation).  
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Table 2.1 Simulation results of pressure drop and shear stress of different single unit for AD2 
type design 
Design 
ΔP single unit 
[mbar] 
Shear stress 
[N/m2] 
Remarks 
1 7.65 28.2 
Small spacing among distributors 
(20 μm); flatter diamond shape, 
approx. 100o inlet angle 
2 3.36 8.25 Bigger spacing (100 μm), more 
convex diamond 
3 1.82 6.62 
Double side distributors; bigger 
reservoir; 50 μm spacing, approx. 
130o inlet angle 
4 1.22 6.37 The same as design 3, but one 
side flow distributors 
5 0.64 4.7 
130 μm spacing, 130o inlet 
angle, curved angles-Chosen 
structure 
The selected AD2 type architecture obey the bifurcation theory introduced by Murray [39] 
which states that the channels for liquid flow should possess equal width and depth (i.e. 100 
μm) so the liquid can be dispersed in a homogenous way.  
The liquid flow velocity, pressure drop and shear stress for the new proposed geometry were 
simulated as it was described in case of AD1 geometry. The final mesh used in COMSOL 
simulations consisted of more than 780 000 triangular elements defining a structured mesh with 
an edge length in the range 0.4-0.0017 cm. 
The graphical representation of such modelling for 1 mL/min blood flow rate is presented 
in Figure 2.6 It is clearly visible that the pressure drop was significantly reduced by 
approximately a half (2.57 mbar for AD1 and 1.3 mbar for AD2). This is mainly due to the 
removal of horizontal and vertical channels. The pressure drop obtained mathematically is way 
below the limit of a thrombus formation, i.e. 26.6 mbar (see Chapter 1). Moreover, shear stress 
decreased as well from 7.93 N/m2 in case of AD1 to 5 N/m2 in AD2. 
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Figure 2.5 AD2 scheme + magnification of a single unit 
 
The simulated results underline the benefits of AD2-type design which improves such a 
structure by minimizing the pressure drop inside the liquid chamber. This is a key factor to 
avoid deformation and/or destruction of RBCs, leading to the non-physiological blood flow. In 
both designs, a number of supporting pillars was added to the gas chamber to avoid membrane 
collapsing and to increase the mechanical stability of the chips. Table 2.2 shows the comparison 
of simulated parameters for the liquid flow rate in the range of 1-5 mL/min for the two designs, 
i.e. AD1 and AD2, respectively.  
Microfluidic devices for blood oxygenation 
 
55 
 
 
Figure 2.6 Mathematical computation results of A) flow velocity, B) pressure drop and C) shear stress for a 
blood flow rate 1 mL/min. A1, B1 and C1 represent the magnifications of single units 
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Table 2.2 Mathematically modelled results of pressure drop and shear stress of an entire 
geometry for AD1 and AD2 type designs 
 Blood flow rate 
[mL/min] ΔP [mbar] 
Shear stress 
[N/m2] 
A
lv
eo
la
r 
D
es
ig
n
 
1 1 2.57 6 
2 6.19 11 
3 9.2 16.4 
4 12.3 22.8 
5 15.4 29 
A
lv
eo
la
r 
D
es
ig
n
 
2 1 1.3 5 
2 3.16 8.7 
3 4.6 13.2 
4 6.25 18.1 
5 7.8 23.7 
 
The pressure drop and shear stress are not the only parameters affecting the performance of 
the chip. For a given blood flow rate, the oxygen saturation mainly depends on the membrane 
surface area, channel depth and chamber volume. Moreover, our target is the market devoted 
to neonates, hence low priming volumes as well as compact systems are anticipated. Table 2.3 
shows the main parameters of the two alveolar designs that have been fabricated and tested for 
blood oxygenation.  
Table 2.3 Main parameters of the proposed alveolar-type liquid side geometries 
Alveolar 
design 
Membrane 
thickness, δ 
[μm] 
Membrane 
Area, SA 
[cm2] 
Gas/liquid 
channel depth 
[μm] 
Chip 
footprint 
[cm2] 
Liquid 
volume1) 
[μL] 
AD1 
120 
2.8 
100 18.7 
28 
AD2 3.9 39 
1)
 similar to priming volume 
It is visible that the membrane surface area increased by approximately 40% in AD2 in 
comparison to AD1 resulting in higher S/V ratio and liquid volume. The membrane thickness 
as well as the channel depth values were kept equal for both designs. 
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2.2.3. Meander design with vertical membrane arrangement 
Meander design (MD) with vertical membrane arrangement is an alternative configuration 
for the blood oxygenation in the microfluidic device. This approach consists of a single “mixed” 
PDMS microfluidic platform comprising a series of meandering flow channels for liquid as 
well as for a gas, in which the adjacent liquid and gas channels are separated by a dense vertical 
membrane.  
The innovative idea of a vertical membrane chip design relies on the ability to deliver 
oxygen to blood from both sides of the liquid channel. This approach is also called double side 
gas diffusion (see Figure 2.7).  
 
Figure 2.7 Schematic representation of the meandering channels arrangements  
In the proposed design, the liquid chamber (red colour) is surrounded by gas channels (blue 
colour) from both sides and separated by a gas-permeable PDMS membrane. Each meander 
unit consists of two length section and two half circular lengths of the liquid channel on both 
sides of a membrane which is situated in between the gas and liquid channels. The total surface 
area for gas exchange is thus the lateral area of one meander unit multiplied by the number of 
units and the number of branches of the entire structure. The distance between the gas channel 
and the liquid channel filled with PDMS is the actual membrane thickness. The gas-liquid 
contact area, i.e. the membrane surface, depends on the depth and the length of the channels. 
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For this reason, the larger channel depth is beneficial in order to increase gas-liquid contact area 
and therefore, the oxygen saturation at the outlet. 
 Among others, the presented configuration is valuable due to simplified fabrication process 
which does not require any extra step for fabrication of the membrane and peeling off the thin 
film from the support, normally a Si wafer, as it is commonly used in the microfabrication of 
membranes for artificial microfluidic oxygenators [26]. Instead, the entire structure is 
embedded inside the same layer. Moreover, the oxygen enters the blood channel from both 
sides, i.e. double side diffusion (see the magnification in Figure 2.7) which increases blood 
oxygenation per unit of length. Considering that the oxygen comes from the sides of the channel 
instead from the top of it, as it is commonly done, narrowing of the liquid channel will increase 
the O2 transfer rate and will decrease the actual dimensions of the chip because the same surface 
area will be loaded in the smaller chip footprint. On the other hand, the wider the channels the 
lower the pressure drop and shear stress in the geometry for a given flow rate. The balance 
among all the parameters has been considered for the selection of the key feature sizes. 
A variety of meandering architectures were examined in order to find the optimum one in 
terms of the criteria mentioned above. Thus, three distinctive designs were proposed with 9 
branches and various number of meandering units. Moreover, in the meandering arrangement, 
all the liquid channels possess equal width and length. Therefore, it was important to “force” 
the liquid to enter all the branches with the same velocity. Accordingly, each branch possessed 
a small “loop” at the entrance in order to force the liquid to follow the same distance, i.e. same 
pressure drop, and as a result to enter all the branches with the same liquid flow velocity. The 
same procedure was repeated at the outlet of the geometry in order to make the structure 
symmetric. It was established that the highest values of the shear stress were present in the inlet 
and outlet. Hence, it was decided to increase their dimensions from 400 μm*100 μm to 800 
μm*100 μm.  
The final mesh of a chosen structure for COMSOL simulations consisted of more than 
40 000 elements triangle defining a structured mesh with an edge length in the range 0.04-0.005 
cm. The boundary conditions were set equal to the simulation performed for both alveolar 
arrangements. Table 2.4 shows computational results of pressure drop and shear stress at 1 
mL/min liquid flow rate in case of three different designs with various liquid channel width. 
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Table 2.4 Simulation results of a pressure drop and shear stress of different meander designs 
for 1 mL/min blood flow rate 
Design 
Liquid channel 
width [μm] 
Liquid volume 
[μL]1) 
ΔP [mbar] 
Shear stress 
[N/m2] 
1 200 36.02 66.4 6.7 
2 300 47.77 42 5 
3 400 57.62 16.9 3.42 
1)
 similar to priming volume 
Figure 2.8 shows the results of the computer modelling for (A) liquid flow velocity, (B) pressure 
drop and (C) shear stress, respectively at 1 mL/min blood flow rate of Design 3. 
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Figure 2.8 Computer modelling results of the meander design of A) liquid flow velocity, B) pressure distribution 
and C) shear stress 
The structure which was finally chosen (Design 3) possesses liquid channel width of 400 μm, 
gas channel width of 100 μm and the spacing in between (the membrane thickness) of 120 μm. 
It is made of 19 meandering units and 9 branches loaded on a surface of 35.04 cm2 of the total 
chip footprint with the membrane surface area of 2.9 cm2. As a result of the flow distributors, 
the liquid transportation was homogenous which means that the total surface area of the 
membrane was used, i.e. no dead volume or mass accumulation. Table 2.5 shows the main 
parameters of the chosen device. 
Table 2.5 Main parameters of the proposed meander vertical-type geometry 
Memb 
thick., 
δ [um] 
Memb 
Area, SA 
[cm2] 
Liq. 
channel 
width 
[um] 
Gas 
channel 
width 
[um] 
Gas/liq 
unit 
length 
[mm] 
Gas/liq 
channel 
depth 
[μm] 
Liq 
vol 
[uL] 
Chip 
footprint 
[cm2] 
120 2.9 400 100 2 100 58 35.0 
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2.3. Mathematical model for blood oxygenation 
After the microfluidic geometries were designed and tested, the mathematical model for 
blood oxygenation was developed and validated by comparison to the experimental data.  
2.3.1. Haemoglobin: oxygen binding protein – structure and properties 
Prior to the description of the experimental procedure of blood oxygenation, it is important 
to understand the structure of haemoglobin and all the processes and modifications that can 
occur. Haemoglobin (Hb) is the oxygen – binding protein, which enables the red blood cells to 
transport more oxygen. Hb is remarkably efficient in carrying oxygen. It is able to use as much 
as 90% of its oxygen-carrying capacity due to its structure [103, 104]. Haemoglobin possesses 
a quaternary structure typical for many multi-subunit globular proteins comprised of four 
polypeptide chains, two of them called the α chains and the other two named the β chains, 
attracted to each other by hydrogen bonds. The four polypeptide chains bind oxygen 
cooperatively, i.e. binding of O2 to a site in one chain increases the probability of binding 
oxygen to the remaining chain. The ability of haemoglobin, to bind oxygen depends on the 
presence of a bound prosthetic group called heme. Figure 2.9 represents the chemical structure 
of the heme group. 
 
Figure 2.9 Chemical structure of Haemoglobin and Heme group. Figure adapted from [103] 
The heme group is responsible for characteristic red colour in muscles and blood. It consists 
of a central iron atom and an organic component called protoporphyrin. Protoporphyrin is made 
of four pyrrole rings connected by methane bridges in order to form a tetrapyrrole ring. Heme 
group also contains of two vinyl groups, four methyl groups, and two propionate side chains. 
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They are well separated by iron-iron distances ranging from 24 to 40 Å [103, 105, 106]. 
Moreover, the chemical structure of heme group is related to the process of binding oxygen. 
Figure 2.10 demonstrates the modification of the heme group in case of A) deoxyhaemoglobin 
and B) oxyhaemoglobin. In case of deoxyHb, the Fe2+ is placed slightly outside the porphyrin 
plane while it moves into the plane of the heme in the case of oxyHb. α1β1 and α2β2 dimers 
are easier to move with respect to one another in the oxygenated state than they are in the 
deoxygenated state. The quaternary structure observed in the deoxy form of Hb is often referred 
to as the highly unstable T (for tense) state because it is quite constrained by subunit-subunit 
interactions. The quaternary structure of the fully oxygenated form is named as the R (for 
relaxed) state. In the R state oxygen-binding sites are free of strain and are capable of binding 
oxygen with higher affinity than are the sites in the T state. In order to haemoglobin works 
efficiently it is required that the T state remain stable until sufficient amount of oxygen is 
bonded and thus converted it to R state [103, 107]. 
 
Figure 2.10 Oxygen binding modifies the position of the iron ion in A) deoxyHb and B) oxyHb 
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2.3.2. Oxygen transport in blood 
For purposes of discussing oxygen transport in the blood, it is considered to be composed 
of two phases: plasma and red blood cells. Oxygen is carried in the blood in two forms: 
dissolved in plasma, denoted as CdO2; and reversibly bounded to haemoglobin (Hb), denoted as 
CO2. 
The oxygen-binding characteristics of Hb are illustrated by an oxygen-binding curve, 
known as the Hill’s curve [108]. The common expression of this equilibrium relationship is the 
following: 
??? = ????????
?
1 + ????????? (2.3) 
Where: SO2 is the fractional oxygen saturation, PO2 is the partial pressure of dissolved oxygen, 
n is the number of binding sites of haemoglobin (called the Hill coefficient) [-]; and P50 is the 
partial pressure of oxygen when blood is 50% saturated; 26.6 [mmHg] (at 37oC, pH of 7.4 and 
PCO2 of 40 mmHg). 
The concentration of oxygen in blood is most conventionally measured by its partial 
pressure, PO2 [103, 104]. Considering that the concentration of dissolved oxygen in the blood, 
CdO2, is directly proportional to the partial pressure of oxygen, Henry’s law could be used for 
its calculation [104]: 
???? = ? ∙ ??? (2.4) 
Where, α is the solubility coefficient of O2 in blood. 
The fractional saturation of blood, SO2, is described as the fraction of possible binding sites 
that contain bound oxygen. From SO2, the values of the haemoglobin concentration in blood, 
[Hb], and the oxygen binding capacity of Hb, denoted as Hbs, the oxygen concentration bound 
to Hb is calculated as follows: 
??? = ??? ∙ ???? ∙ ??? (2.5) 
If the saturation of blood with oxygen is lower than approximately 80%, the hypoxemia is 
formed due to the deficiency of O2 in blood to the pulmonary vein which causes respiratory 
disorders or damage of the vital tissues. 
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Figure 2.11 Oxygen transport by blood at 37oC and pH of 7.4 
Figure 2.11 comparatively shows the oxygen bound to Hb, expressed as fractional 
saturation, and the oxygen dissolved in plasma as a function of the oxygen partial pressure at 
37oC and pH of 7.4. It is clearly seen from the Hill’s curve that the concentration of dissolved 
oxygen in comparison to bound oxygen is negligible.  
The sigmoid shape of Hill’s curve indicates that Hb shows a special binding behaviour, i.e. 
the binding of oxygen at one site increases the likelihood that oxygen binds at the remaining 
unoccupied location. Conversely, the unloading of oxygen at one heme facilitates the unloading 
of oxygen at the others [103]. 
There are several factors influencing the efficiency of oxygen transport in haemoglobin, 
mainly: PO2, temperature and pH. 
Firstly, the partial pressure of oxygen plays a key role in the binding O2 to Hb. Oxygen is 
transported in the blood from the lungs, where the PO2 is quite high, approximately 100 mmHg, 
to the actively metabolizing tissues, where the PO2 is much lower, typically 20 mmHg. In the 
lungs, Hb becomes nearly saturated with O2 such that approximately 98% of the oxygen-
binding sites are occupied. However, immediately upon Hb moves to the tissues and releases 
O2, the saturation level drops down to 32%. Thus, a total of 98 – 32 = 66% of the potential 
oxygen-binding sites contribute to the gas transport.  
Another factor affecting the O2 affinity to bind to Hb is so called the Bohr effect which is 
the regulation of oxygen binding by hydrogen atoms and CO2. The oxygen affinity of Hb 
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decreases with the reduction of pH starting from a value of 7.4. Moreover, as haemoglobin 
moves into a region of lower pH, its tendency to release O2 rises. For instance, 77% of oxygen 
is released when it is transported from lungs, PO2 of 100 mmHg and pH 7.4, to active muscle, 
PO2 of 20 mmHg with a pH of 7.2. However, only 66% of the oxygen would be released in the 
absence of any change in pH. Two sets of chemical groups are responsible for the pH effect: 1) 
the α-amino groups and 2) side chains of histidines: β146 and α122, all of which have pKa 
values near pH 7 [103, 109-111]. Figure 2.12 shows the influence of the pH on the oxygen 
affinity to haemoglobin. 
 
Figure 2.12 Oxygen-haemoglobin dissociation curve as a function of pH  
On the other hand, human lungs work as a gas exchange organ, thus there is not only an 
exchange of oxygen but also carbon dioxide plays a significant role. Carbon dioxide passes 
through the RBC membrane into the red cell and it stimulates oxygen release by two 
mechanisms: 1) the presence of high concentrations of CO2 leads to the drop of H+ atoms within 
the RBC, and 2) a direct chemical reaction between CO2 and Hb that creates carbamates [103]. 
The visual representation and the explanation of the transport of CO2 from tissues to lungs is 
presented in Figure 2.13. 
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Figure 2.13 Transport of CO2 from A) tissues to B) lungs. The biggest amount of CO2 is transported to the lungs 
in the form of bicarbonate which is produced in RBC and next is released into blood plasma. Smaller amount is 
transported by Hb as attached carbamate 
Another factor influencing the oxygen affinity to Hb is the temperature. Increasing the 
temperature of Hb decreases its affinity to oxygen and shifts the oxygen-binding curve to the 
right [111]. The influence of temperature on the oxygen-binding curve is presented in Figure 
2.14. 
 
Figure 2.14 Oxygen-haemoglobin dissociation curve and the influence of temperature on the pO2 and its 
corresponding saturation 
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2.3.3. Mathematical equations and development of a model 
In addition to the velocity profile solving (described earlier in section 2.2.1), the mass 
balance and transport equation for oxygen species in blood was developed from a standard 
convection-diffusion mass transfer expression [108, 112, 113]: 
 
Figure 2.15 Schematic representation of the A) Cartesian control volume for the derivation of the species 
conservation equation, and B) boundary conditions in the alveolar system 
The conservation of a mass balance in the controlled volume can be written as: 
? ?? + ? ?? = ? ?∆ (2.6) 
Where, JD is the mass transfer by diffusion, JC is the mass transfer by convection, and JΔ is the 
rate of mass production. 
Each term can be derived as follows: 
?? = ???? ∙ ∇?(????)?????? (2.7) 
?? = −? ∙ ∇(????)?????? (2.8) 
Substituting equations 2.7 and 2.8 to 2.6, dividing and rearranging terms the partial differential 
equation that governs the oxygen transport in the blood can be expressed as follows: 
? ∙ ? ∙ ∇???? − ? ∙ ?∇??? = ? ??????  (2.9) 
Under steady state, it becomes: 
? ∙ ?∇??? = ? ∙ ???? ∙ ∇???? (2.10) 
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Where, Deff is the effective diffusivity of oxygen in blood which incorporates the effects of 
haemoglobin. Such effective diffusivity is calculated from the following relations [112]: 
???? = ??1 + ?(?) (2.11) 
Where, Db is the O2 diffusion coefficient in blood and λ(P) is the mathematical term developed 
to account O2 bound to Hb. It is expressed as a function of [Hb]:   
?(?) = ???? ∙ ?′???  (2.12) 
And S’O2 can be derived from equation 2.3 as: 
?′?? = ?(???)? ∙ ??????(???? + ???? )?  (2.13) 
Rearranging the above equations, the effective diffusivity is calculated as follows: 
???? = ??1 + ???? ∙ ?(???)? ∙ (???)????(???? + ???? )?
 (2.14) 
When blood enters the microchannel, the partial pressure of dissolved oxygen is low (see 
Figure 2.15 B). As the blood flows along the channel, oxygen diffuses out of the gas side of the 
chip, across the membrane, and into the blood, dissolving in blood plasma and then diffusing 
to and into red blood cells and binding to haemoglobin.  
The coupling between the oxygen mass balance in the plasma and the membrane surface is 
obtained as a boundary condition in the liquid’s mass balance. This condition sets the flux of 
oxygen at the boundary equal to the permeating rate through the PDMS membrane, JO2, and is 
presented below [113]: 
??? = ?? ∙ ?? ∙ ???,?? − ???,????? ∙ 1?? 
(2.14) ??? = ???? ∙ ???,?? − ???,????? ∙ 1?? 
Where Dm is the diffusion coefficient for oxygen in the PDMS membrane, αm is the solubility 
of oxygen in the PDMS membrane, lm is the thickness of the PDMS membrane, PO2,wall is the 
partial pressure of dissolved oxygen at the membrane wall, and PG,O2 is the partial pressure of 
oxygen in the gas side. The oxygen pressure on the gas side of the device has been considered 
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constant due to: i) its supply is greater than its gas exchange rate, and ii) the resistance to 
diffusion on the gas side of the device is negligible compared to that of the membrane and 
blood. 
According to the oxygen permeation results of our PDMS membranes (see Chapter 3), the 
product Dm and αm, also known as permeability (Perm) through PDMS membrane, is 1.49·10-
11
 mol·m·m-2·s-1·mmHg-1. Table 2.6 shows the main constant parameters which are used in the 
blood oxygenation calculations.  
Table 2.6 Summary of the main blood and oxygen related parameters used in the calculations 
Parameter Abbreviation Value Units 
Solubility coefficient of 
O2 in blood 
α 1.25·10-3 moleO2·m-3blood·mmHg-1 
Diffusion coefficient of 
O2 in blood 
Db 1.8·10-9 m2·s-1 
Number of binding sites 
of Hb n 2.7 - 
Partial pressure of O2 at 
50% blood saturation P50 26.6* mmHg 
O2 binding capacity of 
Hb Hbs 1.39·10
-6
 m3·g-1 
O2 density d 1331 g·m-3 
O2 molecular weight M 32 g·mol-1 
Blood density ρ 1060 kg·m-3 
Blood viscosity μ 0.00029 Pa·s 
O2 permeability, PDMS Perm 1.49·10-11 mol·m·m-2·s-1·mmHg-1 
*at 37oC, pH 7.4 and PCO2 of 40 mmHg 
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2.4. Experimental section 
2.4.1. Fabrication process outline 
PDMS has been one of the polymers actively developed for microfluidics and prototyping 
due to its low cost, easy handling, low surface energy and its mechanical properties which 
facilitate release from moulds. Additionally, it possesses physical and chemical properties (see 
Table 2.7) which allows device fabrication with useful functionality, thus it is not only a 
structural material. It belongs to the group of organosilicons, commonly referred as silicones. 
PDMS consists of a repeating monomer [SiO(CH3)2] which appears after the polymerization 
process [114, 115] (see Figure 2.16).  
 
Figure 2.16 Chemical structure of PDMS  
Table 2.7 Physical and chemical properties of PDMS with their characteristics and 
consequences [114, 115] 
Property Characteristic Effect 
Optical Transparent Optical detection (240 nm to 1100 nm) 
Mechanical Elastomeric (Young’s 
modulus: 750 kPa) 
Conforms to surfaces, allows deformations, 
easy release from moulds, 
Electrical Insulating Allows embedded circuits, breakdown voltage 2·107 V/m 
Thermal Insulating Thermal conductivity 0.2 W/(m·K), Can be 
used to insulate heated solutions 
Interfacial Low Surface Free Energy (20 erg/cm2) 
Easy release of replicas from moulds, can be 
reversibly sealed to materials 
Toxicity Non-toxic Can be implanted in vivo, supports cell growth 
Permeability 
Impermeable to liquid 
water, permeable to 
gases 
Allows gas transport, incompatible with many 
organic solvents 
Reactivity Inert; can be oxidized by 
exposure to plasma 
Unreactive towards most reagents; surface can 
be etched or modified to be hydrophilic 
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All the above-mentioned properties of the material lead us to select PDMS for the fabrication 
of the device chambers as well as membrane material.  
The fabrication process of two proposed microfluidic PDMS devices, i.e. alveolar-type and 
meander-type design, is slightly different. In both cases the fabrication involves: 1) chambers 
construction by replica moulding of rigid masters, and 2) microdevice assembly and attachment. 
The only difference refers to the PDMS membrane. Alveolar design requires the separate 
fabrication of the membrane by casting, whereas in meander-type device the membrane is 
already embedded in the chamber structure. 
Chambers construction 
The rigid masters for the liquid and/or gas chambers were prepared by standard lithography 
using SU-8 negative photoresist (SU-8 50 DE MicroChem) as structural layer. 4 in. diameter 
Si wafers (500±20 μm thickness, <100> orientation, “p” doped and resistivity of 5-10 Ω·cm) 
supplied by Sil’Tronix Silicon Technologies were used. Firstly, the Si wafer was coated with 
specific SU-8 (50 DE MicroChem) negative-working photosensitive resist by spin coating at 
1250 rpm during 1 min resulting in the thickness of approximately 100 μm. Next, the wafer 
with the resist was soft baked at 95oC during 30 min. The photolithography process was carried 
out on the SU-8 top layer of the wafer to define the chamber geometry. The patterning was 
transferred from the photomask to SU-8 by exposure to UV (350-400 nm) and post baked at 
65oC during 1 min and later at 95oC during 10 min. Finally, the patterned structure was 
developed by immersing the wafer in the developer (SU-8 developer, MicroChem, USA) during 
10 min followed by hard baking at 150-200oC. Next, the entire wafer was silanized by exposure 
to chlorotrimethylsilane (Sigma Aldrich) vapour for approximately 10 min. This procedure was 
used for easier removal of PDMS from the patterned SU-8 Si wafer [116]. The schematic view 
of the lithographical process flow is shown in Figure 2.17.  
Next, PDMS prepolymer and curing agent (Sylgard 184 Dow Corning, Midland, MI) were 
thoroughly mixed in a ratio 10:1 and placed in the degassing chamber. PDMS was poured on 
the patterned SU8-Si master and placed in the oven at 85oC for 45 min. The moulds were peeled 
off from the wafer, cut to the required size and punched for inlet and outlet (TiN Coated Round 
Punch, Syneo). Fabricated chambers were immersed in the solution of isopropanol (Sigma 
Aldrich, 99.7%) and placed in the ultrasound bath for approximately 2 minutes in order to 
remove any possible dust that could be attached to the inside of the channels prior any further 
procedure (membrane or chamber attachment). 
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Figure 2.17 SU-8 lithography process flow 
2.4.2. Alveolar design device fabrication 
Membrane fabrication 
The membrane which was integrated in the microdevice was made of PDMS as well. The 
PDMS membrane was prepared by spin coating (WS-400BZ, Laurell Technologies Corporation 
Spin Coater) of the PDMS precursor solution on the surface of another wafer at 1000 rpm during 
1 min. The so obtained membrane thickness is approximately 120 μm. The Si wafer with the 
PDMS membrane was placed in the oven at 85oC for approximately 30 min. 
Microdevice assembly and attachment 
The fabricated PDMS platform dedicated to liquid and the PDMS membrane were placed 
inside the O2 plasma chamber (Diener electronic, Plasma-surface-technology) operating at 0.4 
mbar, 120 W and 50% of O2 during 50 sec, in order to activate the surfaces for their subsequent 
bonding [117]. After the surface was functionalized with O2 plasma, the PDMS compartment 
was connected to the membrane and peeled off from the wafer; and finally placed in the oven 
at 85oC for approximately 1 hour.  
The platform dedicated to the gas chamber was prepared following a similar approach. After 
plasma functionalization, the gas chamber was connected to the membrane-liquid chamber 
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stack resulting in the three-layer device. The device was placed in the oven again at 85oC for 1 
hour. Figure 2.18 shows the process outline of the whole microdevice fabrication. 
 
 
 
Figure 2.18 Process outline of the microfluidic chip fabrication. Spin coating of the SU-8 negative photoresist 
on the silicon wafer (A), mask alignment, UV exposure and SU-8 development (B), Pouring of PDMS on a 
created mould (C) and peeling off after curing. Membrane preparation by spin coating on a silicon wafer (D) and 
connecting to the PDMS mould by O2 plasma procedure (E). After curing in the oven, peeling off the membrane 
and the chamber of the wafer and connecting to the other chamber (F). 
2.4.3. Meander type design with vertical membrane arrangement 
fabrication 
Microdevice assembly and attachment 
The fabricated “mixed” PDMS platform was placed inside the oxygen plasma chamber at 
the same conditions as the alveolar design. The chamber and the glass slide were connected and 
placed in the oven at 85oC for 1 hour. Next, the metallic pins in the form of “bridges” were 
inserted at the gas inlets of each branch in order to supply gas to each liquid unit and arm. The 
fabrication process outline is presented in Figure 2.19. 
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Figure 2.19 Process outline of the meander design chip fabrication. Spin coating of SU-8 negative on the silicon 
wafer (A), mask alignment, UV exposure and SU-8 development (B), pouring PDMS on a created mould (C) 
and peeling it off after curing. Connecting the chamber to the glass slide by O2 plasma procedure (D). 
 
2.4.4. Surface modification of the microdevice 
As it was described in Chapter 1, hydrophilic surfaces allow reversible protein adsorption 
due to less protein unfolding [45, 46]. Accordingly, the surface of PDMS liquid channels as 
well as the membrane were modified with a block copolymer in order to make them more 
hydrophilic [118, 119].  
Pluronic F-68 (Sigma Aldrich) is a block copolymer surfactant which terminates in primary 
hydroxyl groups (Figure 2.20). Firstly, the surface of the PDMS platforms were activated in the 
oxygen plasma chamber for 50 seconds at 120 W, 0.4 mbar and 50% of O2. This treatment leads 
to the formation of reactive hydroxyl groups on the surface. Next, Pluronic F-68 was thoroughly 
mixed with DI water in the concentration of 10 mg·mL-1 and introduced into the vascular 
channels with a syringe. The solution was kept inside the channels for 3 hours and subsequently 
washed with DI water for approximately 15 min [32, 119]. A schematic representation of the 
PDMS-Pluronic F-68 condensation reactions on the microdevice surface is depicted in Figure 
2.20.  
The PDMS surface modification was evaluated by means of: 1) contact angle 
measurements, 2) adsorption of fibrinogen, and 3) red blood cells viability after oxygenation in 
the PDMS chips.  
The static contact angle measurements were carried out with NEURTEK OCA 15EC 
instrument. The drop of distilled water (approximately 5 μL) was injected on the surface of 
cleaned untreated PDMS and PDMS modified by O2 plasma and Pluronic F-68. 
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Figure 2.20 Schematic representation of the proposed PDMS surface modification 
Fibrinogen, a large protein present in blood, has high affinity to be adsorbed on the 
hydrophobic, positively charged surfaces [47]. Thanks to this feature fibrinogen is commonly 
used in the measurements of protein adsorption onto different surfaces [44]. Firstly, the surface 
of PDMS was incubated at 37oC overnight in PBS to prepare it for further treatment with 
fibrinogen by maintaining optimal conditions, such as temperature, humidity, oxygen content 
etc. Next, fibrinogen was added to PBS in the concentration of 0.5 mg/mL and the PDMS 
surface was incubated for 24 hours. Finally, in order to clean the polymer surface, the PDMS 
was washed with DI water during approximately 15 minutes. The measurement of the protein 
adsorption on the PDMS surface was done by a Fluorescence Microscope with the Argon laser 
of 488 nm wavelength. Fibrinogen was placed on the: 1) untreated PDMS, and 2) PDMS 
modified by O2 plasma and Pluronic F-68.  
Finally, the viability of RBCs was checked by an observation of the deterioration of the 
cells under the optical microscope. In order to be able to observe and count the cells under the 
optical microscope, the cells had to be first stained. A blood smear was performed and stained 
with hematologic staining (Differential Quik Stain Kit). The kit consists of three reagents: 1) a 
fixative for air-dried cell, 2) an eosinophilic to stain the cytoplasm, and 3) a basophilic solution 
to stain the nucleus. The blood smear was immersed 10 times in each solution and rinsed in 
water. After it dried, the smear was visualized in an optical microscope to assess the cell 
morphology. Additionally, the haemoglobin concentration was also evaluated by gasometry 
after each oxygenation experiment. 
2.4.5. Experimental set-up for blood oxygenation 
All the oxygenation experiments were carried out with sheep blood obtained from Faculty 
of Veterinary at University of Zaragoza without any further modifications. The blood samples 
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were collected and transferred into 10 mL plastic tubes (Becton Dickinson B.V., Spain) with 
Ethylenediaminetetraacetic acid (EDTA) as anticoagulant in the concentration of 1.5 mg/mL. 
The haemoglobin concentration of each batch was measured by gasometry (Vet abc, Animal 
Blood Counter). Blood was stored under refrigeration at 4oC during a maximum period before 
essays of 24 hours.  
Figure 2.21 shows the experimental system used for blood oxygenation experiments.  
Firstly, 50 mL of blood was transferred into a glass bottle and placed on a stirring plate inside 
the climatic chamber in order to maintain the temperature at 37 ºC. Obtained blood was a venous 
blood with the oxygenation of approximately 98%. Therefore, it was necessary to deoxygenate 
it prior to the oxygenation experiment. Thus, the mixture of air and nitrogen with 7.8% of O2 
was bubbled directly to the blood in order to decrease the Hb saturation down to approximately 
70%. Afterwards, the deoxygenated blood (for detailed values see Table 2.8) was transferred 
into a 50 mL syringe (Becton Dickinson B.V., Spain) and placed in the syringe pump (Harvard 
Apparatus, Spain). The experiments were performed at blood flow rates ranging from 0.1 to 5 
mL·min-1. The pressure transducer (Panasonic, DP2-41E) was placed right after the syringe 
pump to evaluate the pressure drop across the entire system, taking into account the device 
itself, piping and metallic pins.  
 
 
Figure 2.21 Experimental set-up for blood oxygenation experiments 
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Next, the gas chamber was purged with oxygen while deoxygenated blood entered the 
microdevice from the liquid chamber side. First part of the outlet blood stream was discarded 
by pumping to the waste reservoir to ensure steady state conditions. The oxygenated blood was 
collected in a glass bottle hermetically sealed where pH electrode (Hamilton, Slimtrode 238150, 
Switzerland) and dissolved oxygen electrode type oximeter (ThermoFisher Scientific, Orion 
Star A223), were immersed. Before each set of experiments, the control sample measurement 
was performed by carrying the blood throughout the experimental system without oxygenating 
it in order to ensure no leaks of the system as well as to measure the exact blood saturation by 
an oximeter.  
As described before, the percentage of blood saturation is calculated from the measurements 
of the concentration of oxygen dissolved provided by the oximeter according to expressions 2.3 
and 2.4, respectively. The evaluation of the oxygenation performance of the microdevice has 
been assessed by the oxygen transfer rate, expressed in mL/min·m2 and calculated from the O2 
macroscopic balance in the liquid chamber, i.e. considering both contributions O2 dissolved and 
O2 bound to Hb: 
???????? = ? ∙ ∆??? + ??? ∙ ∆??? ∙ ?????? ∙ ? (2.16) 
 
Where: ΔPO2 and ΔSO2 are the differences between the outlet and inlet values of partial pressure 
of dissolved oxygen in blood and fractional oxygen saturation in blood, respectively. α is the 
solubility coefficient of oxygen in blood, Hbs is the O2 binding capacity of haemoglobin, [Hb] 
is, haemoglobin concentration in blood, Q is the blood flow rate and SA is the membrane surface 
area. 
Three different devices of each design, i.e. AD1, AD2 and meander type device, were used 
for the oxygenation experiments. Three repetitions at distinctive blood flow rates of each device 
were performed. The concentration of haemoglobin slightly differed from sample to sample. 
Therefore, for each experiment, the Hb concentration was measured by gasometry. The main 
parameters for each oxygenation experiment are shown in Table 2.8. 
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Table 2.8 Main parameters of each oxygenation experiment 
Alveolar Design 1, AD1 
 Hb conc [g/mL] SO2 inlet [%] 
Device 1 0.128 78.6 
Device 2 0.129 66.9 
Device 3 0.132 57.3 
Alveolar Design 2, AD2 
Device 1 0.146 80.2 
Device 2 0.141 82.2 
Device 3 0.142 68.8 
Meander Design with vertical membrane device, MD 
Device 1 0.136 81.4 
Device 2 0.145 83.7 
Device 3 0.141 77.6 
 
2.5. Results 
In this section, the device characterization, as well as the results of the PDMS surface 
modification, RBC viability and blood oxygenation are presented for each type of device. 
2.5.1. Device characterization 
2.5.1.1. Alveolar design 
Two types of the microfluidic devices were fabricated: AD1, based on the liquid geometry 
developed by Kniazeva et al [32], and AD2 with liquid flow distributors in the single unit 
instead of parallel and perpendicular channels. The liquid chamber architecture enabled 
uniform flow of the blood through the branching construction of the microchannels while 
supplying pure O2 permeating through a PDMS membrane to blood from the top side of the 
chip. The use of PDMS elastomer facilitated chip fabrication and reproduction of the same 
design with thin non-porous membrane attached to the chambers. Figure 2.22 demonstrates the 
comparison of two microfluidic devices, A) AD1 and B) AD2, with the liquid chamber filled 
with blood together with their respective magnifications. The images indicate that the filling of 
the liquid channels was homogenous, and well distributed without any dead volume inside. 
Scanning Electron Microscopy (SEM) was used to inspect the chip inside, i.e. the cross section. 
It was of crucial importance to confirm that the membrane which was “sandwiched” in between 
two chambers did not deflect, collapse or detached.  
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Figure 2.22 Optical images of A) AD1 and B) AD2 PDMS microfluidic devices with sheep blood inside the 
liquid chamber. A1 and B1 are the magnifications of AD1 and AD2 respectively 
Figure 2.23 shows SEM photograph for two different microdevices which indicates that the 
membrane was well attached to the microfluidic chambers. No leak was observed and each 
device was capable to work for long time, more than 8 hours, under the experimental conditions. 
The experimental system with the microfluidic device could withstand liquid flow rate up to 5 
mL/min ensuring stable operation and physiological condition, i.e. no thrombosis formation.  
 
Figure 2.23 Cross section analysis of A) AD1 and B) AD2 type microdevices by SEM 
The thickness of the PDMS mould for both compartments was 0.8 – 1 cm. The chip 
footprint, defined as the total size of the microfluidic device taking into account its width and 
length, was equal to 18.7 cm2 making it a very compact system. The volume of the gas chamber 
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was equal to 73 μL for both device types while the volume of the liquid chamber was equal to 
28 μL for AD1 and 39 μL for AD2. The depth of each chamber was equal to approximately 100 
μm and the membrane surface area was 2.8 cm2 and 3.9 cm2, resulting in a S/Vliquid+gas ratio of 
28 cm-1 and 35 cm-1 for AD1 and AD2, respectively. 
2.5.1.2. Meander Design with vertical membrane arrangement 
The liquid chamber architecture enabled uniform flow of the blood through the meandering 
microchannels while supplying pure O2 permeating through a PDMS membrane from both 
lateral sides of the chamber. The gas or liquid was introduced to the chip by Tygon microbore 
tubing (0.020” x 0.060” OD, Cole-Parmer, The Netherlands) and precision stainless steel 
dispense tip (0.010” ID, 0.020 OD, 45o bend, Nordson, The Netherlands). The “bridges” which 
were connecting the gas channels were made of the same precision stainless steel dispense tips 
(see Figure 2.24 C). Figure 2.24 illustrates the optical microscope images (A, B) and a 
photograph of a meandering microfluidic device with coloured liquid (red colour) and gas 
(green colour) channels for better visualisation.   
 
Figure 2.24 MD microfluidic chip. Green and red colours indicate gas and liquid channels, respectively 
The image indicates that the filling of the liquid channels was homogenous, and well 
distributed without any dead volume inside. It is also important to notice that in this 
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architectural conformation there was no risk of membrane deflection or detachment since the 
membrane is “embedded” in the chamber. Fabricated devices were tested under the 
experimental conditions described above. No leak was observed or a “mixed” chamber collapse. 
The device was able to operate, at least, during 8 hours at the maximum liquid flow rate of 1 
mL/min without collapsing or suffering from channel blocking. Three different meander type 
microfluidic devices were fabricated and tested. For all of them, the thickness of the PDMS 
mould for the “mixed” PDMS compartment was approximately 0.8-1 cm and the chip footprint 
was equal to 35 cm2 making it a very compact system. The volume of the liquid chamber was 
equal to 58 μL. The depth of gas and liquid chamber was approximately 100 μm and the 
membrane surface area was 2.9 cm2, resulting in a S/Vliquid+gas ratio of 50 cm-1. 
2.5.2. Blood interaction with PDMS microfluidic systems 
Prior to the blood oxygenation experiments it had to be confirmed that the surface of a 
PDMS microdevice was not altering the physiological properties of blood. The results of the 
surface modification are presented in the sections below. 
Contact angle 
The contact angle measurement was performed on the non-modified and modified (O2 plasma 
+ Pluronic F-68) PDMS surfaces. The obtained contact angle of a modified PDMS surface was 
equal to 10o±3 indicating that the surface was converted to a hydrophilic one, after a comparison 
to non-treated PDMS surface with contact angle of 115o±0.6. Figure 2.25 shows the graphical 
representation of a water drop on the A) hydrophobic and B) hydrophilic surface. 
 
Figure 2.25 Representation of the contact angle in A) hydrophobic and B) hydrophilic surfaces 
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Visual inspection 
The visual inspection of the channels with the optical microscope after perfusion of blood 
was also executed. Figure 2.26 shows the comparison of the two types of microdevices 
(Alveolar and Meander type) with the modified hydrophilic PDMS surface (Figure 2.26 A and 
C) and unmodified hydrophilic superficies (Figure 2.26 B and D) after blood oxygenation 
experiments. It is visible that chips of which surfaces were modified do not possess any traces 
of blood inside the channels, while the inside of the non-modified microdevices are 
contaminated with blood along the entire structure. Moreover, in order to clean the device with 
modified hydrophilic surface after the experiments with blood, PBS was perfused at a maximum 
of 5 mL/min for its reuse. 
 
Figure 2.26 Visual inspection of A) surface of AD1 PDMS modified with O2 plasma and Pluronic, B) non-
modified AD1 PDMS surface, C) meander type device with modified surface and D) non-modified meander 
surface after blood oxygenation experiments 
Adsorption of Fibrinogen 
The adsorption of Fibrinogen was measured by a fluorescence microscope. The protein 
adhesion is indicated by green-fluorescence dots, represented in Figure 2.27. The preferential 
fibrinogen adhesion on the unmodified PDMS surface is clearly visible. Moreover, no proteins 
are observed on PDMS modified by O2 plasma and block copolymer. This observation agrees 
with the assumption of other authors claiming that the more hydrophilic the surface of a 
biomaterial, the less protein adsorption and less probability of red blood cells destruction.  
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Figure 2.27 Visual representation of the fibrinogen adhesion. A) Untreated PDMS without protein, B) untreated 
PDMS with protein, C) O2 plasma + Pluronic without protein and D) O2 plasma + Pluronic with protein 
Blood cell viability 
The sample of blood before and after the oxygenation experiments (maximum of 24 hours) 
was taken for the analysis of RBCs concentration as well as to check the shape and structure of 
the erythrocytes by optical microscopy. Figure 2.28 shows the white and red blood cells 
distribution, shape and structure before and after oxygenation in PDMS microdevices. It is 
visible that blood did undergo some slight modification, (see Figure 2.28 B and C). Small 
deterioration of RBCs represented by darker colour and no uniform outer edge in comparison 
to the cells before the experiment (Figure 2.28 A) is present. Therefore, in order to have an 
overview of the extension of the RBCs deterioration the gasometry analysis was prepared in 
order to analyse the concentration of erythrocytes before and after the experiment (see Table 
2.9). 
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Figure 2.28 Optical microscope images of blood cells A) before and B), C) after the blood oxygenation 
experiments in the microdevice 
 
Table 2.9 Gasometry results before and after the oxygenation experiments 
Measurement Hb conc [g/dL] Erythrocytes [mm-3] 
Before the experiment 13.5±0.6 13.5±0.3·106 
After the experiment 13.1±0.7 12.5±0.4·106 
From the measurements presented above it is visible that some of the red blood cells 
disappeared or they became deteriorated. Nevertheless, the difference in concentration of 
erythrocytes before the experiment and after is small enough to assume that there is no 
significant influence on the blood properties after PDMS surface modification. 
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2.5.3. Blood oxygenation in alveolar design-experimental results and 
modelling 
2.5.3.1. Experimental blood oxygenation 
Blood saturation [%] 
Blood oxygenation experiments were performed in the experimental system presented in 
Figure 2.21. Dissolved oxygen concentration was measured by an oximeter and recalculated 
into blood saturation from equation 2.3 and 2.4. Figure 2.29 depicts the results of blood 
saturation with oxygen at different liquid flow rates for two different devices, AD1 and AD2. 
The figure represents the difference in saturation between a control sample, i.e. approximately 
70% blood saturation (see description in section 2.4.5), and standard oxygenation experiment. 
The error bars represent the standard deviation of three repetitions of the same measurement 
(see Table 2.8 for details of each experiment). 
 
Figure 2.29 Blood saturation with oxygen at different liquid flow rates for AD1 and AD2 type microdevices 
working under identical operating conditions 
It is visible from the figure that the saturation level of blood with oxygen decreases with an 
increase of the blood flow rate due to the lower residence time. Additionally, the AD2 type 
design, shows in general better oxygenation performance for a given blood flow rate than the 
old design, AD1. Moreover, the steepest part of the curve is localized at the blood flow rate 
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ranging from 0.1 to 1 mL/min while an almost plateau is obtained at the flow rates from 2 to 5 
mL/min. Figure 2.30 shows the changes in oxygen saturation as a function of residence time, τ, 
for both AD1 and AD2 chips, respectively. 
 
Figure 2.30 Blood saturation with oxygen as a function of residence time (τ) for AD1 and AD2 type 
microdevices at A) entire range of liquid flow rates and B) magnification of the lowest τ 
The target of such data representation was to discard the differences of the liquid chamber 
volume in each device and to focus entirely on the chip performance resulting from the designed 
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geometry. The figure also indicates the upper oxygenation limit obtained by the alveolar type 
device.  
As it was expected, the higher the τ the higher is the oxygen saturation level. However, this 
relationship is not linear for the whole operational window herein studied. For lower τ values, 
i.e. higher blood flow velocities a linear dependence is observed. In this region, the slope is 
slightly higher for AD2 design. As blood flow decreased, τ increased, the oxygenation 
saturation eventually levelled off. This behaviour is due to the decay in the driving force for 
oxygen diffusion in blood as in the proximity of 100% saturation level.  
As it was mentioned in section 2.2.2, the target of the alveolar design modification was to 
be able to work at lower pressure drop values without compensation of high oxygenation levels. 
Figure 2.31 shows experimentally obtained pressure drops for two proposed designs, AD1 and 
AD2, measured during oxygenation experiments at various blood flow rates. The figure also 
shows mathematically simulated pressure drop values (dashed lines). The registered ΔP values 
of metallic pins and piping were subtracted in order to be able to compare ΔP simulated and 
experimental resulting only from the microdevice geometry.  
 
Figure 2.31 Experimental pressure drop of two alveolar designs under identical working conditions 
The connections that are used for introducing blood to the microdevice are described in 
section 2.4.5. The pressure drop, for instance, in the stainless steel dispense tip at 1 mL/min 
blood flow rate corresponds to 7.9 mbar. Two of these tips are needed for blood inlet and outlet 
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which corresponds to higher ΔP in the system. Moreover, it is observed that the pressure drop 
in AD2 is significantly lower than in AD1. This results also in lower shear stress for RBCs. 
Summarizing, the oxygenation results of two designs are relatively similar, indicating that the 
pressure drop in AD2 was decreased without lowering the oxygenation performance. The 
microfluidic connections are being reconsidered to diminish the pressure drop of the capillaries. 
2.5.3.2. Mathematically modelled oxygenation results for alveolar designs 
Oxygen concentration profile-computer modelling 
The governing equations used for the O2 concentration profile are presented in section 2.3.3. 
The target of this simulation was to compare the modification of a single unit in terms of better 
oxygenation. Therefore, due to the long computation time, only the simulations of 3D single 
units were performed. The computational domain was discretized by more than a 220 0000 
tetrahedra defining a structured mesh with an edge length in the range 0.002-0.0005 cm. An 
“opening” boundary was applied to the 3D single unit. Figure 2.32 shows the oxygen 
concentration profile across the single unit of AD1 liquid geometry at A) 0.1 mL/min and B) 1 
mL/min blood flow rate. The O2 concentration values obtained from the mathematical 
modelling correspond to dissolved oxygen in blood, CdO2, and are given in mol/m3. Secondly, 
they had to be translated to SO2 and later to oxygen transfer rate.  
It is visible that the concentration of oxygen at the outlet of a single unit is higher in case of 
lower blood flow rate, i.e. 5.75 mole/m3 and 5.48 mole/m3 at 0.1 mL/min and 1 mL/min blood 
flow rate, respectively. Moreover, at low blood flow velocity, the oxygen can penetrate deeper 
into the liquid channel.  
The same type of mathematical modelling was performed for the AD2 structure (Figure 
2.33). The final mesh consisted of more than 14 0000 triangular elements defining a structured 
mesh with an edge length in the range 0.02-0.004 cm. The boundary conditions were set equal 
to the previous simulation. The new design exhibit high oxygen concentration at the corners 
situated close to the outlet of the unit. This is connected with the blood flow velocity profiles. 
This geometry leads to more pronounced oxygen concentration profile in x, y direction for a 
given z position. However, AD2 single unit renders in higher value for the average O2 
concentration dissolved at the outlet, i.e. 5.9 mole/m3 and 5.53 mole/m3 for 0.1 mL/min and 1 
mL/min blood flow rate, respectively. 
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Figure 2.32 Oxygen concentration computer modelling of a single unit D1 at A) 0.1 mL/min blood flow rate and 
B) 1 mL/min blood flow rate 
 
Figure 2.33 Oxygen concentration computer modelling of a single unit D2 at A) 0.1 mL/min blood flow rate and 
B) 1 mL/min blood flow rate 
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2.5.4. Blood oxygenation in meander design (MD) with vertical 
membrane arrangement 
2.5.4.1. Experimental blood oxygenation 
Blood saturation [%] 
In the meander type design, the oxygen enters to the liquid chamber from both sides of the 
channel (double side diffusion). The changes in oxygen saturation with increasing blood flow 
rate are presented in Figure 2.34. The observed tendency is similar to the previously shown 
alveolar devices (see Figure 2.29). 
 
Figure 2.34 Change in saturation in the meander type device with vertical membrane arrangement 
Figure 2.35 shows the comparison of ΔSO2 in three proposed microdevices: MD, AD1 and 
AD2 as a function of a residence time (τ) in order to discard the liquid chamber volume 
differences, i.e. 58 μL, 28 μL, 38 μL, respectively. 
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Figure 2.35 Comparison of the change in the saturation in the meander device (MD) and two alveolar 
geometries (AD1 and AD2) as a function of residence time (τ) 
Using similar gas exchange area, alveolar devices with 100 μm channels height, achieve 
clearly superior O2 exchange rates than MD devices with 400 μm wide channels at identical τ 
values. Figure 2.35 underlines the importance of oxygen diffusion along the liquid channel in 
the overall oxygenation process. At a given residence time, the longer the diffusion pathway in 
the liquid side, the lower the oxygen saturation level attained. Therefore, AD designs reveal 
advantages to reduce the diffusion distance limitations. Particularly, AD2 design is clearly 
outstanding in terms of oxygenation performance and pressure drop (see Figure 2.36) 
Accordingly, there is plenty of room for improvement by reduction of the liquid chamber 
height. 
Additionally, in the case of the meander type device, the maximum blood flow rate tested 
was 1 mL/min due to the pressure drop limitations from the metallic pins inserted in the chip in 
the form of “bridges”. Figure 2.36 shows the experimentally obtained pressure drop during 
oxygenation experiments together with the simulated values for comparison for the three 
microfluidic devices: MD, AD1 and AD2. Experimental and simulated results are presented 
together with the thrombosis formation limit. As it was mentioned before, the microfluidic 
connections are being reconsidered to reduce the hydraulic loss in the transfer lines. 
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Figure 2.36 Comparison of a pressure drop among three proposed microdevices: MD, AD1 and AD2 
Each of the three distinctive liquid side geometries presented in this section, possesses 
advantages and disadvantages. The comparison of the performance of such devices is shown in 
Figure 2.35 and Figure 2.36. It is clearly noticed that the performance of the meander device is 
significantly worse than of both alveolar devices even though the oxygen enters the blood 
chamber from both sides. This is due to the liquid chamber geometry, i.e. the distribution of the 
channels and the large diffusion distance in MD with 400 μm width channels in comparison to 
alveolar design containing 100 μm channel depth. 
2.5.4.2. Mathematically modelled oxygenation results in the MD microdevice 
As it was performed in case of the alveolar designs, the oxygen concentration profile of the 
MD geometry was mathematically modelled. The final mesh consisted of more than 40 000 
elements triangle defining a structured mesh with an edge length in the range 0.04-0.005 cm. 
Figure 2.37 demonstrates the oxygen concentration profile across the meander type geometry 
for two liquid flow rates: A) 0.1 mL/min and B) 1 mL/min with their respective magnifications.  
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Figure 2.37 Oxygen concentration profile computer modelling of a MD at A) 0.1 mL/min blood flow rate and 
B) 1 mL/min blood flow rate 
As it was expected, higher values of oxygen concentration are obtained with lower blood 
flow rate. Moreover, it is visible that the highest values of the oxygen concentration dissolved 
are localized near the membrane wall. 
Additionally, Figure 2.38 illustrates how experimental and simulated results on the average 
outlet O2 saturation level and O2 transfer rate compare. The experimental and theoretical values 
are in agreement and are in the range of acceptable deviation of 15%. The highest relative error 
of the oxygen transfer rate between experiment and model is present in the case of the highest 
blood flow rate, i.e. 1 mL/min and is approximately 15%.  
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Figure 2.38 The accordance between the mathematical model and experimental values presented as A) 
comparison of oxygen transfer rate, and B) parity plot with 15% deviation range 
Figure 2.39 shows the oxygen saturation profile along the single meander channel for 
different blood flow rates. The variation of oxygen saturation per unit of length is higher at low 
blood velocities, i.e. higher τ. For a given experiment, this slope is nearly always the same, with 
the exception of the first part of the meander that can be seen in the magnification (see Figure 
Microfluidic devices for blood oxygenation 
 
95 
 
2.39 B). This effect is attributed to the flow development and could correspond to the initial 
part of the meander channels where the distribution loops are allocated. 
 
Figure 2.39 Analysis of the oxygenation along the meander type channel 
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2.5.4.3. Sensitivity analysis of key parameters on oxygenation performance  
The sensitivity analysis was performed in order to evaluate the effect of: 1) oxygen 
concentration from the source gas, 2) membrane thickness, and 3) liquid channel width on the 
overall performance of the device. The target of such parameter sensitivity study was to 
quantify the impact of a relative change of the considered parameters on the O2 transfer rate. 
Figure 2.40 shows the effect of the oxygen dilution in the source gas on the blood oxygenation 
at 120 μm of membrane thickness and 400 μm channel width. Three oxygen concentrations 
were simulated: 100%, 60% and 21% of O2 entering the system from the gas side. As it was 
expected, the highest ΔSO2 and fastest O2 transfer is observed in case of pure oxygen, i.e. 6 
mL/min·m2 of O2 transfer in case of air and 54 mL/min·m2 in case of pure oxygen for 0.5 
mL/min blood flow rate. This effect is more important in the case of higher flow, where an 
increase from 21% to pure oxygen multiplies the O2 transfer rate by nearly 100%. This effect 
was also observed by the group of Fusch where the authors obtained 30 mL/min·m2 of the O2 
transfer rate in case of air as a source gas in comparison to 104 mL/min·m2 in case of pure 
oxygen [29]. Thus, it would be advisable to use pure oxygen to boost the oxygenation process.  
 
Figure 2.40 Comparison of the oxygen concentration from the source gas on the oxygen transfer rate in the MD 
at various blood flow rates at 120 μm of membrane thickness and 400 μm channel width 
Next, the influence of the membrane thickness on the final performance of the chip is 
illustrated in Figure 2.41 for 400 μm channel width and pure oxygen as gas phase. The highest 
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oxygenation was obtained in case of implementing the thinnest membrane due to the minimized 
resistance to gas diffusion through PDMS and the higher PO2,wall values (partial pressure of 
oxygen at the membrane wall in contact with blood). This effect is more pronounced in the case 
of higher blood flow rates when the oxygen demand per unit length is higher. 
 
Figure 2.41 Comparison of the influence that membrane thickness possesses on the oxygen transfer rate in the 
MD at different blood flow rates at 400 μm channel width and pure oxygen as a source gas 
The computer simulation presented in Figure 2.42 shows the modification of the oxygen 
transfer rate and SO2 as a function of channel width but keeping the cross section of the channels 
constant, i.e. the same total volume of the liquid chamber to maintain residence time constant. 
Four channel widths were simulated: 400 μm, 300 μm, 200 μm, and 100 μm. As it was expected, 
the thinner the channel the higher O2 transfer rate due to the smaller pathway that the oxygen 
has to overcome to bind to Hb.  
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Figure 2.42 Influence of the channel depth in the meander device on the oxygen transfer rate at different blood 
flow rates at 120 μm membrane thickness and pure oxygen as a source gas 
According to the simulated results, a weight average factor was calculated to illustrate the 
impact of the different variables studied on the oxygen saturation values, expressed as ΔSO2, at 
standard conditions: pure oxygen, 120 μm as membrane thickness and 400 μm as blood channel 
length. The blood flow rate equal to 0.5 mL/min was chosen for the calculation of these average 
weight sensitivity factors due to the fact that at this flow rate the blood is in the physiological 
environment, i.e. ΔP not higher than 20 mmHg. 
The example of the calculation of such average weight sensitivity factor is as follows: 
? = ? − ?100 − 60 (2.17) 
Where: X is the ΔSO2 mathematically obtained at the 100% of O2 in the source gas, Y is the 
ΔSO2 mathematically obtained at the 60% of O2 in the source gas. The same calculation was 
repeated for all three variables: a, b, c and it is presented below in detail. The results are 
presented in Table 2.10. 
? = ∆??????% − ∆?????%100 − 60  (2.18) 
? = ∆???????? − ∆???????120 − 60  (2.19) 
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? = ∆???????? − ∆????????400 − 200  (2.20) 
Table 2.10 Average weight sensitivity factors for the MD design 
Value Description 
a=0.07 Concentration of O2 in the gas phase [%] 
b=0.03 Membrane thickness [μm] 
c=0.02 Channel width [μm] 
 
The parametric sensitivity analysis showed that the major factor which influences the blood 
oxygenation in the microfluidic meander device is the concentration of oxygen in the gas side. 
Membrane thickness and channel width are influencing the oxygenation in a comparable way. 
Taking into account typical blood saturation values in neonates with respiratory problems (80% 
O2) and the oxygen blood saturation of healthy neonates (95% O2), Figure 2.43 illustrates how 
the total liquid chamber volume of the meander type microdevice should change as a function 
of the membrane thickness and channel width to achieve this target. In this parametric study, 
the rated flow and blood channel depth were established, being 0.1 mL/min and 100 μm, 
respectively and pure oxygen was used as a supply gas. The total of 30 simulations were 
performed where five different channel widths were examined, i.e. in the range of 100-400 μm, 
and six membrane thicknesses, i.e. in the range of 20-120 μm. Figure 2.43 shows the effect of 
miniaturization on blood oxygenation inside the meander design chip.  
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Figure 2.43 A theoretical plot demonstrating the impact of a microfluidic oxygenator device's membrane 
thickness and blood channel width on the liquid chamber volume for 0.1 mL/min as rated flow. PDMS was 
assumed to be the membrane material and pure oxygen was supplied from the gas side 
As it is visible in the figure above, the membrane thickness as well as the blood channel width 
have a clear impact on the liquid chamber volume for a given rated flow. As the channel width 
becomes shorter the effect of membrane thickness on liquid chamber volume is less noticeable.  
 
 
2.6. Conclusions 
In the presented chapter, two microfluidic chip configurations have been discussed, i.e. 
alveolar and meander design. The alveolar geometry was successfully modified in order to 
decrease pressure drop inside the architecture keeping the oxygenation at the same level. The 
ΔP was decreased by approximately a half of AD2 design in comparison to AD1 (1.3 mbar in 
comparison to 2.57 mbar respectively) without compensation on oxygenation performance. 
Computer modelling in COMSOL Multiphysics has enabled to predict the performance of 
designed structures in terms of pressure drop, homogenous liquid flow and oxygen 
concentration profile. The fabricated devices exhibit adequate mechanical stability for blood 
oxygenation applications and the surface modification reveals diminished protein adsorption. 
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At the blood flow rate of 1 mL/min the oxygen transfer rate for three devices are: 92 
mL/min·m2, 106 mL/min·m2 and 108 mL/min·m2 for MD, AD1 and AD2, respectively. 
Moreover, the microfluidic chips presented here possess not only high oxygenation 
performance, but also they are characterized by low pressure drop, can withstand high blood 
flow rates, i.e. up to 5 mL/min, and have biocompatible surface. 
The comparison of the oxygen transfer rate obtained in AD and MD to the leading research 
groups is presented in Figure 2.44. The O2 transfer rate was calculated from equation 2.16 and 
normalized with the membrane surface area of each device. The values shown in brackets 
represent the priming volumes of each microfluidic device. The oxygen transfer velocity 
increases with an increase of the blood flow rate. However, such increment is not linear, as the 
ΔSO2 dependence. It is visible that especially the performances of the alveolar designs are truly 
outstanding in comparison to the leading research groups. Only the values presented by the 
group of Borenstein are characterized by higher oxygen transfer rate with significantly lower 
priming volume. 
The mathematical model for oxygen transfer presented in this section predicted that the 
performance of the vertical membrane design will be slightly worse than both of the alveolar 
designs. This is connected with bigger dimensions of blood channels in case of the meander 
design, i.e. 400 μm, in comparison to alveolar architecture, i.e. with the width of approximately 
100 μm. These dimensions influence the diffusion distance of oxygen to blood. Moreover, the 
alveolar designs demonstrate the branching architecture, similar to a natural lung which helps 
in homogenous distribution of a gas. Furthermore, computer simulations show that by 
decreasing the blood channel width in MD down to 100 μm, the oxygen transfer rate of MD 
and AD would be comparable (see Figure 2.44 B) at low rated flows if hydraulic losses in MD 
remain acceptable. The oxygen transfer model was validated by means of intercomparison to 
the experimental results of the meander design.  
Additionally, parameter sensitivity analysis was also performed in order to envision the 
possible guidelines and to be aware of the importance of each parameter. The chip performance 
would improve notably by minimizing the values of membrane thickness, channel width and 
by using pure O2 as supply gas.  
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Figure 2.44 Oxygen transfer rate at various liquid flow rates for three different geometries: MD, AD1 and AD2 
in comparison to the leading groups at A) entire range of blood flow rates and B) blood flow in the range of 0.1-
1 mL/min together with the computer simulations for 100 μm and 400 μm channel width of MD. PV indicates 
priming volume 
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The concept of a microfluidic device as gas – ionic liquid contactor for CO2 removal from 
anaesthesia gas (containing Xe) is introduced. The working principle involves the transport of 
CO2 through a flat PDMS membrane followed by the capture and enzymatic bioconversion in 
the ionic liquid solvent. Thanks to miniaturization, the volume of ionic liquid required to fill the 
micro-chamber and the amount of the enzyme are notably reduced while providing high 
throughput for the preliminary screening of different ionic liquids and operational conditions. 
As proof of concept demonstration, simple gas permeability experiments were performed 
followed by the experiments with ionic liquid and ionic liquid combined with the enzyme.  
 
 
 
The contents of this chapter were adapted from the following published work: 
Malankowska, M., Martins, C.F., Rho, H.S., Neves, L.A., Tiggelaar, R.M., Crespo, J.G., Pina, 
M.P., Mallada, R., Gardeniers, H., Coelhoso, I.M. 
“Microfluidic devices as gas-ionic liquid membrane contactors for CO2 removal from 
anaesthesia gases” 
Journal of Membrane Science, 2018. 545: p. 107-115
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3. Microfluidic devices for anaesthetic gas separation 
3.1. Objectives  
The target of the experiments presented in this chapter was to validate a PDMS based gas-
liquid membrane contactor in the form of a microfluidic device for CO2 separation from 
anaesthetic gas. In the liquid side, the stream of either cholinium propionate ionic liquid (CP) 
as CO2 chemical solvent or CP solution containing carbonic anhydrase enzyme (CA) acting as 
a catalyst was carried out.  
3.2. Microfluidic device as G-L Membrane Contactor 
As it was described in Chapter 1 section 1.6, the miniaturization of the G-L membrane 
contactor for anaesthetic gas recovery will be beneficial from fabricating and economical point 
of view. The manufacture of such chip is inexpensive and easy to scale up. Moreover, the 
volume of a liquid phase required to fill the micro-chamber is notably reduced.  
3.2.1. Liquid phase in the G-L microfluidic membrane contactor 
It was described that ionic liquids possess high CO2 absorption properties (see Chapter 1, 
section 1.7.1). Moreover, cholinium based ILs acquire elevated CO2 capturing effect and high 
biodegradability. Based on the work of Martins et al [87] it was decided to use cholinium 
propionate ionic liquid as a liquid phase in the G-L microfluidic membrane contactor for 
anaesthetic gas recovery. Cholinium propionate IL was prepared by neutralization of propionic 
acid (purchased from Sigma-Aldrich, USA) in choline hydroxide in the University Nova de 
Lisboa. One of the significant parameters of IL affecting its viscosity and diffusion of CO2 is 
its water activity (aw). Water activity is defined as the partial pressure of water in a substance 
divided by the standard state partial vapour pressure of water at the same temperature. It is 
related to water content in a non-linear relationship named a moisture sorption isotherm curve. 
Basically, the gas diffusion through an ionic liquid depends on: 1) temperature, 2) molecular 
size of the gas and 3) viscosity of the IL. Keeping in mind that the molecular size of a gas is 
constant as well as the temperature of the experiment, the only variable is the viscosity of IL 
which is related to its aw. The viscosity of cholinium based IL decreases with the elevated values 
of water activity due to the molecular interactions promoted by water inside IL and thus, the 
diffusion of CO2 increases. Additionally, Henry’s constant increases with higher water activity 
which results in lower CO2 solubility values due to diminished ability of IL to solubilize CO2 
because of weak affinity between water and carbon dioxide. The water activity of CP IL 
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selected for the CO2 separation experiments was equal to 0.753 based on the results obtained 
by Martins et al [87]. Therefore, CP IL was equilibrated into a chosen water activity by sodium 
chloride salt (Applichem, Panreac, Germany) [120]. Briefly, CP was placed in the gas 
dessicator with sodium chloride salt at the bottom. The dessicator was placed in the room with 
controlled temperature equal to 30oC. The water content corresponding to a given water activity 
was measured by Karl-Fisher coulometer (Metrohm, model 831 KF coulometer). 
In order to increase the CO2 capturing effect, carbonic anhydrase enzyme was added to the 
cholinium propionate IL. Carbonic anhydrase lyophilized from bovine erythrocytes (ref: 
C3934, Sigma-Aldrich, USA), was used without any further purification. 0.1 mg of the enzyme 
was added to 1 g of ionic liquid, and the resulting mixture was placed on the mixing plate till 
complete dissolution. Enhanced CO2 transport was expected due to the high solubility of CO2 
in cholinium propionate assisted by the enzymatic CO2 conversion, i.e. chemical reaction, due 
to the presence of CA that lead to greater driving force. Table 3.1 represents the parameters of 
the liquid phase selected for the experiments herein described. 
Table 3.1 Parameters of the liquid phase used for CO2 capturing experiments 
Ionic Liquid Cholinium propionate (CP) [9] 
Density [g∙cm-3] 1.07 
 
Molecular weight [g∙mol-1] 177 
Viscosity [Pa∙s-1] 0.039 
Water activity 0.753 
Water content [%] 35.7 
Henry Constant CO2 [bar] 65.59 
CO2 Diffusivity [m2∙s-1] 3.3·10-10 
Enzyme Carbonic Anhydrase (CA) 
CA conc in IL [mg∙g-1IL] 0.1 
 
Water activity 0.753 
Water content for CP [%] 40.9 
Henry constant CO2 [bar] 74.23 
 
Microfluidic device for anaesthesia gas separation 
  
 
107 
 
3.2.2. Microfluidic chip design 
The microdevice, proposed for the G-L membrane contactor for anaesthesia gas recovery, 
consists of two independent chambers, one dedicated to the CO2 capturing liquid phase and the 
second one devoted to a gas, separated by the PDMS dense membrane, 60 μm thick. Simple 
dense membrane was chosen for the proof of concept demonstration in the G-L membrane 
contactor in order to ensure the stability of the chip and no problems with leakage or membrane 
detachment. Entire chip was fabricated from PDMS by soft-lithography as it was described in 
Chapter 2 section 2.4.1. Similarly, to blood oxygenation, the mass transfer limitations are 
mainly attributed to the liquid side; therefore, the key factor in the design of the microfluidic 
gas-liquid membrane contactor is the liquid side geometry. Hence, liquid channels were 
arranged in a branching-like-architecture, as it was described before, so the ionic liquid could 
be distributed in a homogenous flow regime in order to reduce dead volume and to avoid high 
pressure drop across the structure. The depth of the liquid channel, i.e. 100 µm, also aimed to 
minimize the mass transfer limitations in the liquid side. On the other hand, the gas chamber, 
in the form of an empty reservoir, possessed a number of supporting pillars in order to reduce 
the risk of membrane and chip collapse.  
The alveolar design with liquid flow distributors, i.e. AD2 (see Chapter 2 section 2.2.2) has 
been mainly adopted for the liquid chamber to ensure that mass transfer of carbon dioxide 
through the liquid phase, in order to reach the CA active reaction sites, does not become rate 
controlling. Figure 3.1 shows the conformation of the PDMS microfluidic device for 
anaesthetic gas recovery. 
 
Figure 3.1 Schematic representation of the gas-ionic liquid membrane contactor 
The gas, CO2 or Xe, was introduced in one of the microfluidic chambers. The IL was 
continuously fed to the liquid chamber with a low flow rate, i.e. 0.01 mL/min, in order to 
maintain constant and high driving force while the membrane deflection and/or liquid 
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microchannels blockage are avoided. CO2 permeated through the membrane and was captured 
by the liquid side.  
Computer modelling in COMSOL Multiphysics 5.0 was performed to calculate the pressure 
exerted on the walls of the liquid chamber and the homogeneity of the cholinium propionate 
ionic liquid flow. Such computer simulation enabled to predict the ionic liquid behaviour inside 
the microfluidic device and it also helped to define the operational conditions for the IL flow 
rates (for the fluiddynamic mathematical model see Chapter 2 section 2.2.1). As an example, 
Figure 3.2 shows the ionic liquid flow distribution in the liquid chamber at standard working 
conditions (0.01 mL·min-1) for which the resulting ΔP estimated by CFD was equal to 0.014 
mbar. However, it had to be taken into account that the tubing and metallic pins used to connect 
the microdevice to the macro world resulted in elevated pressure drop. Hence, it was observed 
that the maximum ΔP of the total experimental system before the membrane started to be 
deflected was approximately 60 mbar at a liquid flow rate indicated above. Detailed explanation 
and discussion of pressure drop that corresponds to each part of the system is described in 
Chapter 2 section 2.4.5.  
 
Figure 3.2 CFD simulation of ionic liquid flow distribution in the A) entire geometry of a microdevice and B) 
single unit of the total geometry at standard working conditions 
 
3.3. Theoretical calculations 
The equations presented in this section were used for the evaluation of the gas permeation 
through the membrane as well as the CO2 transport from the gas phase to the liquid phase. The 
expressions to calculate mass transfer coefficients are introduced together with the 
enhancement factor equation. 
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3.3.1. Membrane Permeability for Single Components 
The gas permeation measurements were carried out by monitoring the pressure changes 
with time in the feed and permeate side respectively. Thus, pure gas permeability was calculated 
according to the expression (3.1) which was derived from the mass balance equation under non-
steady state conditions [121] and which was also adapted to the experimental system described 
by Neves et al [97] and used in this work (see section 3.4.1): 
1? ?? ??????? − ????????????? − ?????? ? = ?㩐? ??  (3.1) 
where Pfeed and Pperm are the pressures in the feed and permeate side, respectively [bar], t is time 
[s], l corresponds to membrane thickness [m], Perm is the membrane permeability [m2 s-1] and 
β [m-1] is the parameter which depends on the geometry of the compartment and is given by: 
? = ?? ? 1????? + 1?????? (3.2) 
where Vfeed and Vperm are the volumes of the feed and permeate chambers, respectively [m3], 
and SA is the membrane surface area [m2]. In the experimental system used for our 
measurements the value of β was equal to 106.38 [m-1].  
The equation (3.1) results in a permeability with the units of m2 s-1. In order to convert this 
value into commonly used barrer units, the conversion factor (Conv_Factor) introduced by 
Cussler [121] was used: 
????_?????? = 10??????(???) ∙ ????? ∙ ? ∙ ???? ?1 ??? ?? ???22.4 ∙ 10????? ?0.082 ??? ∙ ???? ∙ ? ?
∙ ?76 ????1 ??? ? ∙ ?10????1 ? ? ∙ ? 1 ??10? ???? ∙ ? ??? 
(3.3) 
The conversion factor depends on the temperature. The temperature in each of the 
experiment was equal to 30oC. Therefore, the Conv_Factor for all the presented experiments 
calculated from the equation (3.3) is equal to 8.3·10-13. Then, the permeability expressed in m2 
s-1can be converted to barrer unit simply by dividing it by the Conv_Factor:  
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?㩐?㨌??????  (????㩐 ) = ?㩐?  (?? ∙ ???)????_??????  (3.4) 
3.3.2. Mass Transport in Membrane Contactors 
The CO2 mass transfer in G-L membrane contactors occurs due to the CO2 permeation 
across the membrane [122]. In order to evaluate the supplementary mass transfer resistance 
opposed by the membrane in the G-L absorption process, the overall mass transfer coefficient, 
denoted as K, and individual mas transfer coefficient in the liquid phase denoted as kL, were 
evaluated with and without CA. 
The flux of CO2, denoted as J [mol∙m-2∙s-1], from the gas to the liquid side in a membrane 
contactor [99] was calculated from the equation (3.5): 
? = ?∆? = ?(?? − ??∗) (3.5) 
where K [m·s-1], is the overall mass transfer coefficient for CO2 transport, ΔC is the driving 
force: CG is the CO2 concentration in the gas phase and CG* is the hypothetical CO2 
concentration in the gas phase that is in equilibrium with the CO2 concentration in the bulk 
liquid phase.  
Under the experimental conditions used in this work, for the evaluation of KCO2, the 
hypothetical concentration of CO2 in equilibrium with the CO2 dissolved in the CP (CG*), has 
been considered negligible due to the CO2 Henry constant values of the selected cholinium 
based ionic liquid and the continuous feeding of fresh solvent to the system. Thus, the global 
mass transfer coefficient was calculated from the exponential fit of the normalized pressure 
decay in the gas chamber according to the following: 
−? ????? = ? ∙ ?? ∙ (?? − ?∗) (3.6) 
Where, V is the volume of the pressurized gas chamber filled with the single component [m3] 
and SA is the membrane surface area [m2]. Since C* is assumed 0, then: 
 
??? = ?????? ? (3.7)         or ??? = ?????? ? (3.8)  
The exponential fit of the normalized pressure decrease provides the value of KSA/V. The 
value of global mass transfer K, can be next divided into individual resistances or individual 
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mass transfer coefficients for each experimental configuration from equation (3.9) which 
describes the resistance in series model [99] as shown below:  
1? = 1?? + 1?? + 1????? (3.9) 
where kG is the individual mass transfer coefficient in the gas phase [m·s-1], ??  is the individual 
mass transfer coefficient opposed by the membrane [m·s-1], ??  is the individual liquid phase 
mass transfer coefficient [m·s-1]; ??? is the individual liquid phase mass transfer coefficient 
[m·s-1] in absence of enzyme, m is the Henry’s law constant [-] and E is the enhancement factor 
due to the presence of CA [-]. 
The membrane resistance (RM) is calculated simply by the inverse of the individual mass 
transfer coefficient inside the membrane ( ???). Similarly, the resistances resulting from the 
presence of cholinium propionate (RCP) or cholinium propionate with the enzyme (RCP+CA) are 
calculated from the inverse of the mass transfer coefficient of the IL ? ????? and mass transfer 
coefficient with the enzyme ( ?????) respectively.  
The overall mass transfer coefficient expression can be simplified further to be solely dependent 
on ??  and ??  because all the experiments herein performed have been carried out with pure 
gases resulting in: 
1? = 1?? + 1???? (3.10) 
 
3.4. Anaesthetic gas separation experiments – principle of the 
measurements and experimental procedure 
The principle of the xenon recovery from the anaesthetic gas is based on the separation of 
CO2 from the gas mixture exhaled by the patient during the surgical operation (~65% volume 
of Xe). Basically, the experiments carried out in this chapter are: 
1) Single gas permeation measurements for CO2, O2 and Xe on the free standing PDMS   
membranes; 
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2) CO2 and Xe transport measurements on the microfluidic devices working as G-L 
membrane contactors with continuous feeding of CP as a liquid phase; 
3) CO2 and Xe transport measurements on the microfluidic devices working as G-L 
membrane contactors with continuous feeding of CP+CA as a liquid phase; 
In the following sections, the experimental systems for each type of experiments together 
with the working routines are described.  
3.4.1. Single Gas Permeability of PDMS free – standing membranes 
The permeability of a free standing PDMS membrane was evaluated, according to the 
method previously described by Neves et al [97]. The target of this set of experiments was to 
measure the permeation through non-commercial membranes fabricated in our laboratory.  
The membranes were fabricated by mixing PDMS pre-polymer with a curing agent in a 
ratio 10:1 and placed in the vacuum chamber for degassing. Next, the PDMS precursor solution 
was placed on the silicon wafer and spin coated (WS-400BZ, Laurell Technologies Corporation 
Spin Coater) at 1000 or 500 revolutions per minute (rpm) for 1 minute resulting in a membrane 
thickness of approximately 60 μm or 120 μm respectively. The wafer with spin coated 
membrane was placed in the oven for 45 minutes at 80oC. The thickness of the fabricated 
membranes was measured in the Clean Room by a profiler (P-6 Stylus Profiler, Kla Tencor). 
The PDMS thin films were gently removed from the wafer, cut to the required size, placed on 
the top of one of the gas compartment and covered with second gas compartment. The 
membrane was secured by the O-ring in between the stainless-steel compartments.  
The gas permeation measurements mainly involved the pressure monitoring with time in 
both gas compartments, which was related to the gas permeation through the membrane. The 
experimental system used for the experiments was composed of: 1) gas source, 2) two identical 
gas compartments (GC1 and GC2) dedicated to feed and permeate side respectively, and made 
of stainless-steel (volume: 6cm3) with the 3) PDMS membrane placed in between, 4) two 
pressure transducers (Druck PDCR 910 models 99166 and 991675, England) and 5) 
temperature controller which was immersed in a 6) water bath. The membrane module was 
placed in a water bath at constant temperature (30oC) monitored by temperature controller (TC). 
Figure 3.3 shows the schematic representation of the experimental system for the free standing 
membrane permeation measurements. The permeability of three different pure gases was 
evaluated: CO2, O2 and Xe. The gas was introduced on the feed side (Valve 1 and Valve 2 
opened) and the chamber was pressurized up to approximately 0.7 barg (V3, V4 and V5 closed). 
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As soon as the gas pressure reached 0.7 barg V1 and V2 were closed. The pressure decay on 
the feed side and the pressure increase on the permeate side were recorded using the two 
pressure transducers.  
 
Figure 3.3 Experimental system for the measurement of the gas permeability in the free standing membrane 
3.4.2. Single Gas Transport Measurements on the Microfluidic Devices 
The single gas transport measurements on the microfluidic devices working as G-L 
membrane contactors were carried out in the experimental system shown in Figure 3.4. In this 
case, the system consisted of: 1) gas source, 2) one pressure transducer connected to the 3) one 
stainless-steel gas compartment (volume: 72 cm3), 4) microfluidic device, 5) syringe pump for 
the liquid phase feeding (NE-1000, New Era Pump Systems Inc. USA), and 6) temperature 
controller (TC). The gas compartment together with the microfluidic device was immersed in 
the water bath at 30oC.  The gas (xenon or carbon dioxide) was introduced on the feed side with 
V1 and V2 opened while valves 3 and 4 were closed. The feed side was pressurized up to 0.1 
barg; after equilibrium V1 and V2 were closed and V3 was opened. The liquid phase was fed 
by a syringe pump connected to the liquid chamber (permeate side) at 0.01 cm3·min-1. The outlet 
of the liquid side was left open to the atmosphere so there was always a fresh portion of ionic 
liquid entering the compartment.  
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Figure 3.4 Experimental system for measuring the transport rate of CO2 or Xe in the microfluidic device 
working as G-L membrane contactor 
3.5. Results  
In this section, the microfluidic devices working as a gas-liquid membrane contactor are 
fully characterized. Firstly, proper connections and absence of leaks are checked to ensure 
reliable results. Then, the permeability results of free standing membranes are presented. From 
this information, the effective mass transfer coefficient of the dense PDMS membrane, kM, is 
calculated from equation (3.9). Next, the performance of the microfluidic devices for CO2 and 
Xe is studied for CP and CP+CA as liquid media, respectively. The evaluated values are 
discussed and opportunities for further improvement are identified. 
3.5.1. Device characterization 
Figure 3.5 A shows the photograph of a microchip with liquid chamber (blue dye) and a gas 
compartment (pink dye) in order to visualize the flow path. The image indicates that the filling 
of the gas and liquid channels was homogenous, demonstrating that there was no dead volume. 
Metallic pins were inserted at the inlet and outlet of gas and liquid compartments in order to 
facilitate introducing the piping into the microchip. To avoid deformations or leaks in the chip, 
the maximum allowable pressure in the gas side was 0.1 barg. On the other hand, the maximum 
allowable liquid flow rate was equal to 0.01mL·min-1, leading to the pressure drop of the liquid 
side, considering piping, pins and the chamber, to approximately 60 mbar. Although the use of 
PDMS elastomer facilitated chip fabrication and reproduction of the same design with thin non-
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porous membrane attached to the chambers; one of its main limitations is precisely the narrow 
working conditions for stable operation.  
SEM picture of a cross section of a microdevice (Figure 3.5 B) indicates that the membrane 
was well attached to the microfluidic chambers, resulting in no leaks or deformation of the 
membrane or the microfluidic chambers. Four chips, with approximately 60 μm membrane 
thickness, were built and tested. Each microdevice was capable to work for at least 8 hours 
under the standard conditions for this work:  0.1 barg as pressure on the feed side at t=0 and 
0.01 mL·min-1 as liquid flow rate. 
The membrane surface area in the chip was equal to 3.9 cm2
. 
The chip footprint, defined as 
the total size of the microfluidic device taking into account its width and length, was equal to 
18.9 cm2 making it a very compact system. The thickness of the PDMS mould, where the liquid 
or gas geometry was embedded, for both compartments was in the range of 0.8 – 1 cm. The 
depth of the gas as well as liquid chamber was equal to 100 μm resulting in the volume of the 
gas geometry of 0.073 cm3 and volume of the liquid 0.038 cm3, considering only the volumes 
of the chambers (without any external connections). Hence, the resulting S/V ratio, also denoted 
as specific gas-liquid interfacial area in absorption processes, is 3500 m2/m3, which is higher 
than the 30-330 m2/m3 offered by packed/tray towers and 160-500 m2/m3 for mechanically 
agitated absorption columns. 
 
Figure 3.5 PDMS microfluidic device: A) liquid and gas chambers filled with food dye for better visualisation; 
B) SEM cross section of the chip 
The S/V ratio for the hollow fibre membrane module varies inversely with the fibre diameter, 
nevertheless the ratio is approximately 15000 m2/m3 which exhibits higher values than a 
microfluidic device [123]. The liquid geometry of the microdevice used for the anaesthesia gas 
recovery was the alveolar design 2 (AD2) described in detail in Chapter 2 section 2.2.2. Table 
3.2 shows the main parameters of the microfluidic device used for CO2 gas separation. 
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Table 3.2 Geometry of the microfluidic chip used as G-L membrane contactor 
Parameter Value 
Membrane thickness [μm] 60 
Membrane surface area 
[cm2] 3.9 
Chip footprint [cm2] 18.9 
Gas chamber volume [µL] 73 
Liquid chamber volume 
[µL] 38 
Depth of the liquid/gas 
channels [μm] 100 
S/V ratio [m-1] 3500 
3.5.2. Single Gas Permeation Results 
The gas permeation experiments of a free-standing membrane were performed in the 
experimental system shown in previous section in Figure 3.3. Pressure decrease at the feed and 
pressure increase at the permeate side were measured and the resulting permeability was 
calculated using equation (3.1). Figure 3.6 A shows the pressure variation for two different 
membranes (60 μm thick and 126 μm thick) for a typical carbon dioxide experiment. The raw 
data shows that the pressure decrease of the feed is proportional to the increase of pressure at 
the permeate indicating that the volumes of the feed and permeate chambers are equal and that 
there is no leak in the system. The measurements were performed for oxygen, xenon and carbon 
dioxide and the same behaviour of the gas was observed in all the cases satisfying the mass 
balance with ±5%. Figure 3.6 B shows the normalized ΔP decay (defined using t=0 as reference) 
versus time divided by the thickness for three different gases in two earlier mentioned 
membranes. As it was expected, the slowest normalized pressure drop (ΔP/ΔP0) decay rate was 
observed in case of oxygen which has the lowest permeability through PDMS membrane, i.e. 
310-357 barrer. In contrast, the higher slope was shown for carbon dioxide with highest 
permeability through PDMS, i.e. 854-843 barrer.  Additionally, the decay is overlapped for two 
different thicknesses of the membranes in the case of oxygen and xenon which do not interact 
or absorb in the PDMS. However, in the case of CO2, the decay is faster for the thinner 
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membrane, indicating that CO2 has a specific absorption on the PDMS. This effect will be 
considered later in the experiments with the ionic liquid.  
 
 
Figure 3.6 Two distinctive free standing membranes (60 μm and 126 μm thick) and their A) feed pressure decay 
and permeate pressure increase of CO2; and B) normalized pressure drop of three different pure gases (O2, Xe 
and CO2) 
There are several factors influencing the gas permeation properties of PDMS membranes; 
mainly mixing ratio and curing temperature. The mixing ratio used in this work of the PDMS 
prepolymer to the curing agent was 10:1. This ratio is suggested by the producer and it 
represents a good balance between permeability and mechanical stability of a material. The 
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crosslinking process is defined by the Si – H groups (silicon hydride) and it has a direct 
influence on the resulting elastomeric network. The bigger the mixing ratio, the higher the 
permeability because less of a curing agent is added to the mixture, which means that the cross 
linking between the polymer chains is weaker, the polymer matrix is more relaxed and the free 
volume increases so the gas molecules can move easily within the polymer matrix. Lamberti et 
al analysed the influence of the mixing ratio on the permeability of air through the PDMS 
membrane. The permeability of this gas increased from approximately 600 barrer at the mixing 
ratio 10:1 to about 1600 barrer at the ratio 20:1 [124]. However, during membrane fabrication 
the mechanical stability has to be taken into account for peeling off the membrane from the Si 
wafer. It was observed that the mixing ratio has an impact on the mechanical properties of the 
cross-linked material. The elastic modulus (Young’s modulus) was examined by tensile 
measurements. Young’s modulus escalates with the higher amount of a curing agent due to a 
stronger network formation. Summarizing, the bigger amount of a cross-linker the more 
mechanically stable the structure is with lower permeability at the same time [124-127]. Thus, 
the optimal prepolymer: curing agent ratio depends on the final application. 
The obtained permeability values for three different gases are presented in Table 3.3. As it 
was expected, the permeability values remain almost constant with the membrane thickness. In 
the recovery of the anaesthetic gas, we consider only the separation of CO2 and Xe, thus the 
ideal selectivity αCO2/Xe, calculated as the permeability ratio, was presented in the table. It is 
also noteworthy that the ideal selectivity αCO2/O2, i.e. 2.5, is quite similar to those values 
published in the literature. Lagorsse et al obtained the αCO2/O2 selectivity of 2.69 and 4.55 for 
two commercially fabricated thin films: Blue Membrane and Carbon Membrane, respectively 
[62]. 
Table 3.3 O2, CO2 and Xe permeability values for the prepared free-standing membranes 
Thickness 
[μm] 
Permeability O2 
[barrer] 
Permeability CO2 
[barrer] 
Permeability 
Xe [barrer] 
Ideal Selectivity 
αCO2/Xe 
60 357 854 620 1.4 
126 310 843 612 1.4 
Moreover, it is concluded from Table 3.3 that the permeability of Xe is only slightly lower 
than of CO2 with ideal selectivity of 1.38. In fact the values of the Lennard – Jones kinetic 
diameter are similar, 3.94 Å and 4.04 Å for CO2 and Xe respectively [128]. Merkel et al studied 
the permeability of different gases in PDMS and they concluded that even though the kinetic 
diameters of gases are similar, permeabilities can be different as a result of relative solubility 
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of a gas in PDMS. Typically, gases with higher critical temperatures, 31.1ºCfor CO2 vs. 16.6ºC 
for Xe, exhibit high condensability and are more soluble in polymers as well as in liquids.  
3.5.3. Single Gas Transport Results in the Microfluidic Device 
In this section, the influence of the ionic liquid and ionic liquid combined with the enzyme 
on the transport rate of xenon and carbon dioxide inside the microfluidic chips are presented 
and discussed. Special emphasis has been devoted to the comparative analyses of the following 
processes: 1) CO2 transport through the PDMS membrane in the absence of solvents in the 
liquid chamber, 2) CO2 transport from the gas phase to the liquid phase due to gas permeation 
followed by chemical reaction in the bulk ionic liquid, and 3) in the bulk ionic liquid containing 
CA enzyme as catalyst. The global mass transfer resistances resulting from the three procedures 
and the overall mass transfer coefficients are calculated and interpreted. 
The gas permeation experiments through the membrane integrated in the microfluidic chip 
was carried out in the experimental system shown in Figure 3.4 in section 3.4.2. In this case, 
the liquid chamber was empty and the valves connecting the chamber to the atmosphere were 
closed. The pressure decay was recorded for xenon and carbon dioxide. Figure 3.7 A shows the 
raw data of a pressure decrease at the feed and pressure increase at the permeate side for CO2 
inside one of the chip, while Figure 3.7 B illustrates the comparison of normalized pressure 
drop for four different chips, containing membranes with the same thickness 60±2 μm, in case 
of carbon dioxide.  
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Figure 3.7 A PDMS membrane integrated in the microfluidic device and its (A) feed pressure decay and 
permeate pressure increase of CO2 and (B) normalized CO2 pressure drop recorded for the four different chips 
prepared in this work. 
It is visible from Figure 3.7 A that the pressure at the feed decreases slower than the pressure 
at the permeate increases. This is related to the difference in the volume of two chambers. 
Taking into account that the feed chamber consists of a gas compartment made of a stainless 
steel connected to the gas chamber of a microdevice and considering all the pins, piping and 
valves the total volume of the feed side is 72.83 cm3. On the other hand, the permeate side 
consists only of a liquid chamber of a microfluidic device and the piping leading to the volume 
of 0.12 cm3. 
Additionally, in a proposed microdevice there is not only a membrane which is made of 
PDMS but also both chambers. The thickness of the PDMS mould of all four chips is 
comparable, i.e. 0.8-1 cm. Unlike free standing membrane experiments, shown in section 3.5.2, 
the amount of CO2 moles permeating from the feed side significantly differed from the amount 
of CO2 moles appearing on the permeate side. The contribution of CO2 sorption on the PDMS 
side walls accounts up to 15%. In other words, the gas permeates not only through the 
membrane but through the chamber walls, as well, resulting in modified gas transport values. 
In this scenario, a significant contribution of the PDMS walls effect on the recorded pressure 
variation in the feed side is expected. To corroborate such hypothesis, the CO2 permeability 
measurements of the last chip (chip 4) were carried out slightly different: before the pressure 
decay measurement, the microfluidic device was saturated with carbon dioxide for about 3 
hours. After that time, the measurement was executed as it was described above. The aim of 
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this procedure was to saturate the PDMS walls with CO2 in order to avoid the effect of the 
PDMS sink for a gas. Thus, the total transport of a gas occurred through the membrane rather 
than in the PDMS walls. This is visible in Figure 3.7 B where the biggest decay of a normalized 
pressure is observed in Chip 4. Hence, it was decided that to avoid the PDMS walls effect, the 
values of the membrane permeability and a membrane resistance for a given gas will be taken 
from the experiments presented in the previous section for a free standing membrane. 
In order to increase the driving force for CO2 transport and CO2/Xe selectivity, cholinium 
propionate ionic liquid, CP; alone or combined with carbonic anhydrase enzyme, CA, was 
introduced to the liquid chamber by a syringe pump with the flow rate of 0.01 mL min-1 as it is 
presented in the experimental set-up in Figure 3.4. The experiments were carried out for the 
four different chips with PDMS dense membrane, 60±2 μm thick. To confirm that CP and 
CP+CA does not have any influence on the transport rate of xenon, an identical set of 
experiments were carried out in the case of Xe as well. As it was done in the previous 
measurements, pressure decay in the gas chamber was recorded and the calculation of the total 
resistance for each single experiment was performed.  
Figure 3.8 comparatively shows the normalized pressure decay in the feed side for all three 
experimental configurations as a function of time for CO2 (A) and Xe (B), respectively. There 
is no visible effect of ionic liquid and the enzyme on the affinity of xenon in comparison to the 
measurements with the empty liquid chamber. Additionally, there is a slight enhancement in 
the CO2 pressure decay rate in presence of the CP. The carbon dioxide pressure decreases even 
more rapidly as a result of the catalytic chemical reaction due to the presence of the CA in the 
CP.  
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Figure 3.8 Normalized pressure decay in the feed side over time in the empty chip (no IL), the chip with CP and 
the chip filled with CP and CA for A) CO2 and B) Xe 
Figure 3.9 represents the final decay of gas pressure in the feed side of four different chips 
at the three experimental configurations in the form of a bar graph. It is visible that the ionic 
liquid has a positive influence on the CO2 transport and it increases it slightly. However, the 
biggest rise in the gas transport is obtained when the catalytic enzyme is added to the CP, which 
is in agreement with previous works and results obtained by Martins et al after addition of CA 
to CP in a bulk system [87, 97].  
 
Figure 3.9 Enhanced CO2 transport due to the presence of ionic liquid and the enzyme: results for the four 
different chips prepared in this work 
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Table 3.4 compiles the estimated values for the mass transfer coefficients at the three 
experimental configurations. In particular, for the estimation of the KCO2 in absence of solvents 
in the liquid chamber, i.e. kM, the registered permeability value for the free standing membranes 
(see Table 3.3) and the specific thickness of the PDMS membrane were used. The enhancement 
factor due to the addition of the enzyme is also presented in the table together with the CO2/Xe 
transport selectivity for the CP+CA configuration, which was calculated as a quotient of 
KCO2/KXe.  
As it was expected, the obtained results are indicating that the main controlling resistance 
to CO2 transport in the gas – liquid membrane contactor is located in the liquid phase. When a 
membrane contactor is used in place of a direct contact G-L absorption column, the 
intensification factor (i.e. size reduction effect) essentially depends on the product of the overall 
mass transfer coefficient by the specific gas–liquid interfacial area S/V. In general, compared 
to packed columns, a large increase of the interfacial area is offered by the membrane contactor. 
For the microdevices herein used, this value scales up to 3500 m-1. In contrast, the overall mass 
transfer coefficient K necessarily decreases almost one order of magnitude due to the 
supplementary mass transfer resistance opposed by the membrane, which is directly related to 
the membrane thickness. 
Table 3.4 Microfluidic Device Performance for CO2/Xe separation. 
 Chip Chip+CP Chip+CP+CA 
Chip ????= ?? 
????= ???? + ?????
 
[m∙s-1] 
RCP [%] 
????= ???? + ??????
[m∙s-1] 
RCP+CA 
[%] E 
Transport 
Selectivity 
CO2/Xe 
1 1.19·10-5 1.24·10-6  89.6 2.11·10-6  82.3 1.9 3.5 
2 1.17·10-5 1.25·10-6  89.3 2.07·10-6  82.3 1.8 2.9 
3 1.10·10-5 1.58·10-6  85.6 2.11·10-6  80.8 1.4 3.8 
4 1.14·10-5 1.51·10-6  86.8 1.87·10-6  83.6 1.3 3.0 
In this work, the membrane mass transfer coefficient, thanks to the PDMS permeability and 
the thickness of the spin-coated membrane, is comparable to the range of coefficients when a 
direct gas-ionic liquid contact applies, i.e. 10-4 -10-5 m·s-1 [14]. 
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We found that individual liquid phase resistance values RCP are in the range of 85-90% of 
the total resistance. The overall mass transfer coefficients are two orders of magnitude lower 
than the ones presented by Yong et al due to higher viscosity of the ionic liquid (39 mPa·s vs 2 
mPa·s) and the lower solvent Reynolds number, (0.001 vs. 20) used in this work. Additionally, 
in our case, we were not able to increase the flow rate of the IL because this would augment the 
pressure drop in the entire system, above the limit of 0.1 bar, leading to deformation and leaks 
in the chambers. The enhancement factor on CO2 transport due to the presence of the enzyme 
increases up to 1.9. This value is clearly outstanding compared to published results [99] due to 
the lower amount of free enzyme in the microfluidic device, i.e. 4 µg. The enhancement factor 
(E) results, after addition of carbonic anhydrase to cholinium propionate ionic liquid, are in 
agreement with the results obtained by Martins et al. for bulk experiments [87] where an 
enhancement of 1.6 was obtained. This observation supports the benefits of the alveolar type 
design for ensuring the facile access to the catalytic CA active reaction sites. Finally, the 
CO2/Xe transport selectivity after addition of the ionic liquid and the enzyme increased up to 
3.8. 
3.6. Conclusions and Future Work 
In summary, we have investigated the effect of CP ionic liquid and its combination with 
CA catalyst on the CO2 transport properties in a PDMS microfluidic device working as G-L 
membrane contactor. The microfluidic experimental system, compatible with the solvents used, 
was tested at semi-continuous operation mode, i.e. continuous for the liquid phase but 
discontinuous for the gas phase. Even though the permeability of PDMS for Xe and CO2 was 
similar, the cholinium propionate and cholinium propionate in combination with carbonic 
anhydrase led to a significant improvement on the CO2/Xe transport selectivity due to the 
distinctive chemical absorption of CO2 by the liquid phase. 
This work serves as the proof of concept demonstration for CO2 removal from the 
anaesthesia gas through a membrane contactor in the form of a microfluidic device. Thanks to 
miniaturization, the consumption of the chemicals, i.e. ionic liquid and enzyme, is notably 
reduced; whereas the S/V ratio overpasses the standards for direct G-L contact systems. At the 
same time, it provides noticeable enhancement factor due the reduction of the diffusion 
pathways to access to the catalytic CA active: up to 1.9 in the presence of 4 µg of the enzyme. 
Additionally, this type of liquid side geometry and device assembly could be successfully used 
for the xenon recirculatory machines for neonates where the low capacity is mandatory.  
Microfluidic device for anaesthesia gas separation 
  
 
125 
 
Further research in a close future should also consider:  
-Alternative materials for the fabrication of the microfluidic chambers compatible with the 
IL phase, in order to avoid the sink effect on the walls and to enlarge the operational working 
window ensuring the chip integrity. Ideally, large transmembrane pressure difference is 
desired in order to be used for the regeneration step. In this sense, the use of thicker 
membranes would be more convenient.  
-The exploration of novel membrane architectures (porous, corrugated) to enlarge the S/V 
ratio and, consequently the overall transport rate. 
-The use of higher concentrations of the CA enzyme, playing as catalyst, and solvent flow 
rates to enlarge the mass transfer coefficients in the liquid phase. 
  
  
 
 
 
 
 
 
Chapter IV 
 
 
This chapter introduces an alternative concept of a silicon/glass microfluidic chip with an 
integrated nanoporous SiO2 membrane in the form of three-dimensional fractal geometry with 
nanopores for gas permeation. The fractal structures, that are fabricated by oxide corner 
lithography, are hollow which enable the gas to enter to the 3D geometry and to permeate 
through the nanopore. The chips possess extraordinarily high surface-to-volume ratio, i.e. 2000 
m-1, and are characterized by controlling diffusion distances, in the order of 100 nm. The 
obtained results show that the gas permeation through the nanonozzles in the form of fractal 
geometry, governed by molecular diffusion, is remarkably enhanced in comparison to 
commonly used PDMS dense membrane. The developed chip, emerge as an alternative for G-
L or G-G contactors that require harsh conditions. 
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4. Three-dimensional Fractal geometry for gas 
permeation in microchannels 
4.1. Introduction 
The importance of membranes in microfluidic systems is reflected by numerous 
applications including the detection of chemical reagents and gases, drug screening, cell culture, 
protein separation, chemical synthesis at small scale, and electrokinetic and hydrodynamic fluid 
transport [129, 130]. In particular, when the role of the membrane is to act as a gas-liquid 
interface, effective gas permeation and minimal leakage is required [131].  
The key issue for the combination of membranes and microfluidics is the sealing of the 
interfaces to avoid leakage, especially in the case of gases. The most convenient strategies to 
do this include: i) fabrication of the membrane as an integral part of the silicon chip, and ii) 
exploiting the permeation properties of certain polymers by fabricating the chips directly from 
these materials [129]. In the case of biological applications, this last option has been adopted in 
most of the cases by using PDMS chips. It is well known that this polymer possesses high 
oxygen permeability [132]. However, when chemical or temperature resistance is needed, the 
use of silicon chips is preferred. Therefore, the replacement of a conventionally used gas 
permeable PDMS chips by silicon structure and the concept of porous membrane made of 
fractals containing nanoapertures results in effective, compact and inert gas permeation device. 
Moreover, the elevated surface to volume ratio is emphasized to improve efficiency of the 
process and chip throughput. 
4.2. Fractal geometry 
Fractal geometry describes disciplines that consider symmetry-broken structures where, 
after magnification, the shape appears identical. In other words, the magnified piece is almost 
a copy of the whole [133]. Recently, Berenschot et al from the University of Twente has 
developed the fabrication method, based on a combination of anisotropic etching of silicon and 
so-called corner lithography, to create small nanoapertures of approximately 80-100 nm in the 
form of a three-dimensional fractal geometry [133, 134]. Briefly, conformal deposition of layers 
of silicon nitride by low-pressure chemical vapor deposition (LPCVD), and thermal oxide and 
partly back-etching of a silicon nitride layer that is placed inside the octahedral silicon pits is 
used in order to form dots in sharp concave corners. The crystalline property of silicon and a 
gradual etching characteristic of its (111) planes result in the formation of octahedral cavities. 
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Repeated corner lithography, in combination with anisotropic etching, results in the 
construction of 3D octahedral fractals which are hollow inside and where the number of layers 
can be controlled (for more detailed fabrication procedure see Appendix). 
The important features of the mentioned fabrication process are the possibility to scale up 
to wafer level and the ability to tailor the number of apertures and thus control the diffusion of 
gases through them. These apertures are distributed on the corners of pyramids which are part 
of a 3D fractal structure that can be replicated (see Figure 4.1). This fact adds an additional 
advantage that could not be achieved in other 2D materials that are easily integrated with silicon 
microfluidics, such as porous silicon or anodized alumina. To decrease mass transfer 
limitations, which often are encountered in the liquid side of the channels, the 3D fractal 
structure could be embedded in a microfluidic channel which results in larger interfacial area 
and higher surface to volume ratio. The schematic drawing of this structure and how it evolves 
is presented in Figure 4.1 B. The blue octahedral structures in the fractal correspond to 1st and 
2nd generation and the transparent structures correspond to 3rd generation that will be created 
after a corner lithography process, containing pores represented by the yellow dots.  
 
Figure 4.1 A) SEM image of 3rd generation open fractals, B) Schematic representation of fractal  
In order to maximize gas diffusion and increase surface to volume ratio, the fractals with 
three generations have been selected for this work. Figure 4.2 shows the SEM photograph of 
three fabrication stages of the fractal geometry (the apertures of the 3rd generation fractals are 
not visible in this SEM image). 
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Figure 4.2 SEM image of A) 0th, B) 1st, C) 2nd and D) 3rd fabrication stage 
4.3. Experimental procedure 
4.3.1. Chip design and assembly 
The main considerations in the design of a proposed chip for gas diffusion in a channel are: 
1) the number of fractal levels fabricated, that is directly connected with the number of 
openings, 2) the number of fractals in the channel, 3) the space between them and 4) the distance 
from one phase to another, i.e. the depth of the channel, which is related to the diffusion 
distance. Moreover, it had to be considered that the size and density of the fabricated fractals 
had to be extremely precise in order to avoid merging of fractals during its expansion. 
Therefore, the octahedral size of the next level should never be bigger than the half size of the 
previous fractal geometry. The etch rate should be monitored and nanonozzle size should be 
minimized, when the maximum density is anticipated.  
In this work the fabricated structures were integrated in the microfluidic chip that will be 
adopted for the gas diffusion through the nanonozzles for the first time. In particular, the fractal 
structures were fabricated in a channel 3.5 cm long and 300 (Chip 1) or 500 (Chip 2) microns 
wide, containing a total of 244 (Chip 1) and 308 (Chip 2), 3rd generation fractals, unevenly 
distributed along the channel. Before the experiments, the total number of fractals containing 
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open pores was evaluated by optical microscopy; the final number of estimated pores and 
characteristics of the chips is presented in Table 4.1.  
Table 4.1 Properties of fabricated fractal chips 
 Chip 1 Chip 2 
Channel width (μm) 500 300 
Number open fractal structures 244 308 
Surface area [m2] 1.75·10-5 1.05·10-5 
Volumetric porosity, ε 1.06·10-3 2.23·10-3 
Size of the starting groove of 
fractal, 0th level (μm) 25 
The total surface area of the channel was assumed as the active surface area of the 
membrane, i.e. width*length of the microchannel. The porosity was calculated as the volumetric 
porosity by dividing the volume of the 3rd generation entities by total volume of the structure, 
i.e. the surface area of the channel multiplied by the thickness of the position where the fractals 
were embedded, i.e. 25 μm (see Figure 4.3).  
The channel containing fractal structures was anodically bonded to a glass wafer with 
powder blasted holes and assembled together with another wafer containing a single channel 
500 μm in height and same width and length as the fractal channels. Figure 4.3 shows a 
schematic representation of the final chip vertical and horizontal cross section, containing a 
single freehanging fractal for simplicity. 
To connect the microchip to external piping in order to be able to perform the permeation 
experiments a fractal holder was designed and 3D printed (RapidShape S30L) at the University 
of Twente. Four identical parts were printed from a photopolymer resin and the chip was 
sandwiched in between two parts at the inlet and two parts at the outlet of the chip. The holder 
parts were connected by two pins of 1.5 mm diameter. Each fractal holder part consisted of a 
thread (3.95 mm diameter, 0.7938 threading and 32 pitch) in order to connect the external 
capillary, 360 μm diameter (Teknokroma, Tubing Fused Silica) through the Nanoport fittings 
(IDEX Health&Science, Nanoport Fittings) to enable the transfer line (3.2 mm diameter) 
connection of feed and sweep gases at the inlet as well as retentate and permeate gases at the 
outlet (see Figure 4.4).  
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Figure 4.3 Schematic representation of the silicon nanonozzle chip A) vertical cross-section and B) horizontal 
cross section  
 
Figure 4.4 Fractal holder and chip assembly 
4.3.2. Gas permeation measurements and mechanisms 
To evaluate the permeation through the pores of the fractal geometry two possible 
permeation mechanisms occurring simultaneously could be considered: molecular flow (or 
Knudsen) and viscous flow (or Poiseuille) (see Figure 4.5) [135, 136]. 
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Figure 4.5 Visual demonstration of viscous and Knudsen transport mechanisms 
The expressions shown below describe the molecular (Equation 4.1) and viscous (Equation 
4.2) flows through conventional porous membranes [2].  
? = 4??3 ∙ ?2???? ??/? ∙ ?? − ?????  (4.1) 
Where, j is the flux [mol s-1 m-2], p0 and pl are the pressures in the retentate and permeate 
respectively [Pa], ε is the porosity, r is the pore diameter [m], τ is the tortuosity (assumed as 1), 
t is the membrane thickness [m], M is the gas molecular weight [kg mol-1], R is the gas constant 
[J mol-1 K-1] and T is the temperature [K]. 
? = ???8? ∙ ??? − ?????? + ??????  (4.2) 
Where, η is the gas viscosity [Pa·s] 
Viscous flow occurs when the size of the pore that the gas is flowing through is significantly 
larger than the mean free path of the gas (e.g. dp >> λ), defined as the average distance the 
particle travels between collisions with other moving particles. If the pore diameter decreases 
and becomes smaller than mean free path, (e.g. dp << λ), the flow regime gradually starts to 
change. The mean free path can be calculated from the kinetic theory of ideal gases. Gas 
molecules are immediately adsorbed after each collision, and they are reflected in a random 
direction. The collisions of molecule-molecule are rare, and thus each gas molecule moves 
independently of each other. This type of gas permeation is called Knudsen diffusion. A lower 
limit for the significance of the Knudsen mechanism has usually been set at dp > 20 Å. Different 
flow regimes can be described by the dimensionless Knudsen number: Kn=λ/d, being λ the 
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mean free path of the molecule and d the diameter of the pore. According to the Kn number, 
the gas flow behaviour can be divided into viscous (Kn < 0.01), transition (0.01 < Kn <1) and 
molecular (Kn > 1) flow regime. In our case, the Knudsen number is around 1.4 indicating that 
we are dealing with molecular flow.  
The experimental system for gas permeation (see Figure 4.6) consists of: 1) gas source, 2) 
mass flow controllers (Brooks, 5850 TR, USA), 3) two pressure transducers (Panasonic, DP2-
41E, Spain), 4) microfluidic fractal chip, 5) needle valve and 6) micro-Gas Chromatograph 
(Micro – GC, Varian CP-4900, EVISA, USA). Two bubble meters were placed at the retentate 
and permeate side, respectively in order to measure the gas flow rates to ensure that there were 
no leaks in the system.  
 
Figure 4.6 Experimental system for gas permeation 
The permeation of two gases was measured: O2 (purity grade 99.999% Praxair, USA) and 
CO2 (high-purity grade 99.998% Praxair, USA). One of these two gases was introduced to the 
feed chamber at a given flow rate, controlled by mass flow controller (MFC). The pressure on 
both sides was measured by a pressure transducer (PI). The sweep gas (He, purity grade 
99.999% Praxair, USA) was introduced to the permeate chamber of the fractal microfluidic 
chip at a constant flow rate, 10 mL STP/min. The gas permeated through the nanoapertures to 
the permeate side, i.e. the mixture He + gas (CO2 or O2) was analysed in the Micro GC equipped 
with two modules, one with a M5A mole-sieve column and the other with Pora PLOT Q (PPQ) 
column. He was used as a carrier gas in both columns. The micro-GC was calibrated in the 
range of 2.5 to 4.5% in volume for CO2 and O2, respectively. Table 4.2 shows the details of 
each experiment, i.e. type of gas, different gas concentrations at the feed, driving force 
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calculated as the difference of partial pressure of "i" species at the feed and permeate side, 
respectively, and final gas concentration at the permeate. 
Table 4.2 Experimental conditions of each gas permeation experiment 
Chip Gas Gas concentration 
feed [%] Driving force [bar] 
Gas concentration 
permeate [%] 
1 O2 
50 1.66 2.94 
60 1.85 2.79 
70 2.05 2.83 
80 2.24 3.04 
90 2.43 3.42 
100 2.62 3.19 
1 O2 
50 1.66 3.27 
60 1.85 2.92 
70 2.05 2.84 
80 2.25 3.17 
90 2.43 3.22 
100 2.62 3.08 
2 O2 
50 1.66 3.76 
60 1.85 4.37 
70 2.05 4.52 
80 2.25 4.91 
90 2.44 5.13 
100 2.64 5.85 
2 CO2 
50 1.77 2.56 
60 1.87 2.63 
70 2.07 2.80 
80 2.25 3.26 
90 2.46 3.42 
100 2.66 3.50 
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The gas permeance was calculated according to equation (4.3): 
?? = ????? ???? ∆??  (4.3) 
Where Pi is the permeance of the “i” gas (i.e. O2 or CO2) [mole/m2·s·Pa], Qperm is the total molar 
flow of the permeate [mole/s], Yi is the molar fraction of the “i” gas in the permeate side, SA is 
the membrane surface area [m2], and ΔPi corresponds to the driving force for permeation of “i” 
species and is the difference between the partial pressure in the feed side and the permeate side, 
respectively. 
4.4. Permeation results for single gases 
Figure 4.7 shows two different sets of experimental points for permeation of oxygen versus 
mean pressure obtained for Chip 1 and Figure 4.8 corresponds to the permeation of oxygen and 
carbon dioxide in Chip 2.  
The molecular (Knudsen) flow regime was considered as the dominant flow through the 
nanonozzles, similar to previous work describing the flow through nanopores of 45 nm height 
and 62 nm in diameter described by equation (4.4) [136]: 
???? = ? ∙ ? ?(?)√2????  (4.4) 
Where, Fmol is the flow conductance in the molecular flow regime, i.e. [mole·s-1·Pa-1], A is the 
total membrane surface area [m2], ε is the porosity, M is the gas molecular weight [kg·mole-1], 
R is the gas constant [J·mol-1·K-1], T is the temperature [K] and w(x) is the Clausing function 
that considers the collisions of gas molecules with the walls of the pore and it is related to its 
geometry. The Clausing function, w(x) is the probability, or more precisely the reciprocal of 
this probability, ?(?) = 1 − ?(?), that is related to the distribution of collisions of molecules 
with the walls of the system, related to the geometry of the pore. In other words, it estimates 
how easy it is for a molecule to exit the geometry. We decided to use the correction factor due 
to the shape of the pore which may influence the gas mobility through the aperture. In our case 
we have considered a pyramidal geometry corresponding to the 3rd generation open fractal 
structure. The Clausing function, w(x), for conical orifices according to the conical geometry 
described by Lobo et al. with the angle of the pyramid 30 degrees, and L=495 nm, R0=100 nm, 
has a value of 0.90814 [135, 137]. This value is higher compared to the one for cylinders, which 
means that the probability to exit the cone is higher compared to cylinder. 
Chapter IV 
 
138 
 
  
Figure 4.7 Experimental and theoretical permeation of O2 in Chip 1 
      
Figure 4.8 Experimental and theoretical permeation of O2 and CO2 in Chip 2 
The theoretical calculations showed that the experimental values are approximately 30-40% 
lower than the predictions. This might be due to the difficulty in estimating the real amount of 
truly open apertures/nanonozzles. Some nanonozzles could be closed or not fully opened due 
to the fabrication procedure. Figure 4.9 illustrates the High Resolutions Scanning Electron 
Microscopy photographs with different types of fabrication defects. Some fractals possessed:  
1) most of the apertures closed with one huge opening (see Figure 4.9 A and B), 2) lower 
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aperture diameter than it was estimated (Figure 4.9 C) or 3) not all the fractals were fully opened 
(Figure 4.9 D). The opening was indicated by the square around the fractals. 
 
Figure 4.9 HRSEM images of 3rd generation fractals defects resulting from fabrication procedure. A), B) closed 
fractal apertures with one big opening, C) pore diameter lower than 80 nm, and D) top view of the channel section 
with fractals-square shape around the fractal indicate full opening 
What is more, in case of Knudsen diffusion mechanism (see equation 4.4), the permeation 
of the gas depends on its type, particularly on its molecular weight (M) because the flow is 
inversely proportional to the square root of the M. As expected in the Knudsen regime, the 
diffusion of smaller molecules through the pores is faster than larger molecules, i.e. oxygen is 
faster than carbon dioxide. According to equation (4.5) the ideal selectivity of O2 over CO2 
should be 1.2, whereas we found a slightly higher value of 1.6. 
? ????? = ? ??????? = ?4432 = 1.2 (4.5) 
The permeation values obtained, in the order of 10-7 mole/m2·s·Pa are high in comparison 
to polymeric materials such as PDMS, with a permeability values of 334 Barrer and 849 Barrer 
for O2 and CO2, respectively [132]. Table 4.3 shows the experimentally obtained fluxes of O2 
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and CO2 in two chips as a function of Pmean and their corresponding theoretical thicknesses of 
the PDMS film. It is seen from the Table that a membrane film of just 1-4 micrometers would 
be required to get the same permeation flux as the nanonozzles presented here (but such thin 
PDMS membrane cannot be handled).  
Table 4.3 O2 and CO2 permeation fluxes in the 3D fractal chips as a function of mean 
pressure and corresponding theoretical PDMS membrane thickness 
Pmean·10-5 
[Pa]  PO2 [mol/m
2∙s∙Pa] 
 Equivalent 
PDMS 
thickness [μm] 
PCO2 
[mol/m2∙s∙Pa] 
Equivalent 
PDMS 
thickness [μm] 
   Chip 1             Chip 2     O2        Chip 2       CO2 
1.38 8.79·10-8 1.02·10-7 1.12 6.48·10-8 4.1 
1.48 9.31·10-8 1.06·10-7 1.07 6.31·10-8 4.2 
1.58 9.34·10-8 9.88·10-8 1.09 6.10·10-8 4.3 
1.7 9.48·10-8 9.85·10-8 1.08 6.46·10-8 4.1 
1.8 1.08·10-7 9.46·10-8 1.00 6.26·10-8 4.2 
1.9 1.18·10-7 1.01·10-7 0.93 5.96·10-8 4.4 
Furthermore, if, theoretically, the fractal chip could be used as an alternative to PDMS 
microdevice for blood oxygenation, some theoretical calculations would have to be performed 
in order to fulfil the artificial lung approach. For instance, in order to achieve 1.9 mL of O2 per 
minute in blood at a blood flow rate of 30 mL/min (see blood oxygenation requirements in 
Chapter 1 section 1.3) that is 1.4·10-11 mole/m2·s·Pa, it is necessary to have approximately 2500 
fractals in the chip, taking into account the permeation of O2 that was obtained through fractal 
nanoapertures. The example of such calculation is presented below: 
??_???? = ??_????????  (4.6) 
?????? = ???? ∙ ??_??????  (4.7) 
Where, SA_lung is the surface area Artificial Lung [cm2], O2_blood is the blood oxygenation 
requirement [mL/min] Frlung- number of fractals in Artificial Lung, nrfr are the fractals in the 
fabricated chip (Chip 1 or Chip 2) and SA is the surface area of the current chip (Chip 1 or Chip 
2) [cm2] 
Finally, 2500 of fractals would have to be embedded in the channel in order to fulfil the 
requirements presented above. 
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4.5. Conclusions 
In this chapter, we have validated the concept of a new 3D membrane structure incorporated 
in a chip for gas transfer to a microfluidic channel. We measured experimentally and calculated 
theoretically the permeation of oxygen and carbon dioxide. The chip presented by our group is 
characterized by portability, low consumption of reagents, increased contact surface area, 
mechanical stability since the membrane is made of a silicon wafer. Thus, there is no risk of a 
thin film deflection or material swelling. Moreover, due to the compactness of the system, the 
distance for gas diffusion was extremely reduced which resulted in decreased travelling time 
and path. The average permeation obtained from the fractal chips is approximately 9.95·10-8 
mol/m2·s·Pa and 6.26·10-8 mol/m2·s·Pa for O2 and CO2 respectively. This approach could work 
as an alternative to PDMS thin films since the membrane thickness corresponding to the 
equivalent fractal gas permeation is in the range 1-4 μm making it impossible to fabricate and 
handle.  
Other applications apart from the single gas permeation tested here include gas-liquid 
contactors, where the 3D structure presents an advantage due to the higher surface to volume 
ratio compared to 2D membranes, and also application requiring high temperatures and gas 
distribution or removal such as micromembrane microreactors [138]. 
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5. Conclusions 
5.1. How far we have reached? 
The main scope of the work conducted in this thesis was to design and fabricate microfluidic 
devices with integrated membrane and to validate them for various biomedical applications. 
The gained experience and results brought us to the following conclusions: 
• In the design of lung-on-a-chip, the synergistic effect of various parameters has to be 
carefully considered. The microfluidic liquid structure plays a crucial role in the 
oxygenation and general performance of the microdevice. High oxygen transfer rate, 
low pressure drop, and shear stress, homogenous liquid flow, biocompatibility, low 
priming volume and high surface to volume ratio are the main parameters that define a 
perfect artificial lung.  
• The liquid chamber of the PDMS devices fabricated in this thesis, either alveolar type 
or meander type design, exhibit homogenous blood flow profile, low pressure drop and 
shear stress for similar operational conditions to those previously reported in the 
scientific literature. The surface properties of PDMS microfluidic channels and 
membrane integrated in the chip have been successfully modified into more hydrophilic 
one to prevent the fibrinogen adhesion. The preliminary evaluation of RBCs viability 
after the oxygenation experiments proofs that the haemodynamics of the designed 
devices, i.e. shape and dimensions of the liquid channels, did not negatively affect the 
blood.  
• The modelling of the oxygen transfer process on the main units of the microfluidic 
devices clearly underlines the importance of the branching architecture and flow 
distributors allocation within the liquid chamber.  
• We have learnt that the main controlling resistance to O2 transport in the gas-liquid 
membrane contactor is located in the liquid phase, i.e. diffusion distance of dissolved 
oxygen. In general, the membrane permeation properties (permeability values, thickness 
of the selective layer) play a secondary role in the oxygenation process that become 
more notorious when shortening the diffusion pathways. In general, the thinner the 
membrane and the narrower the blood channel, the faster and more profound the 
oxygenation. Nevertheless, pressure drop across the geometry and fabrication constrains 
have to be taken into account to establish the scaling limits in the design of the future 
chips with enhanced performance. 
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• The alveolar design 2 (AD2) device exhibited 108 mL/min·m2 O2 transfer rate at 1 
mL/min blood flow rate and was characterized by low priming volume, i.e. 39 μL, high 
surface-to-volume ratio, i.e. 35 cm-1 and low pressure drop of 1.3 mbar at 1 mL/min 
blood flow rate. These values are in the range of J.A. Potkay results and much higher 
that the results obtained by the group of Fusch and Vacanti, i.e. 12 mL/min·m2 and 30 
mL/min·m2, respectively. 
• The application of a gas-ionic liquid membrane microcontactor for the on-line removal 
of CO2 demonstrated how effective the miniaturized devices can be for the fundamental 
studies of anaesthesia gas recovery. The individual mass transfer resistance of the dense 
PDMS membrane for the CO2 transport through the PDMS microfluidic device accounts 
for less than 20% of the total value. Thanks to miniaturization, the volume of ionic liquid 
required to fill the micro – chamber and the amount of enzyme were notably reduced 
while providing high throughput for the preliminary screening of different ionic liquid-
enzyme formulations at several working conditions. 
• The combination of cholinium propionate ionic liquid with carbonic anhydrase enzyme 
leads to high CO2 capturing effect and provides an enhancement factor up to 1.9 in CO2 
removal using very small concentration of enzyme 0.1 mgCA/gIL due to the stabilizing 
role of cholinium based ionic liquid. The CO2/Xe molar flux ratio after addition of the 
ionic liquid and the enzyme is as high as 3.3 compared to 1.4 ideal selectivity obtained 
using the PDMS membrane. 
• The study of gas permeation properties of a microfluidic silicon/glass chip with an 
integrated silicon oxide membrane in the form of three-dimensional fractal geometry 
with nanopores reveals that the transport mechanism is governed by Knudsen diffusion. 
Lower resistance to mass transfer in comparison to commonly used PDMS dense 
membranes is obtained, due to the hierarchical branched structure of the fractals, and 
infinitesimal thickness of the opened pores.  
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5.2. Future scope: where can we go from here? 
Further research should consider improvements of the microfluidic device designs, 
materials development as well as additional experimental procedures to increase the 
reproducibility of the results. 
• In the microfluidic device, designing and fabricating the alveolar chamber with various 
liquid channel depths within one geometry would be beneficial. The liquid chamber 
fabricated by micro machining technology used by Hoganson et al [35] demonstrated 
significantly lower pressure drop and shear stress due to the controlled depth of the 
channels, especially at the inlet of the structure, in comparison to the geometries with 
constant depths. 
• Exploring novel system architectures, i.e. porous or corrugated membranes assembled 
in a 3D bundle, which would further increase the surface-to-volume ratio is really 
promising. 
• In the anaesthetic gas recovery experiments, alternative non-permeable materials with 
higher mechanical resistance for the fabrication of microfluidic chambers should be 
considered. This would avoid the gas permeation from the system through the PDMS 
chambers to the surroundings. Moreover, the experimental system could be upgraded in 
order to allow the regeneration and recirculation of ionic liquid for closed loop 
operation. The selectivity of CO2/N2 as well as the recovery of Xe in the real anaesthetic 
gas mixture should be also measured. Moreover, it would be beneficial to monitor the 
effect of higher concentration of CA enzyme on the CO2 capture. 
• Fractal geometry could be used for G-G or G-L contact at harsh conditions upon further 
optimization of the nanopores opening step. Computer modelling would help to predict 
the advantageous fractal distribution across the channel and the necessary number of 
opened apertures in order to satisfy the criteria design. 
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Conclusiones: ¿Hasta donde hemos llegado? 
El objetivo principal del trabajo realizado en esta tesis fue diseñar y fabricar dispositivos 
microfluídicos con membrana integrada y evaluar su comporamiento como contactores gas-
líquido en dos aplicaciones biomédicas. Así pues, la experiencia adquirida y los resultados 
obtenidos han permitido formular las siguientes conclusiones: 
• El diseño del microdispositvo “lung-on-a-chip” ha de considerar microcanales en los 
que las células y plaquetas experimenten  presiones, esfuerzos rasantes y ángulos de 
ramificación que emulen las del cuerpo humano. La estructura microfluídica para la 
cámara del líquido desempeña un papel clave en el proceso de oxigenación y en el 
rendimiento global del dispositivo. Las principales características que definen un 
pulmón artificial perfecto son: alta tasa de transferencia de oxígeno, baja caída de 
presión y esfuerzo cortante, flujo homogéneo de sangre, biocompatibilidad, bajo 
volumen de cebado y alta relación superficie/volumen. 
• La cámara de líquido de los dispositivos PDMS fabricados en esta tesis, ya sea de tipo 
alveolar o de meandro, exhiben un perfil de flujo sanguíneo homogéneo, baja caída de 
presión y tensión de cizalla para condiciones operativas similares a las informadas 
previamente en la literatura científica. Las propiedades de superficie de los canales de 
microfluidos PDMS y la membrana integrada en el chip se han modificado con éxito en 
uno más hidrofílico para evitar la adhesión de fibrinógeno. La evaluación preliminar de 
la viabilidad de los glóbulos rojos después de los experimentos de oxigenación prueba 
que la hemodinámica de los dispositivos diseñados, es decir, la forma y las dimensiones 
de los canales de líquido, no afectaron negativamente a la sangre. 
• El modelado del proceso de transferencia de oxígeno en las unidades principales de los 
dispositivos microfluídicos subraya claramente la importancia de la arquitectura de 
bifurcación y la distribución de los distribuidores del flujo dentro de la cámara de 
líquido. 
• Hemos aprendido que la resistencia de control principal al transporte de O2 en el 
contactor de la membrana gas-líquido se encuentra en la fase líquida, es decir, la 
distancia de difusión del oxígeno disuelto. En general, las propiedades de permeación 
de la membrana (valores de permeabilidad, espesor de la capa selectiva) juegan un papel 
secundario en el proceso de oxigenación que se vuelve más notorio cuando se acortan 
las vías de difusión. En general, cuanto más delgada es la membrana y más estrecho es 
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el canal de sangre, más rápida y más profunda es la oxigenación. Sin embargo, la caída 
de presión en la geometría y las restricciones de fabricación deben tenerse en cuenta 
para establecer los límites de escala en el diseño de los futuros chips con un rendimiento 
mejorado. 
• El dispositivo de diseño alveolar 2 (AD2) exhibió una tasa de transferencia de 108 
mL/min·m2 de O2 a un flujo sanguíneo de 1 mL/min y se caracterizó por un bajo 
volumen de cebado, es decir, 39 μL, alta relación superficie/volumen, 35 cm-1 y baja 
caída de presión de 1.3 mbar a un caudal de sangre de 1 mL/min. Estos valores 
experimentales están en el rango de J.A. Potkay y mucho más alto que los resultados 
obtenidos por el grupo de Fusch y Vacanti, es decir, 12 mL/min·m2 y 30 mL/min·m2, 
respectivamente. 
• La aplicación de un microcontactor de membrana líquida gaseosa para la eliminación 
en línea de CO2 demostró cuán efectivos pueden ser los dispositivos miniaturizados para 
los estudios fundamentales de recuperación de gas anestésico. La resistencia de 
transferencia de masa individual de la membrana PDMS densa para el transporte de CO2 
a través del dispositivo microfluídico PDMS representa menos del 20% del valor total. 
Gracias a la miniaturización, el volumen de líquido iónico requerido para llenar la 
microcámara y la cantidad de enzima se redujeron notablemente al tiempo que 
proporcionaban un alto rendimiento para el cribado preliminar de diferentes 
formulaciones de líquidos iónicos-enzimas en diversas condiciones de trabajo. 
• La combinación de líquido iónico de propionato de colina con enzima anhidrasa 
carbónica conduce a un alto efecto de captura de CO2 y proporciona un factor de mejora 
de hasta 1.9 en la eliminación de CO2 utilizando una concentración muy pequeña de 
enzima 0.1 mgCA/gIL debido al papel estabilizador del líquido iónico a base de colinio. 
La relación de flujo molar CO2/Xe después de la adición del líquido iónico y la enzima 
es tan alta como 3.3 en comparación con la selectividad ideal 1.4 obtenida utilizando la 
membrana PDMS. 
• El estudio de las propiedades de permeación de gas de un chip microfluídico de 
silicio/vidrio con una membrana de óxido de silicio integrada en forma de geometría 
fractal tridimensional con nanoporos revela que el mecanismo de transporte se rige por 
la difusión de Knudsen. Se obtiene una menor resistencia a la transferencia de masa en 
comparación con las membranas densas PDMS comúnmente utilizadas, debido a la 
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estructura ramificada jerárquica de los fractales, y al grosor infinitesimal de los poros 
abiertos.  
Trabajo futuro 
La investigación futura debería considerar mejoras en los diseños de los microdispositivos, 
en la propuesta y desarrollo de nuevos  materiales y experimentación adicional  para corroborar 
la reproducibilidad y representatividad de los resultados ya obtenidos. Algunas de estas 
propuestas se comentan a continuación: 
• En el microdispositivo, sería beneficioso diseñar y fabricar la cámara de la fase líquida 
con varias profundidades dentro del mismo  microcanal conforme el fluido avanza. La 
cámara de líquido fabricada por la tecnología de micro mecanizado utilizada por 
Hoganson et al [35] demostró una caída de presión y un esfuerzo cortante 
significativamente más bajos debido a la profundidad controlada de los canales, 
especialmente en la entrada de la estructura, en comparación con las geometrías 
comúnmente estudiadas de profundidad constante. 
• Explorar nuevas arquitecturas de sistemas, es decir, membranas porosas o corrugadas 
ensambladas en un paquete 3D, que aumentaría aún más la relación superficie-volumen 
es realmente prometedor. 
• En los experimentos de recuperación de gas anestésico, se deben considerar materiales 
alternativos no permeables con mayor resistencia mecánica para la fabricación de 
cámaras microfluídicas. Esto evitaría la penetración de gas del sistema a través de las 
cámaras de PDMS a los alrededores. Además, el sistema experimental podría 
actualizarse para permitir la regeneración y la recirculación del líquido iónico para el 
funcionamiento en circuito cerrado. También se debe medir la selectividad de CO2/N2 
así como la recuperación de Xe en la mezcla de gas anestésico real. Además, sería 
beneficioso controlar el efecto de una mayor concentración de enzima CA en la captura 
de CO2. 
• La geometría fractal podría usarse para contacto G-G o G-L en condiciones adversas 
con una mayor optimización de la etapa de apertura de nanoporos. El modelado por 
computadora ayudaría a predecir la distribución fractal ventajosa a través del canal y el 
número necesario de aperturas abiertas para satisfacer el diseño de los criterios. 
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Conclusões: até onde chegamos? 
O escopo principal do trabalho realizado nesta tese foi projetar e fabricar microdispositivos 
com membrana integrada e testá-los para várias aplicações biomédicas. A experiência adquirida 
e os resultados nos trouxeram as seguintes conclusões: 
• No projeto de lung-on-a-chip, o efeito sinérgico de vários parâmetros deve ser 
cuidadosamente considerado. A estrutura líquida microfluídica desempenha um papel 
crucial na oxigenação e no desempenho geral do microdispositivo. A alta taxa de 
transferência de oxigênio, baixa queda de pressão e tensão de cisalhamento, fluxo de 
líquido homogêneo, biocompatibilidade, baixo volume de iniciação e alta relação 
superfície/volume são os principais parâmetros que definem um pulmão artificial 
perfeito. 
• A câmara de líquido dos dispositivos PDMS fabricados nesta tese, de tipo alveolar ou 
de tipo meandro, apresentam perfil de fluxo sanguíneo homogêneo, baixa queda de 
pressão e tensão de cisalhamento para condições operacionais semelhantes às 
anteriormente relatadas na literatura científica. As propriedades superficiais dos canais 
microfluídicos PDMS e a membrana integrada no chip foram modificadas com sucesso 
em mais hidrofílicas para evitar a adesão do fibrinogênio. A avaliação preliminar da 
viabilidade dos RBCs após os experimentos de oxigenação prova que a hemodinâmica 
dos dispositivos projetados, ou seja, a forma e as dimensões dos canais líquidos, não 
afetou negativamente o sangue. 
• A modelagem do processo de transferência de oxigênio nas unidades principais dos 
dispositivos microfluídicos sublinha claramente a importância da arquitetura de 
ramificação e distribuição dos distribuidores de fluxo dentro da câmara de líquido. 
• Aprendemos que a principal resistência ao transporte de O2 no contator de membrana 
gás-líquido está localizada na fase líquida, isto é, a distância de difusão do oxigênio 
dissolvido. Em geral, as propriedades de permeação da membrana (valores de 
permeabilidade, espessura da camada seletiva) desempenham um papel secundário no 
processo de oxigenação que se tornam mais notórios quando encurta as vias de difusão. 
Em geral, quanto mais fina a membrana e mais estreita o canal de sangue, mais rápida 
e profunda é a oxigenação. No entanto, a queda de pressão através da geometria e as 
restrições de fabricação devem ser levadas em consideração para estabelecer os limites 
de escala no design dos futuros chips com desempenho aprimorado. 
Chapter V 
 
152 
 
• O dispositivo de design alveolar 2 (AD2) exibiu taxa de transferência de O2 de 108 
mL/min·m2 a 1 mL/min de fluxo sanguíneo e foi caracterizada por baixo volume de 
iniciação, ou seja, 39 μL, alta relação superfície/volume, 35 cm-1 e baixa queda de 
pressão de 1.3 mbar a 1 mL/min de fluxo sanguíneo. Estes valores estão no intervalo de 
los resultados de J.A. Potkay e muito maior que os resultados obtidos pelo grupo de 
Fusch e Vacanti, isto é, 12 mL/min·m2 e 30 mL/min·m2, respectivamente. 
• A aplicação de um microcontactor de membrana líquida gás-iônica para a remoção on-
line de CO2 demonstrou a eficácia dos dispositivos miniaturizados para os estudos 
fundamentais de recuperação de gás de anestesia. A resistência individual à 
transferência de massa da membrana PDMS densa para o transporte de CO2 através do 
dispositivo microfluídico PDMS representa menos de 20% do valor total. Graças à 
miniaturização, o volume de líquido iónico necessário para preencher a microcámara e 
a quantidade de enzima foram notadamente reduzidos, proporcionando alta produção 
para a triagem preliminar de diferentes formulações de enzimas líquidas iónicas em 
várias condições de trabalho. 
• A combinação de líquido iónico de propionato de colólio com enzima de anidrase 
carbônica leva a um alto efeito de captura de CO2 e fornece um fator de aprimoramento 
até 1.9 em remoção de CO2 usando uma concentração muito pequena de enzima 0.1 
mgCA/gIL devido ao papel estabilizador do líquido iónico baseado em colinio. A 
relação de fluxo molar CO2/Xe após a adição do líquido iônico e a enzima é tão alta 
quanto 3.3 em comparação com 1.4 seletividade ideal obtida usando a membrana 
PDMS. 
• O estudo das propriedades de permeação de gás de um chip de microfilfo de silício/vidro 
com uma membrana integrada de óxido de silício na forma de geometria fractal 
tridimensional com nanopores revela que o mecanismo de transporte é governado pela 
difusão de Knudsen. É obtida menor resistência à transferência de massa em 
comparação com as membranas densas PDMS comumente usadas, devido à estrutura 
hierárquica ramificada dos fractals e à espessura infinitesimal dos poros abertos. 
 
 
 
 
Conclusions 
 
153 
 
Trabalho futuro 
Outras pesquisas devem considerar melhorias nos projetos de dispositivos microfluídicos, 
desenvolvimento de materiais e procedimentos experimentais adicionais para aumentar a 
reprodutibilidade dos resultados. 
• No dispositivo microfluídico, o projeto e fabricação da câmara com várias 
profundidades de canais líquidos dentro de uma geometria seria benéfico. A câmara de 
líquido fabricada pela tecnologia de micro-usinagem utilizada por Hoganson et al [35] 
demonstrou queda de pressão e tensão de cisalhamento significativamente menores 
devido à profundidade controlada dos canais, especialmente na entrada da estrutura, em 
comparação com as geometrias com profundidades constantes. 
• A exploração de novas arquiteturas de sistemas, ou seja, membranas porosas ou 
onduladas montadas em um feixe 3D, o que aumentaria ainda mais a relação 
superfície/volume é realmente promissor. 
• Nas experiências de recuperação de gás anestésico, devem ser considerados materiais 
alternativos não permeáveis com maior resistência mecânica para a fabricação de 
câmaras microfluídicas. Isso evitaria a permeação do gás do sistema através das câmaras 
PDMS para os ambientes. Além disso, o sistema experimental pode ser atualizado para 
permitir a regeneração e recirculação do líquido iônico para operação em circuito 
fechado. A selectividade de CO2/N2, bem como a recuperação de Xe na mistura de gás 
anestésico real também devem ser medidas. Além disso, seria benéfico monitorar o 
efeito de maior concentração de enzima CA na captura de CO2. 
• A geometria Fractal pode ser usada para contato G-G ou G-L em condições difíceis após 
otimização do passo de abertura de nanopores. A modelagem de computador ajudaria a 
prever a distribuição fractal vantajosa através do canal e o número necessário de 
aberturas abertas para satisfazer o design dos critérios. 
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Conclusies: hoe ver zijn we gekomen? 
Het hoofddoel van het uitgevoerde werk in dit proefschrift was het ontwerpen en fabriceren 
van microapparaten met een geïntegreerd membraan en het testen van deze apparaten voor een 
aantal biomedische applicaties. The opgedane ervaring en resultaten brengt ons tot de volgende 
conclusies: 
● In het ontwerp van lung-on-a-chip is het synergetische effect van verschillende 
variabelen opgemerkt. De microfluidische vloeistofstructuur speelt een cruciale rol in 
het oxygeniseren en de algemene werking van het microapparaat. Hoge zuurstof 
transfersnelheid, laag verlies van druk en schuifspanning, homogene vloeistofstroom, 
biocompatibiliteit, een laag vulvolume en een hoge oppervlakte-volume verhouding zijn 
de voornaamste variabelen die een perfecte kunstlong defineren. 
● De vloeistofkamer van de PDMS-apparaten vervaardigd in dit proefschrift, ofwel het 
alveolaire type ofwel het meander-type ontwerp, vertonen een homogeen 
bloedstroomprofiel, lage drukval en schuifspanning voor vergelijkbare operationele 
omstandigheden als die eerder gerapporteerd in de wetenschappelijke literatuur. De 
oppervlakte-eigenschappen van PDMS microfluïdische kanalen en membraan 
geïntegreerd in de chip zijn met succes gemodificeerd in meer hydrofiele om de 
fibrinogeen-adhesie te voorkomen. De voorlopige evaluatie van de levensvatbaarheid 
van de rode bloedcellen na de oxygenatie-experimenten bewijst dat de hemodynamiek 
van de ontworpen apparaten, d.w.z. vorm en afmetingen van de vloeistofkanalen, het 
bloed niet negatief beïnvloedde. 
● Het modelleren van het zuurstofoverdrachtsproces op de hoofdeenheden van de 
microfluïdische apparaten onderstreept duidelijk het belang van de 
vertakkingsarchitectuur en verdeling van stroomverdelingen in de vloeistofkamer. 
● We hebben geleerd dat de belangrijkste besturingsweerstand tegen O2-transport in de 
gas-vloeistofmembraancontactor zich in de vloeistoffase bevindt, d.w.z. diffusieafstand 
van opgeloste zuurstof. In het algemeen spelen de membraanpermeatie-eigenschappen 
(permeabiliteitswaarden, dikte van de selectieve laag) een secundaire rol in het 
oxygenatieproces dat berucht wordt bij het verkorten van de diffusiepaden. Over het 
algemeen geldt: hoe dunner het membraan en hoe smaller het bloedkanaal, des te sneller 
en dieper de oxygenatie. Niettemin moet rekening worden gehouden met drukdaling 
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over de geometrie en fabricagebeperkingen om de schaalgrenzen voor het ontwerp van 
de toekomstige chips met verbeterde prestaties vast te stellen. 
● Het alveolaire ontwerp 2 (AD2) apparaat vertoonde een overdrachtssnelheid van 108 
mL/min·m2 O2 bij een bloeddoorstroming van 1 mL/min en werd gekenmerkt door een 
laag priming volume, dwz 39 μL, een hoge oppervlakte-volume-verhouding, dat wil 
zeggen 35 cm-1 en lage drukval van 1.3 mbar bij 1 mL/min bloedstroom. Deze waarden 
liggen in het bereik van J.A. Potkay-resultaten en veel hoger dan de resultaten verkregen 
door de groep van Fusch en Vacanti, d.w.z. respectievelijk 12 mL/min·m2 en 30 
mL/min·m2. 
● De toepassing van een gasionische vloeistofmembraamicrocontactor voor de on-line 
verwijdering van CO2 heeft aangetoond hoe effectief de geminiaturiseerde apparaten 
kunnen zijn voor de fundamentele onderzoeken naar de terugwinning van anesthesiegas. 
De individuele massaoverdrachtsweerstand van het dichte PDMS-membraan voor het 
CO2-transport door het PDMS microfluïdische apparaat neemt minder dan 20% van de 
totale waarde voor zijn rekening. Dankzij de miniaturisatie was het volume ionische 
vloeistof dat nodig was om de microkamer en de hoeveelheid enzym te vullen 
aanzienlijk verminderd, terwijl het een hoge doorvoer bood voor de voorlopige 
screening van verschillende ionische vloeistof-enzymformuleringen onder 
verschillende werkomstandigheden. 
● De combinatie van choliniumpropionaat-ionische vloeistof met koolzuuranhydrase-
enzym leidt tot een hoog CO2 -vangend effect en biedt een versterkingsfactor tot 1.9 in 
CO2-verwijdering met een zeer kleine concentratie van 0.1 mgCA / gIL enzym als 
gevolg van de stabiliserende rol van op cholinium gebaseerde ionische vloeistof. De 
CO2/Xe molaire fluxverhouding na toevoeging van de ionische vloeistof en het enzym 
is zo hoog als 3.3 vergeleken met 1.4 ideale selectiviteit verkregen met behulp van het 
PDMS-membraan. 
● De studie van gaspermeatie-eigenschappen van een microfluïdische silicium/glas-chip 
met een geïntegreerd siliciumoxidemembraan in de vorm van een driedimensionale 
fractale geometrie met nanoporiën, laat zien dat het transportmechanisme wordt bepaald 
door Knudsen-diffusie. Lagere weerstand tegen massaoverdracht in vergelijking met 
veelgebruikte PDMS dichte membranen wordt verkregen, vanwege de hiërarchische 
vertakte structuur van de fractals, en de kleinste dikte van de geopende poriën. 
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Toekomstige rijkwijdte: Waar kunnen we vanaf hier gaan? 
Toekomstig onderzoek dient te kijken naar verbeteringen van het microfluïdisch apparaat 
ontwerp en materiaal ontwikkeling. Ook dient er gekeken te worden naar verder experimenten 
om de reproduceerbaarheid van de resultaten te vergroten. 
● Het kan voordelig zijn om de kamer in het microfluïdische apparaat met verschillende 
kanaaldieptes en geometrieën te ontwerpen. De door Hoganson et al [35] gebruikte 
microverspaning technologie liet significant minder drukverlies en schuifspanning zien 
door de gecontroleerde diepte van de kanalen, met name bij de inlet van de structuur, 
ten opzichte van de geometrieën met constante dieptes. 
● Onderzoek naar nieuwe systeemarchitecturen, d.w.z. poreuze of gegolfde membranen 
geassembleerd in een 3D-bundel, waardoor de oppervlakte-volume-verhouding nog 
veelbelovend zou zijn. 
● In de anesthetische experimenten voor gaswinning moeten alternatieve niet-permeabele 
materialen met hogere mechanische weerstand voor de fabricage van microfluïdische 
kamers worden overwogen. Dit zou de gaspermeatie van het systeem via de PDMS-
kamers naar de omgeving voorkomen. Bovendien zou het experimentele systeem 
kunnen worden opgewaardeerd om regeneratie en recirculatie van ionische vloeistof 
mogelijk te maken voor gesloten luswerking. De selectiviteit van CO2/N2 evenals het 
herstel van Xe in het echte anesthetische gasmengsel moet ook worden gemeten. 
Bovendien zou het nuttig zijn om het effect van een hogere concentratie van CA-enzym 
op de CO2 -afvang te volgen. 
● Fractale geometrie zou kunnen worden gebruikt voor contact met G-G of G-L onder 
barre omstandigheden bij verdere optimalisatie van de openingstap van de nanoporiën. 
Computermodellering zou helpen om de voordelige fractieverdeling over het kanaal en 
het benodigde aantal geopende openingen te voorspellen om aan het ontwerp van de 
criteria te voldoen.
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Corner lithography 
The method of engineering of a 3D fractal structure is based on a combination of anisotropic 
etching of silicon and corner lithography. Corner lithography is a technique that allows 
production of truly three-dimensional features. It uses conformal deposition of layers of silicon 
nitride by low-pressure chemical vapour deposition (LPCVD), and thermal oxide and partly 
back-etching of a silicon nitride layer that is placed inside the octahedral silicon pits in order to 
form dots in sharp concave corners. The crystalline property of silicon and a gradual etching 
characteristic of its (111) planes result in the formation of octahedral cavities. Repeated corner 
lithography, in combination with anisotropic etching, results in the construction of 3D 
octahedral fractals where the number of layers can be controlled.  
Fractal fabrication procedure 
Silicon dioxide (SiO2) thermal growing 
The fractal fabrication procedure starts with a (100) plane single crystalline silicon wafer 
having a layer of thermally grown silicon dioxide (SiO2). The thickness of the grown oxide 
layer should be equal on the silicon (100) and (111) crystal planes because it affects the oxide 
growth speed. 
The oxidation of silicon is achieved by (dry) thermal oxidation at 1100oC. Such high 
oxidation temperature leads to the differences in grown oxide in terms of layer thickness on 
(100) and (111) silicon crystal planes in comparison to low oxidation temperatures (≤ 950oC). 
At temperatures lower or equal to 950oC, the oxide thickness is thinner at convex and concave 
corners than a flat (100) Si planes. However, there is a difference in oxide growth speed on the 
main crystal directions of silicon. The amount of intersecting (111) planes influences the degree 
of sharpening of the thermal oxide layer in the concave corners. Generally, the more the 
intersecting planes, the thinner the grown oxide layer. Therefore, in ribbons – i.e. two 
intersecting (111) planes – less oxide sharpening occurs in comparison to an intersection of 
three or four (111) planes (i.e. apices). Such process is presented in Figure A.0.1. 
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Figure A.0.1 Selective opening of the thermally grown silicon oxide at the apex of the pyramidal pit after HF 
etching [139] 
Patterning and creating 3D structures 
Silicon wafer with thermally grown silicon dioxide was patterned in buffered hydrofluoric 
acid (BHF) using a resist mask with a regular pattern of holes (25 μm diameter and 25 μm 
periodicity). The silicon which was unprotected, was anisotropically etched in a potassium 
hydroxide (KOH) in order to create a pyramidal etch pits. The remaining oxide mask was 
stripped. Next, the wafer was uniformly coated with 160 nm of low-pressure chemical vapour 
deposited silicon nitride. The next step, called corner lithography, was used to remove the 
nitride in hot phosphoric acid (H3PO4) and to leave it only in the corner of the pyramid (see 
Figure A.0.2 C). The thin oxide was used to protect the silicon from erosion by the H3PO4. The 
following step was the process called LOCOS (LOCal Oxidation of Silicon). In this stage 
silicon was locally oxidized at 1100oC during 45 min into 77 nm SiO2 using the nitride as a 
mask. The nitride in the corner of a pyramid was stripped and it created a single nanonozzle. 
Next, the unprotected silicon in the pyramidal apex was etched anisotropically during 125 min 
using tetra methyl ammonium hydroxide (TMAH) which formed a single octahedral shape 
feature at the vertex of the pyramid (Figure A.0.2 D). The size of the single octahedral feature 
was determined by the (111) silicon etch rate that was approximately 15-20 nm min-1. The 
zeroth level of processing was finished by stripping of SiO2 and depositing around 88 nm of 
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nitride. The entire process was repeated in order to create the first generation of substructures. 
To do that, the nitride was partly etched (Figure A.0.2 E), 77 nm of LOCOS was grown, and 
thin oxide and nitride were stripped in the vertices. Silicon was etched again in TMAH but this 
time only the half of the etching time was used. This procedure created five octahedra at the 
vertex corners of each octahedron of the previous step. However, the size of new created 
octahedra decreased by a half in comparison to the previous generation (Figure A.0.2 F). The 
cycle was repeated for the second and third level always creating the octahedra half in size in 
comparison to previous generation. The octahedral fractal fabrication scheme in the crystalline 
silicon is presented in Figure A.0.2.  
 
Figure A.0.2 Octahedral 3D fractal fabrication scheme in the crystalline silicon [133]
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